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Abstract 
 
Tissue engineering is a growing field of science that relies on the use of material chemistry, 
engineering, genetics, and cell biology to produce functional tissues for use in transplantation, 
drug testing and disease modelling.  Presently, there is an urgent need for a technology which 
would enable assembly of cells into 3-dimensional multilayered tissues. Current cell-assembly 
technologies rely on biodegradable polymer scaffolds to assemble cells into 3D structures and to 
support the cell mass of the growing tissue. The presence of these materials in tissues, however, 
lowers the cell density and the process of scaffold biodegradation results in accumulation of 
monomer byproducts within the tissue.  To overcome these issues we developed a scaffold free 
method of cell-assembly based on bio-orthogonal ligation reactions between oxyamine and 
ketone groups to form a stable oxime bond. The reaction is quick, specific and occurs under 
physiological conditions without a catalyst.  To deliver the bio-orthogonal functionalities onto 
cell surfaces, ketone- and oxyamine- functionalized lipids were incorporated into liposomes 
which were subsequently fused with cell membranes. The surface engineered cells were 
assembled into three-dimensional tissues. Using this approach, we were able to produce 
functional cardiac and liver tissues with variable thicknesses and cell orientations for drug testing 
as well as the complex 3D co-cultures of stem cells to study stem cell differentiation. The rapid 
bio-orthogonal cell ligation process also enables assembly of cells into co-culture spheroids in 
flow, inside a microchannel. The introduction of a bi-functional oxyamine crosslinker molecule 
allowed for the rapid crosslinking of ketone-functionalized cells into 3D tissues. This bio-
orthogonal click chemistry technology can be used with different cell types to produce 
customized tissues for applications in drug development and regenerative medicine.  
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Chapter 1 
Introduction: Application of Bio-orthogonal 
Chemistry in Tissue Engineering 
 
 
 
 
2 
 
1.0 The three-dimensional architecture of organs and tissues 
In the body, cells exist in a complex environment and are an integral part of all vital 
processes. Every second, millions of cells undergo division, migration, differentiation and 
apoptosis. Each of these processes is regulated through a number of intricate molecular 
mechanisms, which facilitate intercellular communication as well as communication between 
cells and the environment.1-3  Some cells, such as the red blood cells, are free-floating and 
circulate constantly inside the body, while others such as cardiomyocytes (the heart cells) and 
adipocytes (the fat cells) form tissues and organs. In a tissue, which in most cases is composed of 
different cells types, there exists a defined architecture, where cells are arranged in a specific 
structure serving to enhance functionality of the tissue. For example, the liver tissue is composed 
of multiple hexagonal units called lobules. This geometry allows for efficient exchange between 
the incoming materials and the secreted substances produced by the liver.4 Thus, the 
functionality of a specific organ depends entirely on the arrangement of cells in the tissue, their 
quantity, cell types and proportion. In order for organs to perform optimally, temporal 
coordination between the cells is required. For example, the heart’s pumping action is achieved 
through the simultaneous contraction of all cardiomyocytes which is coordinated through 
pacemaker cells.5 Therefore, effective cell-cell communication is crucial for the tissue to perform 
its physiological function. Such communication is achieved through both physical contact and 
cytokine exchange, which are regulated with integrin proteins, tight junction proteins called 
connexins and various other membrane receptors.6,7   
 For years, scientists worked to re-create functional tissues in vitro. In the emerging field 
of tissue engineering there have been multiple attempts to assemble single cells into a thick 
multicellular construct with defined architecture.8-13 The first tissue models were simple two-
3 
 
dimensional (2D) monolayers of cells grown in Petrie dishes.14,15 Later, with development of 
polymer technologies and invention of scaffolds, the formation of the first thick three-
dimensional tissues became possible.16,17 Areas of application for the engineered 3D tissues are 
numerous but this technology is especially important in transplantation medicine, drug testing 
and disease modeling (Figure 1.0). Below, I will describe how 3D tissue technology is used to 
solve problems specific to these fields.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.0: Areas of application for three-dimensional tissues. 3D tissues have become essential 
tools in biology and are currently used in the areas of transplantation, drug testing and disease 
modelling.  
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1.1 Areas of application for three-dimensional tissues. 
 
1.1.1 Transplantation 
 
A major problem encountered by medical professionals around the world today is a deficit of 
donor organs for transplantation. In 2006 alone, approximately 95,000 patients in North America 
were on the waiting list for organ transplants. Of those, only 28,140 patients received 
transplantations and 6120 died while waiting for an organ.18 The median waiting time for a 
kidney transplant in Ontario, Canada is 41 months.19 Such delays are caused by the lack of both 
living and deceased donors.  
Few individuals agree to donate their organs, whether it is because of potential health 
complications or their ethical views. Organ donation for children is especially complicated due to 
both ethical and consent issues.20  
Finding an appropriate donor for organ transplant is challenging. The organ must be of 
the right size and have suitable cell surface receptors to prevent an autoimmune response. Even 
after successful transplantation there is a high risk of rejection.21 Successfully transplanted 
patients have to receive expensive immunosuppressive therapy over the duration of their life.22 
The alternative supporting therapies such as dialysis used for kidney disorders are costly and  
significantly less effective than transplantation in terms of increasing the patient’s life 
expectancy as well as improving the quality of their life.23,24  
 Developing technologies that allow for the engineering of artificial organs and tissues 
will eliminate or reduce many problems associated with donor organ transplant. The custom-
made tissues will solve these issues by utilizing the patient’s own cells.25,26 This autologous 
5 
 
transplantation of artificial organs has potential to reduce the risk of autoimmunity and decrease 
the waiting time. Modern stem cell technologies are promising in terms of their ability to 
differentiate into a specific cell type. If assembled into 3D tissues with the right cell-assembly 
method, stem cells will become a powerful tool.27 Therefore, developing the universal cell-
assembly method is essential for the field of regenerative medicine.   
 
 
1.1.2 Drug Testing: 
 
Developing a new treatment for a specific condition is a long and expensive process. The 
average time for a drug to advance from bench to bedside is 17 years.28 The process starts with in 
vitro screening of the selected molecule for its ability to inhibit the receptor target. Following 
that, the molecule is tested for safety, first in cell culture and then in animal studies. Finally, the 
new drug is administered to human subjects in the three stages of clinical trials.  If the drug 
candidate demonstrates its efficiency in treating the condition as well as safety, it becomes 
approved for use as a treatment.29 The average cost to develop a new therapy is estimated to be 
close to 2.6 billion dollars.30 
Since most of the potential drug candidates fail animal or human trials due to 
cytotoxicity, it is critical to develop a powerful in vitro system that would be capable to 
accurately demonstrate potentially toxic effects the molecule may induce if administered to a 
patient.31  The current in vitro test systems are based on monolayers of cells cultured on plastic 
substrates.32 The environment of this two-dimensional cell monoculture is drastically different 
from those of the three-dimensional multicellular tissue. Since in 2D cultures cells behave 
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differently than they do in in vivo conditions, the cell response to a specific drug concentration 
may also vary.33 Therefore, it is important to create a functional three-dimensional tissue model 
containing the relevant cell types. The perfect model would recapitulate the 3D environment of 
tissue where cells would form functional intercellular connections while performing the same 
functions they perform in the body. 
 
1.1.3 A 3D Model for Intercellular Interactions 
 
Another important application of 3D co-cultures is to model cell-cell interactions in 
healthy and diseased tissues. Biological processes such as stem cell differentiation, 
organogenesis, cancer development, immune response and infections involve intercellular 
interactions between cells of different types.34-36 To study these processes biologists traditionally 
employed the standard animal models for in vivo and the 2D cell monoculture for in vitro 
experiments. Animals, such as transgenic mice with specific gene alterations have long been 
used to model disease manifestations and phenotypes similar to the conditions observed in 
humans.37 Although used to replicate many diseases, animal models show limitations when 
applied to conditions like sepsis where mice and humans with the same disease phenotype 
demonstrate significant differences in the underlying molecular mechanisms.38,39 This inability to 
efficiently mimic human disease with a single animal model drives the need to employ multiple 
animal models such as drosophila and Caenorhabditis elegans in the attempt to extrapolate the 
relevant data. The current 2D in vitro models, as mentioned above, are oversimplified and use a 
monoculture of cells which cannot recapitulate the organ-level structures including functions 
crucial for studying the intercellular interactions and their role in disease.40 
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 Recent efforts in the fields of chemistry, developmental biology and biological 
engineering have focused on creating complex functional multicellular 3D tissue models.41,42  
The perfect model would be flexible and allow alteration of parameters such as the types of cells 
used, their proportion, tissue thickness as well as cell orientation and distribution in the co-
culture. Such customized 3D tissue model will enable investigation of complex interactions 
between the cells in tissues and provide a universal platform to study pathologies.43,44 
Generating functional tissues for either transplantation, drug development or disease 
modeling is a challenging task which has attracted a lot of attention from specialists working in 
the fields of chemistry, bioengineering and developmental biology. To generate such tissues, one 
has to assemble single cells into a complex 3D structure. The challenge here is in in the fact that 
healthy non-cancerous cells in vitro grow as a single layer. Thus, one has to create a robust 
method for the bottom to top cell assembly that would “glue” cells together without damaging 
their function. In functional tissue, cells must be connected with tight junctions for intercellular 
transport of proteins and ions.45 In addition, the inner cell mass of thick tissues requires the 
supply of oxygen and nutrients, thus one has to induce the formation of blood vessels through the 
process of angiogenesis or by introducing pores or channels into the tissue architecture.46,47 
Although this task is challenging, recent advances in tissue engineering have produced promising 
results.48 The methods that will be reviewed in detail in this chapter are based on the use of 
natural, decellularized and polymer scaffolds, genetic engineering or employ our novel scaffold 
free bio-orthogonal tissue assembly technology which is the focus of this work.      
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1.2 Scaffolds and Biomaterials for Tissue Engineering. 
Cells are normally grown as a monolayer in a 2D environment of plastic flasks in vitro. 
However, in vivo the cells form complex multilayered 3D tissues. In order to obtain a complex 3 
dimensional co-culture of cells, scientists have utilized different approaches varying from casting 
cells into  polymer, ECM-based scaffolds via 3D printing or other means which can  form simple 
organoids from induced pluripotent stem cells (iPSC).49,50 Each method has its advantages and 
disadvantages which are described below.  
1.2.1 ECM-based scaffolds and hydrogels. 
The extracellular matrix is a protein meshwork secreted by cells into intercellular space which 
plays an important role in the structural integrity of tissues (Figure 1.2). It regulates cell-cell 
adhesion and recognition, facilitates cell motility and performs many other biological tasks. The 
ECM is present in every tissue, but its content varies significantly depending on tissue type.51 
Structural components of the ECM include collagen and fibronectin, proteins most extensively 
used for tissue engineering. The idea behind this method is to obtain a naturally-occurring 
biomaterial, which is native to tissues, and use it as scaffold to support cells. Since ECM proteins 
are naturally occurring, their application is supposed to lower the risk of cytotoxicity which is 
present in methods involving synthetic polymer scaffolds.52  
 Collagen suspensions can be processed to have different physical properties for different 
applications by changing their formulations. One type of collagen suspension called hydrogel is a 
soft and elastic form which can absorb water and be molded into various shapes. The hard and 
dry form of collagen matrix called IntegraTM serves as a wound dressing.53 The typical procedure 
of making collagen-based tissues involves mixing different types of cells with the liquid form of 
9 
 
collagen and then incubating the sample at 37oC for 30-60 min to induce crosslinking of collagen 
fibrils and harden the scaffold. The cells are trapped inside the scaffold where they easily adhere 
to collagen fibrils.54 Alternatively, the cells can be seeded on top of a dry scaffold, where they 
penetrate through the pores and adhere to the inside. Collagen is a biodegradable material and 
can be degraded via enzymatic action of metalloproteases.55 To obtain a wide range physical and 
biological properties collagen scaffolds often include different additives, such as growth factors, 
polymers, nanoparticles as well as other ECM components  including glycosaminoglycans.56 
Wang and Stegemann (2010) constructed a collagen-chitosan scaffold to induce osteogenesis in 
3D cultured bone marrow-derived human mesenchymal stem cells.57 It was established that 
addition of chitosan (a polysaccharide material derived from crustacean exoskeletons) improved 
the formation of the bone tissue while collagen, due to presence of integrin-binding motifs, 
greatly enhanced the adhesive properties of cells. 
 
 
 
 
 
 
Figure 1.2: The three-dimensional ECM scaffold. Extracellular matrix proteins such as collagen 
and fibronectin are used for 3D tissue assembly. Cells are seeded on top of the ECM scaffold, where 
they adhere to ECM proteins to form a 3D tissue. Alternatively, cells can be mixed with liquid 
collagen or Matrigel, which solidifies trapping cells inside the gel. 
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1.2.2 Alginate 
Another popular biomaterial used in tissue engineering is alginate. Alginate or alginic 
acid is an anionic polysaccharide found in the cell walls of brown algae. It consists of 
copolymers containing blocks of (1,4)-linked β-D-mannuronate (M) and α-L-guluronate (G) 
residues. The blocks can be composed of multiple consecutive or alternating M and G monomers 
arranged in linear geometry.58 Alginate is a common food additive which recently found an 
application in drug encapsulation and wound dressing. The hydroscopic properties of alginate 
allow it to trap water during the process of gelation, thus providing cells that are enclosed inside 
the gel with the essential ions and nutrients contained in the medium. The process of alginate 
gelation is initiated with addition of calcium ions to the solution of sodium alginate. Ca+2 
replaces sodium ions and crosslinks the polysaccharide chains (Figure 1.3).  The sources of 
calcium ions are buffered solutions of simple inorganic salts such as CaCl2 and CaSO4.
59 Just 
like collagen and fibronectin, alginate is biodegradable, non-immunogenic and is a very 
commonly used scaffold material in tissue-engineering experiments.  
 
 
 
 
 
 
Figure 1.3: The alginate hydrogel. Alginate is an anionic polysaccharide derived from brown algae. 
To form an alginate scaffold, cells are mixed with a buffered solution of alginate; calcium ions are 
used to crosslink alginate strands to form a solid scaffold. 
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In addition, alginate is a moldable, elastic material which can sustain a significant stretch and is 
easy to handle. To construct harder structures such as bone tissue, hydroxyl apatite 
Ca5(PO4)3(OH), is mixed with powder of sodium alginate and osteoblasts prior to gelation with a 
solution of calcium chloride.60 The system however has several drawbacks. Unlike ECM-based 
scaffolds, alginate does not have integrin attachment sites such as RGD (Arginine-Glycine-
Asparagine) motif which abolishes cell adhesion and spreading. Therefore, in alginate-based 
scaffolds, cells adopt a spherical shape, which is different from the star-like geometry of cells in 
a healthy tissue. In addition, high concentrations of calcium used in the gelation process are toxic 
to many types of cells.  
 
1.2.3 Polymer scaffolds 
Polymer-based scaffolds are another methodology for tissue engineering that has become 
popular in the last decade. Since different polymers have different physical and chemical 
properties, it is possible to build a scaffold with parameters that are suitable for a specific tissue. 
This high level of customization gives this system a significant advantage over other platforms 
where the properties of scaffolds cannot be easily changed.61 When constructing a polymer-
based scaffold for optimal tissue growth, it is important to consider the following parameters:  
1) Stiffness: It is known that some cell types such as osteoblasts and osteoclasts (bone cells) 
grow better on stiff surfaces while others such as neurons perform a lot better on softer 
materials. The stem cells, which are used extensively in tissue engineering, differentiate 
into different lineages depending on stiffness of the material.62 
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2) Elasticity: In the body, tissues such as muscles and blood vessels undergo constant cycles 
of stretch and relaxation; therefore, it is important for the scaffold material to have proper 
elasticity to sustain the function of these tissues.63 
3) Porosity: While the scaffold is in place, cells must have an access to oxygen and 
nutrients. Since in some cases tissue thickness can reach 5 mm or more, it is important for 
cells that are found deep inside the scaffold to be exposed to the medium, which is 
achieved through use of porous scaffolds. The pores, however, must be of proper size: 
large enough to allow nutrient exchange, but small enough to keep the tissue intact, still 
allowing for cell-cell contact.64 
4) Biodegradability: The scaffold is designed to be a temporary structure, supporting the cell 
mass before the cells form intercellular junctions and, in the case of stem cells, 
differentiate into the right lineage. The scaffold, since it is an exogenous structure, must 
degrade away leaving the intact functional tissue. The process of degradation must 
proceed at the right pace allowing for gradual replacement of the polymer with growing 
cell mass.65 There are two different mechanisms of scaffold degradation: via surface 
erosion or via bulk erosion (Figure 1.4). During surface erosion, the thin layers of 
polymers gradually degrade from the surface of the scaffold proportionally decreasing its 
overall size. In bulk erosion, the scaffold is degraded from within.61 The density of the 
material decreases while the overall shape of the scaffold is preserved. Each method is 
appropriate for a specific tissue type. 
5) Non-cytotoxicity: During the process of scaffold biodegradation, by-products are 
produced; these by-products must be non-cytotoxic and non-immunogenic.66 In addition, 
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they must not interfere with the process of tissue growth and diffuse from the scaffold 
shortly after being generated. 
These are the essential parameters that need to be controlled for any scaffold system to be 
effective. These requirements significantly narrow the choice of polymers for tissue engineering.  
There is a multitude of biodegradable polymers available for basic research which 
includes polyanhydrides, polyorthoesters, polyhydroxyalkanoates, and newly synthesized 
biomaterials, such as polypyrroles. Today, however, there are only three biodegradable polymers 
that have been approved by the American Food and Drug Administration (FDA):  polyglycolide 
(PGA), polylactides (PLA) and polycaprolactone (PCL)67,68 These polymers belong to the 
polymer class of polyhydroxyalkanonates and have long been used as sutures, grafts and 
prosthetic devices in medicine.  
 
 
 
 
 
 
 
 
Figure 1.4: Two models of scaffold degradation. Scaffolds demonstrate different degradation patterns. 
A) Bulk erosion is common in materials made of polyesters while polyanhydrides (B) undergo surface 
erosion. 
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Recently, PGA, PLA, PCL and their co-polymers became essential for the tissue engineering 
field due to their biodegradability, biocompatibility and relatively low cytotoxicity.  
Polyhydroxyalkanonates are degraded via hydrolysis and their by-products are non-cytotoxic in 
moderate amounts.69,70 For example, PLA is composed of lactic acid monomers – the natural 
components of glucose metabolism that accumulate in muscle tissue during exercise. During the 
hydrolysis of the PLA scaffold, lactic acid monomers are released into the body where they are 
metabolized though cellular metabolic pathways.71,72 The rate of degradation, however is 
strongly affected by the architecture of the scaffold and exposure of the polymer to water. Under 
certain conditions, a large portion of scaffold is exposed to water, which leads to quick polymer 
degradation and the release of a large amount of lactic acid molecules at once, causing a decrease 
in pH and thus cytotoxicity. 69,73PGA-based scaffolds are characterized by their high 
hydrophilicity and fast rate of degradation (4-8 weeks). Although suitable for fast growing 
tissues such as skin, quick degradation often limits the amount of time for tissue regeneration of 
other, more complex organs. 74 
PCL-scaffolds contain multiples caprolactone monomers. The hydrolysis of PCL, 
however, is very slow and can last from 9 months to 3 years and is thus only suitable for slowly 
growing tissues such as bone and cartilage.75 Since each given protein has its distinct properties 
and degradation rates, designing customized scaffolds often requires combining these materials 
in the form of co-polymers. Today PGA-PLA co-polymers are gaining popularity. The 
monomers are combined into different ratios providing properties such as tensile strength and 
changing the rate of degradation of the intermediate to the original PGA or PLA scaffolds. 76 
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Since, the growing tissue requires cytokine stimulation, specific growth factors are often 
embedded into polymer scaffolds.  For example, VEGF is used to promote angiogenesis, while 
BMP4 is utilized to promote bone formation. 77,78   
 
1.3 Scaffold Fabrication Methods 
 
Both biodegradable polymers and naturally occurring biomaterials play an important role in 
building scaffolds for tissue engineering. Depending on the material in the manufacturing 
process, the properties of the resulting structure can differ substantially. The choice of material 
however is only one parameter that needs to be considered in tissue building process. The other 
one is the fabrication methodology.  Building a scaffold is achieved through slow deposition of a 
polymer material which can be done via several methods. 
1.3.1 Electrospinning. 
Electrospinning is a unique method that utilizes electric force to draw charged threads of viscous 
polymer solution extending it to form thin fibers. The diameter of the fibers can range from 2-4 
nm to several microns. The technique is applicable for a wide range of both natural and synthetic 
materials including chitosan, PLA, PGA,PLC, alginate and collagen.79-81 The technique, 
developed in late 19th century, has been used ever since in various fields. The typical 
electrospinner setup looks the following way:79,82 A syringe containing polymer solution is 
inserted into an infusion pump - a device used to administer small amounts of liquid (Figure 
1.5). A spinneret is a nozzle on a syringe which is made of conductive material and has an 
opening of small diameter. The spinneret is aimed towards the collector – a quickly rotating 
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drum. The voltage source is connected to the spinneret and is grounded onto the collector. The 
polymer solution is prepared in a volatile solvent and its concentration is carefully adjusted. The 
procedure starts when the syringe pump pushes the extruder and a small drop of polymer 
solution is formed on the tip of the spinneret. The drop is held on the tip with surface tension. 
When voltage is applied, the solution particles become charged, the electrostatic repulsion 
overtakes the surface tension and a jet of polymer solution is ejected towards the spinning 
collector.  
 
 
 
Figure 1.5: Generating scaffolds via electrospinning. In the process of electrospinning, a polymer 
solution is loaded into a syringe. The solution is ionized as it is extruded through the spinneret and thin 
threads of polymer fiber are formed on the collector screen. 
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The solvent evaporates quickly, leaving thin threads of polymer material. The method produces a 
patch made of a thick meshwork of polymer threads. The resulting material can be molded into a 
scaffold and seeded with cells. The cells can penetrate the scaffold through pores between the 
fibres, where they are trapped.  The electrospinning technique has been used to produce tissues 
such as skin, bone and bladder.83 
 
1.3.2 3D Printing 
The second method that has become popular in recent years is 3D printing.  The technology is 
based on the successive addition of thin layers of material to produce a three-dimensional object. 
Just like in electrospinning, different types of polymers and biomaterials can be used in 3D 
printing.84 The simplest design of a 3D printer involves a syringe, containing a viscous solution 
of collagen, alginate or synthetic polymer. The syringe is attached to a robotic arm that is capable 
of moving along the x, y and z axes.85 The arm moves along the programmed path extruding 
layers of polymer, which are deposited on top of each other in layer-by-layer fashion allowing 
formation of a 3D object. More advanced versions of 3D printers can use solid materials such as 
PLA. The polymer is melted inside the machine and is then extruded through the printing head. 
This allows for high-resolution printing. If melting is not required, cells can be added directly 
into the solution of a biomaterial and thus be embedded into the structure of the resulting 
scaffold.86-88 3D printing technology allows for the precise positioning of cells and the formation 
of complex structures. In 2015, Atala and colleagues utilized 3D printing to build an artificial 
tendon. They mixed C2C12 myoblasts and NIH/3T3 fibroblasts with a hydrogel containing 
hyaluronic acid, gelatin and fibrinogen in one syringe, while another syringe contained PCL.89 
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The content of the syringes was simultaneously extracted producing a complex scaffold. This 
complex approach is called co-printing and is used to produce complex tissues.  In this particular 
case, the scaffold contained cells embedded into a soft hydrogel covered with hard PCL polymer 
mimicking the tendon structure.  
Similar to previous approaches used to create scaffolds with different properties, various 
proteins, growth factors or nanoparticles can be added into the biomaterial. In 2013, Mannoor et 
al, printed a bionic ear out of alginate containing chondrocytes and silver nanoparticles. Though 
the printed tissue morphology was different from the actual tissue, it demonstrated a step 
forwards method for creating a functional 3D organ.90 
 
1.3.3 Decellularized Scaffolds. 
Engineering a functional 3D tissue on a scaffold is a complicated task which must take into 
account multiple parameters such as cell seeding density, degradation rate of a polymer material, 
porosity of scaffold, cell adhesion, migration and others. The level of complexity of natural 
tissues is hard to replicate in in vitro conditions.91,92 In 2010, Ott and colleagues developed a new 
method to build scaffolds using an extracellular matrix derived from the organs of a dead donor 
(Figure 1.6). The idea behind this method is to utilize the ECM from cadaveric organs or tissues 
to seed new cells and produce a living organ or tissue. The procedure includes the following 
steps.94  
1) An organ is removed from a dead body.  
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2) The organ is perfused with either trypsin or a chemical detergent to remove dead cells 
leaving a decellularized scaffold. The digestion must be very gentle so as not to damage 
ECM proteins. 
3) Living cells are seeded onto the decellularized scaffold.  
4) The cells attach to collagen or fibronectin fibers and migrate to the specific site guided by 
the physical cues received from the ECM. The future goal of this method is to re-create 
the cell niche, where cells can interact with each other and the extracellular matrix 
receiving all the necessary physical and chemical signals.   
5)   The resulting construct is then transplanted into the body of the recipient where it is 
supposed to perform all the functions of the replaced organ. In the case of paired organs 
such as the kidneys or lungs, the failed organ can be removed from the patient, 
decellularized and then seeded with cells from the second organ which is healthy. This 
procedure is supposed to reduce the immune response since both the cells and the ECM 
are obtained from the patient. 
 
 
Figure 1.6: Decellularized scaffolds. A) Cadaverous organs or tissues are treated with a mild 
detergent or solution of protease to remove dead cells. B) The resulting carcass, which consists 
mainly of the components of the ECM, is seeded with patient or donor cells. C) The cells 
adhere to the matrix and restore some of the organ’s functions.  
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The decellularization technique has been used to build organs such as the heart, lung, liver and 
kidney.95-97 The constructs were transplanted into immunocompromised mice. Although, some of 
the tissue function was restored, there was still a very big difference in performance as well as 
structure between the healthy tissue and the re-seeded scaffold. The major limitation of this 
technique is that it does not control for the distribution of different cell types within the tissue.  
 
 
1.3.4 Organoids 
Significant steps towards creating artificial organs have been created by developmental 
biologists. The formation of any organ or tissue starts during the embryonic stage of human 
development. From the moment of fertilization and the formation of blastocyst, unspecialized 
totipotent stem cells undergo greater and greater degree of specialization leading to formation of 
organs and tissues.98 In the early stages of embryogenesis, cells receive signals from other cells 
and the environment which, along with DNA markers, influence their choice of lineage. The 
resulting specialized cells of one cell type tend to self-aggregate excluding other cells. In this 
process, cells that belong to different cell types self-organize into complex tissues. 
Using genetic engineering and co-culture techniques developmental biologists 
investigated the possibility of inducing the formation of a specific organ or tissue from 
pluripotent or totipotent stem cells (Figure 1.7).  The stem cells commit to specific lineages, 
differentiate and then self-organize into miniature multicellular structures that resemble organs in 
their morphology and are called organoids.99 A typical organoid contains two to three cell layers 
each containing a different cell type.  
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The first organoid developed from pluripotent stem cells was intestine. In the experiment by 
Spence et al (2011), human embryonic stem cells (ES cells) as well as induced pluripotent stem 
cells (iPSC) were treated with a combination of growth factors that play an important role in 
intestine development during embryogenesis.100 Since the intestine is a part of endoderm (an 
inner germ layer inside an embryo), it was important to direct the stem cells towards endoderm 
development first.  
 
 
 
 
 
 
Figure 1.7: The formation of intestinal organoids. A) Embryonic stem cells are treated with 
activin A to induce formation of the definitive endoderm (B). Following that, the samples are 
treated with WNT3A and FGF4 to promote gut morphogenesis (C). Then, the tissues are 
transferred onto soft matrigel-coated plates to produce 3D spheroids (D), which are then treated 
with RSPO1 and NOG for the duration of 30 days to induce the formation of intestinal organoids.  
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Therefore, at day 1, the stem cells were treated with activin A – a nodal-related TGF-β molecule 
which induces endoderm formation. After 72h of activin A treatment the cells displayed 
endodermal markers and were subsequently treated with WNT3A and FGF4, the growth factors 
that directed further differentiation of stem cells into intestine-like organoids. At day 4, the 
dividing cells produced aggregate spheroids. Finally, at day 28, the spheroids transformed into 
organoids which contained morphological structures characterizing intestine (villus and crypts) 
and also expressed the intestine-specific markers: KLF5, CDX2, and SOX9. 
As of today, several organoids have been generated including stomach, brain, heart, liver 
and kidney.101-103 Organoids are capable of performing some functions of the corresponding 
organs and can be useful for studying cellular behavior in the process of organogenesis as well as 
for use as working models in the simulation of drug metabolism, infections and other processes. 
The disadvantage of this technique of cell assembly is that it is time-consuming and does not 
allow for flexibility in terms of the choice of cell types introduced into the organoid. Given that 
organoids are miniature structures and their generation is regulated indirectly (through the 
activation of genetic pathways), scaling this technology for commercial production may prove to 
be a challenge.  
 
1.4 Extracellular Matrix 
The extracellular matrix (ECM) is a meshwork of proteins and glycans secreted by cells 
into extracellular space. It provides a biochemical support to the surrounding cells and plays an 
important role in such processes as cell motility, stem cell differentiation, wound healing and 
angiogenesis.104 To undergo these fundamental biological processes the cells must adhere to 
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different components of underlying the ECM.  Upon adhesion, the cells receive molecular 
signals from ECM and respond to them in a specific manner. These physical and chemical 
interactions between the cell and ECM allow the cell to sense its position and orient itself 
correctly in space. The ECM also regulates intercellular communication and plays s an integral 
role in supporting the tissue organization. 105  
1.4.1 Durotaxis 
The direction and rate of cell migration in the body are controlled through a process 
called durotaxis. This phenomenon is based on cells sensing the rigidity of ECM and migrating 
towards softer or harder regions.106 ECM rigidity on the other hand is determined by the 
concentration of proteins such as collagen, elastin and fibronectin. Organs such as the brain have 
lower ECM rigidity, while in bone tissue the ECM rigidity is high.106,107 The content of ECM in 
tissues varies depending on their function. Typically, tissues that need to endure a lot of stress 
such as bone, skin and cartilage have higher ECM content (up to 72%) as compared to internal 
organs such as the heart, liver and brain. 108 
The structure of ECM is dynamic and is being continuously modified. Specific protein 
complexes called metalloproteases are responsible for degradation of most ECM proteins, thus 
regulating the rigidity and composition of ECM and controlling such important processes as 
organogenesis and wound healing.109 
1.4.2 ECM composition 
The ECM is a complex and dynamic structure composed of proteins such as collagen, 
elastin, fibronectin and laminin; glycosaminoglycans such as hyaluronan, heparin sulfate and 
chondroitin sulfate as well as proteoglycans such as perlecan and syndecan (Figure 1.8). 110 
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1.4.2.1 Collagen: 
Collagen is the most abundant protein in mammals and is a major component the ECM. 
In bone and skin collagen makes up 25% of the total protein mass. Collagen has a unique triple-
stranded helical structure composed of three α chains. These α chains contain mainly glycine and 
proline, however, other amino acids such as alanine and glutamic acid are also abundant.111 The 
α chains are made up of series of three amino acids such as Gly-Pro-X, where X can be any 
amino acid other than glycine or proline. Three α chains intertwine with each other to form triple 
Figure 1.8: Detailed depiction of the extracellular matrix. The ECM is a complex dynamic 
structure which is composed of molecules secreted by cells. The ECM facilitates intercellular 
communication, cell-cell adhesion and provides structural and biochemical support for the 
surrounding cells. 
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helices which are then assembled into a complex structure called collagen fibril. Oxidation of 
lysine residues initiates the assembly of multiple collagen fibrils into collagen fibre – a protein 
superstructure with high molecular weight. Collagen fibres provide tensile strength and physical 
support to tissues such as bones, skin, tendons and blood vessels.112 In these tissues it is 
fibroblasts that are generally responsible for secretion of collagen. Depending on the content of 
amino acids, collagen can be classified into different types (collagen I–XII). Each collagen type 
has specific properties. For example collagens I, II, III, V and VI form fibrils, while collagen VII 
XI and XII anchor to the plasma membrane. Collagen IV fibres form durable β sheets. 113 
1.4.2.2 Elastin: 
Elastin is hydrophobic protein that allows tissues to transiently stretch and is found in 
large quantities in tissues such as skin and blood vessels. Elastin is a complex protein which is 
produced via polymerization of 72 kD tropoelastin monomers.114 Tropoelastin is synthesized 
inside the cell and is then secreted into the ECM where it polymerizes to form elastin. 
Tropoelastin has two alternating domains: hydrophilic and hydrophobic. The hydrophilic region 
contains lysine and alanine amino acids while the hydrophobic domain contains non-polar amino 
acids. It is the hydrophobic domain that is responsible for the stretching capabilities of elastin. 
1.4.2.3 Fibronectin: 
Fibronectin is a large (270kD) secreted glycoprotein composed of two dimers joined by a 
disulfide linkage.115 Fibronectin exists in multiple isoforms, one of which is soluble and 
participates such biological processes as blood clotting and wound healing. The other isoforms 
are insoluble; they are assembled on the cell surface and become the parts of ECM structure. 
Fibronectin interacts with the cell though a protein called integrin. Integrin attaches to the 
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fibronectin through the focal adhesion points and links the actin filaments inside the cell with 
ECM. Fibronectin contains specific RGD (arginine, glycine, aspartic acid) amino acid repeats. 
Every motif containing RGD repeats is a binding site for integrin receptors. Although RGD is 
mainly present in fibronectin, it can be also found in laminin, fibrinogen vitronectin and some 
collagens. 
1.4.2.4 Integrins 
Integrins are transmembrane receptor proteins that link the ECM with the actin 
cytoskeleton inside the cell. Along with cadherins, selectins and syndecans, integrins can receive 
a mechanical signal from the ECM which can then be transfered to the nucleus through a specific 
signaling cascade, resulting in a biological response such as changing the cell shape, direction of 
movement or transferring to a different stage of the cell cycle. 116 Integrins are structured as 
heterodimers and are composed of α and β transmembrane subunits. There are 18 α and 9 β 
subunits known which can combine to form 24 different integrin heterodimers. This immense 
complexity of integrin receptors is responsible for a great diversity of biological functions 
integrins can perform. 117 These include cell-ECM and cell-cell adhesion, cell growth and 
differentiation, cell survival, organization of actin filaments and assembly of the cytoskeleton. 
Thus, integrins serve as a bridge between the cell's internal proteins and enzymes and the outside 
environment. 
1.4.2.5 Glycosaminoglycans (GAGs) 
 In addition to protein components, the ECM contains carbohydrates. 
Glycosaminoglycans (GAGs) such as hyaluronic acid are important components of tissues such 
as skin and tendons. GAGs are hydrophilic and thus attract water molecules acting as a lubricant 
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or shock absorber which protects tissues from impact and shear stress. GAGs consist of repeating 
disaccharide units, typically amino sugar (N-acetylglucosamine or N-acetylgalactosamine) along 
with galactose or uronic sugar.118   
 
1.5 Plasma Membrane 
The cell membrane is a phospholipid bilayer that acts as semipermeable barrier between the cell 
cytoplasm and outside environment. The plasma membrane regulates the uptake and secretion of  
K+, Na+, Ca2+, Cl- ions, glucose, proteins, as well as water molecules.119  
 
 
 
Figure 1.9: The structure of the eukaryotic plasma membrane. The plasma membrane is a 
phospholipid bilayer that separates the cellular interior from the external environment. It is 
semipermeable and regulates transport of molecules that enter and leave the cell. The plasma 
membrane contains various receptor and structural proteins which play an important role in 
maintaining membrane integrity, cell adhesion regulation, motility and intercellular communication 
facilitation.  
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Due to the amphiphillic structure of the plasma membrane, sporadic diffusion of substances 
across the lipid bilayer rarely happens, thus the transport is generally achieved through regulated 
protein channels or controlled endocytosis.120  
Communication between the cell and the surroundings as well as cell-cell communication 
takes place via both chemical and mechanical signaling, and in either case, it is the membrane-
bound receptors that receive the signal and transmit them into the cell through signaling cascade 
(Figure 1.9)121. 
 Amphiphilic polar lipids make up the cellular membrane and are composed of 
hydrophobic tails and hydrophilic heads. Hydrophobic moieties have the propensity to self- 
associate which is driven entropically by water.122 Hydrophilic moieties, on the other hand, have 
a tendency to interact with the aqueous environment. These properties allow the cells to 
segregate the internal constituents from the external surroundings.   Glycerophospholipids are the 
most abundant lipids in the plasma membrane. Phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylserine, phosphatidylinositol and phosphatidic acid are the key structural components 
of the membrane. Each glycerophospholipid has a hydrophobic diacyglycerol portion which 
contains two saturated or cys-unsaturated acyl chains of different lengths. 
The lipid membrane is a dynamic structure which contains both liquid and solid regions. 
Membrane fluidity is regulated by different proportions of saturated and unsaturated fats. 
Phosphatidylcholine is the most common glycerophospholipid and constitutes more than 50% of 
all plasma membrane lipids. It has one cis-unsaturated fatty acyl chain, one saturated fatty acid 
chain and a polar head group.123 Remarkably, the molecules have nearly cylindrical shape and 
self-assemble into a lipid bilayer in the aqueous environment. The cis-unsaturated acyl chains in 
phosphatidylcholine molecules give the plasma membrane its fluidity.  
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 The eukaryotic plasma membrane, although mostly fluid, contains solid patches called 
lipid rafts.  Lipid rafts are composed of non-polar cholesterol molecules, sphingolipids and 
integral membrane proteins such as caveolin which are anchored inside the lipid raft. 
Sphingolipids such as sphingomyelin, ceramide and sphingosine contain a polar head group and 
a long saturated hydrocarbon tail.124 Due to their saturated structure and streamline geometry, 
sphingolipids are able to tightly pack together, producing solid regions in plasma membrane. In 
addition to that, sphingolipids can form structurally stable complexes with cholesterol. Lipid 
rafts can incorporate various transmembrane proteins into their structure, which play an integral 
role in different biological process such as antigen detection in immunology (B and T antigen 
receptors as well as the anchored IgE protein) and cell-cell signaling.  
 Membrane charge is a very important physical property of the plasma membrane.  Under 
typical physiological conditions, the mammalian plasma membrane has a negative charge 
provided by negatively charged lipid phosphatidylserine as well as by glycolipids and 
glycoproteins found in glycocalyx.125,126 This negative charge on the membrane prevents 
unspecific binding of proteins to the cell surface, thus promoting selective entry of exogenous 
proteins i.e cytokines through designated protein channels or endosome-facilitated endocytosis. 
In addition, it helps to protect the cell from the entry of pathogens such as viruses that have a 
lipid coating which would easily fuse with plasma membrane if it was neutral. Membrane 
distribution of negatively changed phosphatidylserine lipids is also an important factor for cell 
survival. The lipid belongs to the cytosolic leaflet in a healthy cell where sporadic migration into 
the outer leaflet is prevented by the flippase enzyme which “flips” phosphatidylserine lipids back 
to inside. In a damaged cell, on the other hand, this catalysis is abolished, thus leading to 
accumulation of the negatively charged lipids in the outer leaflet which triggers apoptosis.127  
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 Glycolipids and glycoproteins are essential components of plasma membrane. They 
contain long chains of carbohydrates which stick out towards the aqueous environment and form 
a thick polysaccharide matrix of glycocalyx.  Glycocalyx can be as thick as 11 µm and plays an 
important role in cell adhesion, cell-cell signaling, modulation of red blood cell volume as well 
as immune recognition. 128 Each individual has a unique combination of sugar monomers in 
glycocalyx and which for instance can enable a transplant patient’s immune system to 
differentiate between the host and the donor organ, thus triggering the immune response and 
organ rejection.129 
In addition to carbohydrates and lipids, the eukaryotic plasma membrane contains many 
complex proteins. Channel proteins such as aquaporins are responsible for regulated intake of 
water, ABC transporters pump out toxins; sodium and potassium channels regulate the ion 
balance. In addition, intercellular communication is accomplished through gap junction proteins 
called connexins that can span across the plasma membranes of two cells and allow for direct 
exchange of cytoplasmic content between the cells in the tissue which plays an important role in 
cardiac muscle depolarization and proper embryonic development.130-132  
The immense complexity of both the ECM and the plasma membrane allows for 
intercellular communication and formation of complex tissues and organs.  
 
1.6 Cell Surface Engineering 
 
The cell membrane is a lipid bilayer containing proteins that span either side, and serves 
as barrier between the cytoplasm and the outside environment.  It is responsible for many key 
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processes that are essential for cell survival.  The membrane has a sensory function, mediates 
communication between the cell and its surroundings, promotes intercellular communication, 
aids in locomotion, and controls the inflow and secretion of substances. 133Since the role of 
cellular membrane is important, its modification can be used to control the cellular behaviour. 
Cell surface engineering can be used to modify the cellular membrane for a variety of purposes.  
Such modifications include labeling with fluorescent probe for imaging, expressing a receptor 
protein on a lymphocyte surface to target a cancer cell, homing a stem cell towards the injured 
region of heart muscle, assembling cells into a functional tissue and many others.134,135 Cell 
surface engineering however is challenging due to the dynamic nature of plasma membrane. 
Lipids, glycoproteins and proteoglycans are being constantly modified, displaced, internalized 
and replaced with de novo synthesis.136 Thus, functionalization of cellular membrane with target 
molecules, chemical tags, recombinant receptors and nanomaterials has become an important 
area of research in the fields of chemistry and molecular biology.137,138 Applying the right 
strategy to decorate the plasma membrane enables control over such important cellular processes 
as adhesion, migration, differentiation and apoptosis.  There are several cell surface engineering 
strategies that are in use today. 
1.6.1 Genetic Engineering 
Genetic engineering is the most widespread technique used for modification of cell 
surface. It is based on genetic expression of surface proteins via the standard molecular biology 
techniques. Well known, widely used, genetic engineering allows for on demand expression of 
natural and unnatural proteins (Figure 1.10). The technique is based on host DNA modification 
which is performed in the following way: 139,140 
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The DNA sequence which codes for the gene of interest is delivered into the cell via a 
DNA plasmid. For this purpose, both the plasmid and the DNA fragment containing the gene of 
interest are digested with restriction enzymes producing the sticky ends. The DNA fragment is 
then ligated into the plasmid next to the promoter. The plasmid is delivered inside the cell, where 
the gene is then expressed producing the protein of interest. The modern methods of DNA 
transfection are based on liposome delivery strategy (Figure 1.10). DNA is incorporated into 
liposome and is delivered into the cell via endocytosis.  Other methods of DNA modification are 
based on viral transduction and the novel CRISPR-cas9 system. The biggest advantage of genetic 
engineering is that one can produce a variety of recombinant proteins for specific purposes. In 
Figure 1.10: Genetic transfection of cells via a liposomal transfection agent. DNA plasmid 
containing the gene of interest (A) is encapsulated into the structure of the liposomal transfection 
agent (B) to form a DNA-lipid complex which is then endocytosed by the cell (C,D).  The DNA is 
then released from the endosome and translated into the receptor protein (E) which is displayed on 
the cell surface (F). 
33 
 
one such experiment Kato and Mrksich produced a chimeric integrin protein to adhere 
specifically to a surface coated with benzenesulfonamide — a synthetic ligand (Figure 1.11).142 
The chimeric receptor was constructed from α5β1 integrin, a common transmembrane protein 
which binds to the components of extracellular matrix. The chimeric protein was constructed by 
fusing the intracellular and transmembrane domains of β1 protein with an extracellular domain of 
carbonic IV anhydrase. Carbonic IV anhydrase binds specifically to benzenesulfonamide, 
therefore the chimeric integrin had affinity for the artificial surface. As the result, genetically 
modified cells were able to attach and migrate on the surface coated with artificial ligand which 
would not be possible for cells with natural form of integrin.  
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Genetically engineered integrin receptors. Surface receptors can be modified to 
bind a synthetic ligand. A) The α5β1 integrin which normally binds Arg-Gly-Asp (RGD) peptide 
was modified into a chimeric receptor protein which binds an artificial benzenesulfonamide 
surface ligand (B). 
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Molecular biology is a powerful tool for cell surface engineering, since it allows generating 
different surface proteins for different tasks. The method however has several intrinsic 
drawbacks. It is relatively complicated for commercial use. Prolonged expression and secretion 
of proteins does not allow for rapid cell surface engineering. The technique relies on DNA 
modifications, thus permanently alters the biological processes inside the cell. Finally, the 
application of this method is restricted by the use of proteins that span the plasma membrane, 
thus not every protein or ligand can be introduced to the cell surface.   
 
1.6.2 Metabolic Engineering  
The alternative technique to engineer cell surfaces is by metabolic engineering. As 
opposed to genetic engineering, this method does not require permanent genetic modifications, 
thus expression of surface ligands has temporal effect. Metabolic engineering utilizes the cell’s 
metabolism machinery to deliver specific proteins or carbohydrates onto cell surface. The 
convenience of this technique comes from the fact that the precursors of the required ligands can 
be added directly to the cell medium, absorbed by the cell as the nutrient, metabolized inside the 
cell and then secreted onto the cell surface in the final form. Bertozzi and colleagues used this 
approach to tether cells with biomolecules and fluorescent markers.143 They utilized a sugar 
biosynthetic pathway to incorporate the azide-functionalized sugar into the structure of a 
glycoprotein (Figure 1.12). N-acetylmannosamine derivative (ManNAz) containing an 
azidoacetyl group was introduced into cell culture medium.  
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Given that azide group is relatively small, ManNAz was effectively incorporated into a 
biosynthetic pathway, brought to the cell surface and inserted into the glycoprotein in a form of 
sialic acid.  The glycoprotein was then labeled with fluorescent probe via the bio-orthogonal 
click chemistry reaction of Staudinger ligation.  
 Although metabolic cell surface engineering opens new possibilities for chemical 
modification of cellular membranes and provides a non-genetic alternative of cell surface 
engineering, the method has several limitations. Since sialic acid’s functions inside the cell are 
Figure 1.12: Metabolic engineering.  A) An azide-functionalized N-Acetylmannosamine 
(Ac4ManNAz) is introduced into the cell medium. B) The carbohydrate is introduced into the 
biochemical pathway, converted into N-Acetylneuraminic acid and incorporated into a glycoprotein, 
bringing the azide functionality onto the cell surface. C) Bio-orthogonal fluorescent labeling is 
achieved via the click-reaction between the surface-presented azide and the phosphine.  
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diverse, the metabolic processes inside the cell can be affected which might cause unwanted 
biological changes. In addition to this, large quantities of functionalized sugars can be lost inside 
an organism if the azide-functionalized sugar is introduced systemically in in vivo studies, which 
can potentially be toxic.  
 
1.6.3 Layer by Layer Self-assembly Technique 
Another important self-surface engineering method is the layer by layer self-assembly 
technique (LbL). The technology is based on coating the cell surface with a very thin layer of 
polymer (6-300 nm thick) with given properties. The advantage of this technique is that it does 
not utilize the cellular metabolic processes and does not rely on genetic modifications, which 
means any change is transient and can be made and removed at any given time.144 This 
technology allows for the deposit of different synthetic materials, such as polymers, small 
molecules and nanoparticles, thus providing cells with new (i.e magnetic) properties that would 
be impossible to introduce with the standard molecular biology tools.  Swiston et. al utilized the 
layer by layer approach to introduce three different layers of polymers (Figure 1.13).145 The first 
layer is the cell-adhesive region, the region containing a hydrogel that binds directly to the cell 
membrane. The second layer is the payload region, a part that contains the cargo nanoparticles 
and FITC stain for visualization.  And finally, the release region containing a temperature-
sensitive polymer due to which a cell can attach to and detach from any surface with a slight 
temperature change.  Due to presence of Fe2O3 nanoparticles, the cell acquires magnetic 
properties and can be moved with magnetic field.  
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The Lbl methodology however has major drawback. The layers of polymer create a barrier 
between the cell surface and the environment which can detrimental to cell-cell interactions as 
well as to intake of water, ions and nutrients and excretion of the products of metabolism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: The layer by layer (LbL) self-assembly technique. The technique is used to deposit 
layers of material onto the plasma membrane to effectively modify the cell surface properties. A) The 
substrate surface is coated with patches of material and each patch has three layers. The cell adhesive 
layer is composed of hydrogel which binds the cell membrane. The payload region contains FITC stain 
and nanoparticles. The release region is attached to the substrate. B) The cells are deposited onto the 
coated surface and the material from the patches is transferred onto the cell membrane. C) The release 
region is dissolved promoting release of cells which are now functionalized with both:  the fluorescent 
FITC stain and Fe
2
O
3
 nanoparticles. 
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1.7 Liposome Fusion 
Another method used in engineering of the cell surface is liposome fusion. Liposomes are 
small artificial spherical vesicles composed mainly of amphiphilic phospholipids. Liposomal 
properties can vary considerably with size, surface charge and membrane composition.146 Since 
the lipid composition of a typical liposome is very similar to the composition plasma membrane, 
liposome fusion can occur without damaging the membrane and is also considered to be non-
cytotoxic. Liposome fusion is an established technology that has been around for several decades 
and is currently used for intercellular drug delivery, DNA transfection and vaccination. 147 
Liposomes can have different architecture but the classical liposome is a spheroid 
phospholipid bilayer with an aqueous core. The lipid membrane of liposome is composed of 
polar phospholipids arranged in a form of a bilayer containing two leaflets. In aqueous solvents 
hydrophilic heads of the phospholipids lipids of the outer leaflet are facing the environment, and 
the ones belonging to inner leaflet face the aqueous core (Figure 1.14). The hydrophobic tails on 
both leaflets are stacked in the membrane creating the hydrophobic environment inside the 
bilayer. 148 This creates three different carrier slots that can be used for delivery of different types 
of molecules. Water soluble molecules (ie polysaccharides) can readily be transported into the 
aqueous core of the liposome.149 Non- polar drugs (ie hormones) and amphiphilic lipids can be 
inserted inside the phospholipid bilayer. Finally, if a liposome contains positively charged lipids 
in its structure, negatively charged molecules such as DNA can find their place on the liposomal 
membrane surface.150-153 
Lipid composition directly influences the properties of the liposome. A typical liposome 
contains lipids that are identical or similar in structure to those usually found in eukaryotic 
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plasma membrane.  The presence of saturated or unsaturated hydrophobic tails impact the 
stability and thus degradation properties of a liposome. Unsaturated fats promote greater fluidity 
of the phospholipid bilayer while saturated fats make the structure more rigid.154,155  
 
 
 
 
 
 
 
 
Figure 1.14: Liposome delivery system. Liposomes are versatile carriers capable of transporting a 
wide range of molecules into cells. Hydrophobic drugs are incorporated into the lipid bilayer, while 
water-soluble drugs are found in the aqueous core. In addition, liposomes are capable of carrying 
nucleic acids, anchored lipids as well as surface conjugated ligands. Synthetic lipids can be inserted 
into liposomes and delivered onto cell membrane.   
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Liposome size can vary considerably depending on the purpose of use. The typical size of a 
liposome varies from very small (30 nm) to large (25 µm). Small liposomes with sizes ranging 
from 20nm to 100nm are called small unilamellar vesicles (SUVs).  Large unilamellar vesicles 
(LUVs) have sizes ranging from 100 nm to 400 nm. Finally, the giant unilamellar vesicles 
(GUVs) can often be larger than 1 µm. The vast majority are composed of only one lipid bilayer 
(unilamellar vesicles), however some of them can have an onion-like structure with two and 
more phospholipid bilayers (multilamellar vesicles).156-158   
Liposome fusion involves the fusion of lipid membranes, a process where two initially 
distinct lipid bilayers with hydrophobic cores fuse to produce a single interconnected structure. 
Membrane fusion is involved in many cellular processes such as fertilization of an egg by sperm, 
exocytosis and formation of lysosome to excrete metabolic waste products. In addition, 
membrane fusion is a key step in lipid transport from the site of lipid synthesis to the plasma 
membrane. Even pathogenic processes such as viral infections utilize lipid membrane fusion to 
transport their genetic material into the host cell.159 
 If the liposome contains only uncharged lipids, such as phoshphotidylcholine (POPC), 
this process is thermodynamically unfavourable and involves four steps (Figure 1.15).159 At 
first, the liposome must approach the plasma membrane closely (few nanometers) through 
aggregation. Second, the liposome must come very close to the plasma membrane so that the 
distance does not exceed a few angstroms. At this distance it is important that two surfaces 
remain at least partially dehydrated as the water molecules if they remain between the lipid 
membranes will at this distance cause strong repulsion between the bilayers. Third, a 
destabilization must occur between the lipid surfaces.160 It is this important that it happens 
simultaneously between the two leaflets of lipid bilayers, which is very difficult in the aqueous 
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environment since the hydrophobic lipid tails strongly avoid any contact with water. If only one 
leaflet from each bilayer is destabilized, hemifusion occurs. In the event of hemifusion, lipid 
exchange between outer leaflets of the liposome and the plasma membrane can occur; the inner 
leaflets, however remain intact thus the mixing of the internal content is impossible.  
 
 
 
 
 
 
Figure 1.15: The mechanism of lipid membrane fusion depicting the key intermediate 
structures. A) Two lipid membranes approach each other until the distance between them 
does not exceed 10-15Å. B) Membrane destabilization occurs between the two inner leaflets 
leading to the formation of a stalk. Lipid exchange between the inner leaflets is initiated 
promoting membrane destabilization. C) Lipid exchange between the outer leaflets is initiated 
enlarging the stalk and resulting in pore formation. D) The pore grows and the content of 
fusing vesicles is exchanged.  
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Finally, in the event of complete fusion two leaflets of each bilayer come into contact. 
Destabilization produces a fusion pore which grows and causes the content of liposome to mix 
with the cytosol from the cell. This exchange enlarges the pore and leads to the complete fusion.  
Fusion between the uncharged liposome and the negatively changed membrane does not happen 
simultaneously. Therefore, liposomal structure must be modified to promote membrane 
destabilization and subsequently fusion (Figure 1.16).  
One way is based on inserting specific proteins into the structure of a liposome. This 
method was adapted from the natural events which occur with lipid vesicles trafficking protein 
and lipid cargo between the endoplasmic reticulum and the Golgi apparatus. Specific proteins 
called SNAREs are found on lipid vesicles and on the target organelles.  
 
 
 
 
 
 
Figure 1.16: The membrane destabilization strategies: A) Fusion proteins destabilize lipid 
membranes and promote liposome fusion. B) Lowering pH causes protonation of negatively 
charged glycocalyx and facilitates liposome fusion. C) Cationic lipids incorporated into the 
liposome structure will enhance fusion with the negatively charged eukaryotic plasma 
membrane.   
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SNAREs promote lipid membrane destabilization and subsequent fusion of the vesicle 
and the lipid membrane of the organelle. The ability of liposomes to fuse with the plasma 
membrane was greatly increased with the introduction of proteins. The liposome is decorated 
with short amphiphilic peptides which when inserted into the plasma membrane promote 
destabilization of the lipid bilayer with subsequent liposome fusion. Protein-functionalized 
liposomes can be used to target cells which express specific surface receptors and thus facilitate 
the delivery of substances such as drugs or other cargo to the place where it is needed.161,162  This 
approach however, has a major disadvantage. In in vivo applications the presence of exogenous 
proteins can trigger an immune response which is greatly undesirable. 
Another important feature that was employed to promote membrane destabilization is 
alteration of the pH. Decreasing pH would cause protonation of negatively charged lipids thus 
reducing the electrostatic repulsion between the liposome and the plasma membrane and 
promoting liposome fusion.163 A similar effect can be achieved with introduction of calcium and 
magnesium ions.164 Since the environment around malignant tissues is mildly acidic (pH=6.5), 
the pH sensitive approach is very useful, because liposomes loaded with anticancer drugs  can 
fuse  to the area of malignancy, thus promoting targeted drug delivery.165  
The introduction of cationic lipids into the liposome structure was proven to be an 
effective method to promote liposome fusion. Positively charged lipids such as 1,2-dioleoyl-3 
trimethylammonium-propane (DOTAP) can be incorporated into otherwise uncharged liposomes 
containing natural phospholipids such as palmitoyl-oleoyl phosphatidylcholine (POPC). The 
positively charged liposome can be electrostatically attracted to the negatively charged plasma 
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membrane and fuse with it under physiological conditions with pH 7.4.166 The approach is 
simple, reliable and non-cytotoxic, thus is our method of choice for cell surface engineering. 
There are multiple applications for liposome technology, the most popular being drug 
delivery. Liposomes provide an ideal environment for drug transport. Drugs with different 
properties can be carried inside the liposome within the aqueous layer inside the lipid bilayer if 
they are hydrophobic or outside on the membrane if they are charged. In 2012, there were 8 
liposome based drugs on the market that are used to treat such conditions as influenza, hepatitis 
A, fungal infections and different types of cancer.167  
Liposomes are also used for immunization. Liposome-based adjuvants are gaining 
popularity and there are several liposome-based vaccines on the market. To induce an immune 
response, T cells and B cells are activated with proteins delivered via liposomes. The proteins are 
typically attached to a lipid linker which is inserted into the lipid bilayer, thus displaying the 
antigen on the outer layer.168 The antigen stimulates the lymphocytes and induces the immune 
response.   
Recent advances in chemistry have allowed for creation of liposome-based DNA/RNA 
transfection system such as LipofectamineTM. The cationic lipids in the liposome electrostatically 
attract the negatively charged nucleic acids promoting rapid delivery into the cell.  Liposome 
technology is an outstanding tool for cell surface engineering. Liposome fusion allows for easy 
delivery of natural and synthetic lipid moieties onto the cell surface.169 The engineered liposomes 
can fuse to the cell surface and transform the plasma membrane with different ligands for various 
purposes such as fluorescent labeling, DNA transfection and cell assembly. Since the technology 
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is simple, predictable and non-cytotoxic liposome fusion opens many possibilities for cell 
surface engineering.  
 
1.8 Bio-orthogonal Chemistry 
The term bio-orthogonal click chemistry was introduced in 2003 by an American scientist 
Carolyn Bertozzi. 170 Bio-orthogonal reactions are chemical reactions that do not interact or 
interfere with biological processes in a biological system or living organism, exhibiting no 
cellular toxicity and providing high specificity (Figure 1.17). These biologically inert click-
chemistry reactions are of great importance for the coupling of cells and biological 
macromolecules (lipids, carbohydrates and proteins).171 
For a chemical reaction to be applicable for biological purposes it has to satisfy the following 
criteria. 1) It has to proceed under physiological conditions: 37oC pH 7. 2) The reaction has to 
proceed in an aqueous environment. 3) Reactants and products of the reaction have to be non-
cytotoxic. 4) Products of the reaction should not undergo hydrolysis and must be stable in an 
aqueous environment. 5) The reaction must be specific, thus the reactants must react exclusively 
with each other and be inert towards the cellular proteins, carbohydrates or lipids. Out of all the 
diversity of organic reactions which lead to formation of covalent bonds, only few can be 
classified as bio-orthogonal.171,172  
The first such reaction was introduced by Bertozzi and colleagues in the year of 2000.173 It 
involved a modified version of the well-known Staudinger Ligation. This is a reaction between 
an azide, a soft nucleophile, and a phosphine, a soft electrophile. The original Staudinger ligation 
reaction was prone to hydrolysis. To avoid this Bertozzi and colleagues modified the classic 
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Staudinger ligation reaction mechanism by introducing an ester group ortho to the phosphorus 
atom on the aryl ring (Figure 1.18). This led to the formation of the aza-ylide intermediate. 
Addition of an ester group yielded the second intermediate which upon hydrolysis led to a stable 
amide-linked product.  This was the first attempt to generate a quick bioorthogonal reaction. 
Although non-cytotoxic, the reaction however had very slow kinetics with a second-order 
constant of only 0.0020 M-1s-1.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17: Bio-orthogonal chemistry as an effective molecular ligation strategy. Bio-orthogonal 
ligation is a robust and specific method that can be used to assemble small molecules, biological 
ligands, nanoparticles and cells into complex structures. These objects can be tethered with a bio-
orthogonal pair of molecules which interact exclusively with each other and are completely inert 
towards reactions with other substances. The reaction between the moieties happens instantaneously 
resulting in the formation of a strong covalent bond. As the result, the two objects are assembled into a 
single structure. 
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In the early 2000s, Sharpless and Meldal introduced a copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) - a variation of Huisgen cycloaddition method in which the rate of 
reaction between an azide and alkyne is dramatically increased via Cu(I) catalysis               
(Figure 1.19).174 Due to week acidity and basicity of both alkyne and azide, their interaction 
with biological molecules is limited, making the reaction very specific.  Today, it is the most 
widely used in vitro click-chemistry reaction. It can proceed in aqueous buffers under 
physiological conditions. CuAAC was demonstrated to work for labelling glycoproteins, nucleic 
acids and glycans with fluorescent tags and crosslinking them with each other.175,176  In 2003, 
Figure 1.18: The modified Staudinger ligation reaction. The first bio-orthogonal reaction 
used for ligation of biomolecules. Phosphine, which is a soft electrophile, is attacked by an 
azide, a soft nucleophile, to form an aza-ylide intermediate. Due to the presence of an ester 
group, the final product is resistant to hydrolysis.  
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Finn and colleagues reported the use of CuACC for labeling Cowpea mosaic virus.177 They 
coupled the azide-functionalized chemical linkers to the surface of viral protein and then coupled 
an alkyne-functionalized dye. This was the first example of the use of click chemistry within a 
biological system.   The process of bio-orthogonal functionalization of bio-molecules however 
requires a complicated chemical synthesis which can be potentially damaging to the bio-
molecule of interest. In addition, the use of copper in living cells and organisms is associated 
with increased cytotoxicity, which is strongly undesirable in biological experiments. 
 
 
 
In order to eliminate the use of copper and still preserve the high rate of reaction, 
Bertozzi and colleagues came up with an idea to apply the steric strain onto alkyne group to 
activate the alkyne towards the reaction with the azide (Figure 1.20). The alkyne functionality in 
the form of cyclooctyne, due to the ring strain, reacts selectively with azides through strain-
promoted cycloaddition.178 The first copper-free click chemistry reactions with cyclooctyne had 
very slow kinetics with the second-order constant of only 0.0024 M-1 s-1. Later, the rate of 
reaction was significantly enhanced with addition of two electron-withdrawing fluorine atoms 
yielding difluorinated cyclooctyne with k = 0.076 M-1 s-1.179 Despite decreased cytotoxicity and 
increased reaction rates, this reaction still has significant limitations. One of which is low water 
solubility of alkyne-functionalized moieties due their hydrophobicity, which can ultimately 
Figure 1.19: The copper-catalyzed azide−alkyne cycloaddition (CuAAC). Organic azides are 
capable of reacting with terminal alkynes to produce the stable triazole conjugate. The reaction 
requires copper for catalysis.   
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change the solubility and reactivity of alkyne-conjugated biological molecules. This increased 
hydrophobicity can also result in non-specific sticking to proteins and insertion into lipid 
membranes. The low stability of cyclooctynes also decreases the range of their application.  
 
 
 
 
 
 
 
 
Finally, Fox and colleagues (2008) demonstrated the use of the inverse electron-demand Diels-
Alders cycloaddition of strained cyclooctene with tetrazine.  This is the fastest bioorthogonal 
reaction known today with rate constants ranging from 103 to 106 M-1s-1.180 The technology was 
applied to label antibodies with radioactive probes and eradicating tumors in mouse models. The 
system however has the same limitations as the cyclooctyne-azide coupling reaction.     
1.8.1 Oxime chemistry 
In the present study we have demonstrated the use of covalent bioorthogonal reaction between an 
oxyamine and ketone to form a stable oxime (Figure 1.21). The reaction is quick, stable and 
Figure 1.20:  The strain-promoted alkyne-azide cycloaddition. To obviate the need to use 
cytotoxic copper, the activation energy for the reaction between alkyne and azide was effectively 
lowered by introducing the ring-strained cyclooctyne. The free energy from this bond deformation 
was sufficient enough to induce the reaction of the alkyne with the azide under mild conditions. 
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specific; it requires no catalysis and can proceed at low temperatures. These properties can be 
explained by the increased nucleophilicity of oxyamine. Unlike the regular amine, oxyamine is 
strongly nucleophilic due to alpha-effect created by the presence of an oxygen atom with two 
lone pairs of electrons adjacent to the nitrogen atom with one lone pair.  Kinetics studies by 
O’Brian et al (2015) demonstrated that the reaction is fast (k =0.0098 M-1s-1) with t1/2= 9s.181 The 
oxime is resistant to hydrolysis under physiological conditions in the aqueous environment of 
phosphate buffered saline (pH 7.4) and is known to be stable for at least three weeks. Oximes are 
non-existent in biological systems and do not interact with enzymes and other biomolecules. The 
only by-product of oxime formation is water, thus the reaction between oxyamine and ketone is 
non-cytotoxic.181,182 
 
 
 
 
 
Another advantage of oxime chemistry is that both oxyamine and ketone are small and 
polar chemical groups. This makes it easy to create both ketone and oxyamine functionalized 
biomolecules, such as proteins, carbohydrates and lipids without significant alteration of their 
properties (i.e solubility). For example, ketone and oxyamine lipids just like the regular 
Figure 1.21: The bio-orthogonal reaction between oxyamine and ketone. The reaction between 
oxyamine and ketone results in the formation of a stable covalent oxime bond. The reaction can 
occur under physiological conditions (37 C, pH 7.2), requires no catalyst and is resilient to 
hydrolysis. All reactants and products of this reaction are non-cytotoxic. The process provides 
significant atom economy and the only by-product produced in this reaction is water. 
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phospholipids will contain polar heads and non-polar tails, which makes them suitable for 
incorporation into the cellular membrane via the process of liposome fusion. 
Ketone-functionalized lipids such as dodecanone are commercially available and the 
oxyamine-functionalized lipids can be obtained via a simple two-step organic synthesis. These 
properties make bio-orthogonal oxime chemistry our system of choice. 
 
1.9 Bio-orthogonal Cell-Assembly Strategy 
 
Over the last decade, a number of new methods to build 3D tissues have appeared. These 
tissue assembly methods have been described above and most of them rely either on the use of 
exogenous scaffolds to support the cell mass or on genetic engineering to create organoids from 
stem cells. 183,184 Scaffold technologies, although providing structural support for the cells, have 
some disadvantages. When using the scaffold system one has to account for many parameters 
such as the degradation rate of scaffold material, porosity of the scaffold and the ability of cells 
to adhere to the material among many others.185  
 
Table 1.1: Advantages and disadvantages of applying scaffolds for tissue engineering. 
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Scaffolds are made of biodegradable materials which leach degradation byproducts in 
tissue and can potentially be toxic for the cells or trigger an immune response.186,187 In addition, 
in scaffold-based tissues a large portion of tissue volume is occupied by polymer material; this 
material may create a barrier between the cells, lowering the cell density and preventing 
formation of cell-cell junctions thus disrupting extracellular communication.188 
 Approaches based on developmental biology and use of stem cells result in organoids — 
structures reminiscent of organs. These constructs capture some of the 3D structure of the real 
organ and do not require a scaffold to be built. The system however is not flexible and does not 
allow for formation of tissues with variable dimensions and architecture. It is impossible to 
control what cell types are used to build the tissue and the ratios in which they can be combined. 
183 In addition, stem cell differentiation is a time consuming process and the methods that involve 
use of human embryonic stem cells are controversial.189 Therefore, the most optimal method to 
construct a functional 3D tissue for either transplantation, drug testing or disease modeling 
would be the one that requires no scaffold, is robust and easily customizable for a variety of 
applications.  
The method of cell assembly presented in this work is scaffold-free and does not utilize 
any polymer materials. The technology is based on a bio-orthogonal click chemistry reaction 
between an oxyamine and ketone functionalities to form a stable covalent oxime bond.  This 
ligation reaction is quick, specific and requires no catalyst. The reaction occurs under 
physiological conditions, is stable, and produces no toxic byproducts. The only byproduct of this 
reaction is water.  
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For delivery onto the cell membrane, oxyamine and ketone lipids are incorporated into 
liposomes (Figure 1.22). The liposome composition includes a neutral POPC lipid, DOTAP – a 
positively charged lipid which enables destabilization of the negatively charged lipid membrane 
initiating the membrane fusion.190 Ketone and oxyamine functionalities are incorporated into the 
liposome in the form of dodecanone and O-dodecyloxyamine lipids. Liposome technology is a 
well-established and safe method of drug delivery. There are currently 8 drugs that utilize 
liposome fusion to deliver the therapeutic molecules into cells.167 Our group was the first to 
use liposome fusion for cell surface engineering.191   
 
 
 
Figure 1.22: The synthesis of functionalized liposomes for cell surface engineering. A) A 
ligand of choice which can be either a biological molecule, a chemical moiety, a polymer bead 
or a nanoparticle is functionalized with hydrophobic lipid tail for incorporation into a liposome 
with subsequent delivery onto the cell membrane. B) The functionalized lipid is mixed with the 
background lipids (POPC and DOTAP) and sonicated to produce a liposome tethered with the 
molecule of interest. Oxyamine (C) and ketone (D) liposomes are used for the shuttling of bio-
orthogonal moieties onto cell surfaces for the purpose of tissue assembly.   
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Through liposome fusion, cell membranes can be tethered with ketone or oxyamine 
moieties (Figure 1.23). The process quick, simple and requires less than 5 minutes. After that, 
the cells with engineered membranes can be assembled into spheroid cell aggregates within 
seconds. These spheroids then adhere to the substrate, the cells secrete an extracellular matrix 
and spread forming tissues.192 Only ~10,000 oxyamine or ketone molecules per cell are 
required to effectively assemble cells, and this chemistry is gradually diluted out as the cells 
divide renewing the membrane.191  
 
 
 
 
 
 
Figure 1.23: Cell surface engineering via liposome fusion. Liposomes rapidly fuse with the cell 
membrane delivering the ligands onto cell surfaces. A) Cell surfaces can be functionalized with 
biological ligands, nanoparticles or small molecules for different purposes such as fluorescent 
labeling, cell sorting and immunological studies. Using this approach, cells can be labeled with 
bio-orthogonal oxyamine and ketone groups (B,C). 
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The ketone and oxyamine-functionalized lipids are incorporated into liposomes and 
delivered onto the cell membrane via liposome fusion. This cell surface engineering method is 
robust, simple and applicable to all cell-types. The ketone and oxyamine-tethered cells clicked 
together resulting in cell assembly.193 
Although in this work cell surface engineering was applied for tissue assembly, other 
applications of this technology are possible. Surface engineering enables binding of practically 
any ligand to the cell surface. The ligand must contain an oxyamine or ketone functionality and 
can be tethered to a membrane-engineered cell.194 The ligand can be a fluorescent molecule for 
microscopic visualization, a cytokine to induce a specific cellular response, a drug molecule, or a 
physical object, such as nanoparticle or a polymer bead for cell-sorting and purification. In the 
case of protein ligands, this approach is especially useful because it eliminates the need to use 
genetic engineering. Since genetically expressed proteins need to utilize biochemical pathways to 
be delivered to the cell surface, the only the proteins inserted into plasma membrane are the ones 
that have the right amino acid sequence, size and conformation. Since oxime chemistry works 
from the outside of the cell, a wide range of proteins with different characteristics can be 
installed onto cell surface.  
Liposome fusion has long been used for targeted drug delivery and DNA transfection. 
Although a lot of progress has been made in these areas of research, the bottleneck of the current 
technologies is the low efficiency of the fusion process which happens as result of lipid vesicles 
being too stable. In other words, a large percentage of vesicles come in contact with the cell 
membrane and bounce off without fusion. Adding oxime chemistry to the cell surface and the 
liposome will fix the liposome in proximity to the cell membrane, induce membrane 
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destabilization and promote fusion. Cell surface engineering is a promising method in the 
creation of technologies that can be used for efficient DNA transfection and drug delivery.195 
The liposome cell surface engineering method is used not only for eukaryotic, but also 
for prokaryotic organisms. The ketone and oxyamine-functionalized lipids were incorporated 
into liposomes and delivered onto the cell membrane via liposome fusion. This cell surface 
engineering method is robust, simple and applicable to all cell-types. The ketone and oxyamine-
tethered cells clicked together resulting in cell assembly. 
Bio-orthogonal liposome fusion technology can be used not only with eukaryotic, but 
also with prokaryotic organisms. Using bio-orthogonal chemistry our team engineered the 
cellular surfaces of E.coli bacteria with oxyamine and ketone moieties via liposome fusion.196 
This chemistry enabled functionalization of ketone tethered bacterial cells with florescent 
oxyamine- FITC dye. Likewise, an oxyamine biotin molecule was introduced to the cell surface 
and subsequently tagged with fluorescent streptavidin protein. Thus, aside from tissue 
engineering, oxime chemistry is also a powerful tool for functionalization of eukaryotic and 
prokaryotic cell surfaces with a wide variety of ligands. 
Bio-orthogonal oxime chemistry is a powerful tool that can be used to assemble cells into 
multicellular 3D tissues. It enables tissue assembly without the use of exogenous polymers or 
scaffolds. The system is versatile and can be used with different cell types. The chemistry can be 
used to assemble multiple cell types into a functional tissue with varied thickness and geometry 
(Figure 1.24). In my research work, I have conducted five different projects.  
In the first two projects, I demonstrated how the click-assembled 3D tissues can be used 
to assess the test cardiac and liver drug toxicity in vitro. Using this scaffold- free technology, I 
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was able to construct functional 3D cardiac and liver tissues, which contained cells from 
different cell types. The tissue performance was characterized with the standard function assays. 
The samples were subsequently treated with variable concentrations of drugs for different time 
periods to assess drug toxicity.   
 
 
 
 
 
 
 
Figure 1.24: The bio-orthogonal cell ligation strategy. A) When oxyamine-labeled and ketone-labeled 
cells are brought into contact, the bio-orthogonal chemical groups displayed on the cell surface react with 
each other producing a stable oxime bond linking the cells together. Using this approach, a variety of 
functional tissues can be assembled. These tissues may contain various cell types and have different 
configurations. The cells can be mixed (B) or deposited layer by layer to yield thin (C) or thick (D,E) three-
dimensional co-cultures with the defined cell-layer orientation.  
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In the body, cells form distinct patterns which are determined by the function of the 
specific tissue they belong to. Tissues such as skin are composed of multiple cell layers where 
each cell layer contains specific cell types. Our methodology allows the formation of such 
stratified tissues. One of the possible applications for such tissues is in the modelling of cell 
behavior in a complex 3D environment. In my third project, I created a multilayered 3D co-
culture of human mesenchymal stem cells (hMSC) and C3H10T1/2 cells. The position of cells in 
the co-culture (at the top, at the bottom or mixed) determined the rate of stem cell differentiation 
as well as the choice of lineage.  
 The reaction between oxyamine and ketone is rapid, specific and can proceed in the 
aqueous environment which allows the assembly of cells into tissues via microfluidics. 
Oxyamine and ketone-tethered cells can click together as they flow inside a microfluidic 
channel. The four’s introduces microfluidics system as a powerful tool for rapid cell assembly.  
In my last project, I created a di-oxyamine crosslinker, a molecule which crosslinks 
ketone-functionalized cells into tissues. The resulting 3D construct is a polymer composed of 
multiple monomers which are cells. The technology allows to create a hybrid polymer that can 
potentially include several components at once: cells, cytokines, nanoparticles, polymer beads, 
etc. The construct can be used for transplantation, drug testing and disease modeling.  
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Cardiac Tissue via Cell Surface Engineering 
 
 
 
 
 
 
This work has been published in Nature Scientific Reports, Volume 6, Article number 39806 in 
2016 under the title " Scaffold Free Bio-orthogonal Assembly of 3-Dimensional Cardiac Tissue 
via Cell Surface Engineering" It is reprinted with permission (© Nature Publishing Group 2016). 
Rogozhnikov, D., O’Brien, P. J.,Elahipanah, S. & Yousaf, M. N are co-authors of this work." 
 
 
Contributions 
M.N.Y. designed the study. D.R., P.J.O. and S.E. performed the experiments. M.N.Y., 
D.R.,P.J.O., and S.E. analyzed the data. D.R., and M.N.Y. wrote the manuscript. 
 
 
 
74 
 
2.1 Summary  
 
There has been tremendous interest in constructing in vitro cardiac tissue for a range of 
fundamental studies of cardiac development and disease and as a commercial system to 
evaluate therapeutic drug discovery prioritization and toxicity. Although there has been 
progress towards studying 2-dimensional cardiac function in vitro, there remain challenging 
obstacles to generate rapid and efficient scaffold-free 3-dimensional multiple cell type co-
culture cardiac tissue models. Herein, we develop a programmed rapid self-assembly strategy 
to induce specific and stable cell-cell contacts among multiple cell types found in heart tissue 
to generate 3D tissues through cell-surface engineering based on liposome delivery and fusion 
to display bio-orthogonal functional groups from cell membranes. We generate, for the first 
time, a scaffold free and stable self-assembled 3 cell line co-culture 3D cardiac tissue model 
by assembling cardiomyocytes, endothelial cells and cardiac fibroblast cells via a rapid inter-
cell click ligation process. We compare and analyze the function of the 3D cardiac tissue 
chips with 2D co-culture monolayers by assessing cardiac specific markers, electromechanical 
cell coupling, beating rates and evaluating drug toxicity. 
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2.2 Introduction 
 
The generation of complex three-dimensional (3D) tissues with multiple cell types in vitro is the 
pinnacle of the lab on a chip, tissue engineering and artificial organ research fields.1-3 
Innovations in developing these types of tissues and assemblies are needed in order to 
revolutionize transplantation medicine, biomedical and drug discovery research. 4-6 
Multidisciplinary approaches combining cell biology, bioengineering, polymer chemistry and 
regenerative medicine have resulted in the first wave of artificial tissue prototypes spanning 
pancreas, liver, kidney, skin and lung.7-10 Although each organ has a specific architecture and 
comprise of multiple cell types, a special challenge in the artificial tissue field is the generation 
of cardiac tissue. The heart is a very cell dense muscular organ which pumps blood through 
arteries and veins of the circulatory system. Cardiovascular associated diseases are the leading 
cause of death globally and account for 40% of deaths in North America.11 Furthermore, during 
the drug discovery process, cardiotoxicity is one of the major obstacles that result in the removal 
of drug candidates from clinical trials.12 Therefore, production of 3-dimensional artificial cardiac 
tissues for fundamental studies of heart disease, transplantation and evaluation of drug toxicity is 
an important and intense area of research. A key design criteria to create a functional tissue in 
vitro is a method to assemble multiple cell types into a 3D structure.13 The assembly method has 
to be efficient, inexpensive, non-immunogenic and non-cytotoxic. Techniques currently used for 
making 3D tissues include trapping cells in synthetic and natural polymer scaffolds. Natural 
scaffolds include collagen, matrigel, alginate, gelatin, chitosan as well as silk fibers and synthetic 
scaffolds include polymers such as polylactic acid, polyglycolic acid and their composites.14-16 
These materials have revolutionized tissue engineering research and allowed for 3D cell 
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encapsulation and provide tunable mechanical properties such as controlled stiffness and 
elasticity. However, there are many parameters that need to be considered to make a scaffold-
based tissue. These include: scaffold stability, porosity for oxygen and nutrients exchange, the 
rate of scaffold degradation, cytotoxicity of degradation by-products and potential inflammatory 
responses.17 Furthermore, each scaffold type has a certain cross-linking density and therefore 
volume, and when mixed with cells, significantly reduces the cell density in the matrix/tissue 
hybrid material. This excluded volume from the scaffold creates a barrier for formation of high-
density cell-cell junctions to establish intercellular communication. Such inter-connections are 
especially crucial for cardiac tissue, which requires a very high density of cells in order to enable 
long-range communication between cells via propagation of electrical signals to produce 
mechanical contractions that pump blood through long range synchronous beating. Cardiac tissue 
generation via polymer scaffolds in vitro is particularly challenging due to the much higher 
density of cells contained in the heart compared to any other organ (2–3% of heart tissue 
contains extracellular matrix while skin contains approximately 70%).18 In order to achieve 
synchronized long distance beating of tissue, the cells must have control of uninterrupted ion 
flow through their cytoplasms, which is only possible when they are physically interconnected 
through intercellular junction proteins called connexins.19 
Herein, we present a scaffold-free method to generate high density 3- dimensional 
cardiac tissue consisting of multiple cardiac cell types. The self-assembly strategy combines for 
the first time, cell surface engineering and bio-orthogonal chemistry to rapidly click together 3 
different cell types to generate a functional in vitro cardiac tissue. No external scaffold is used 
and the cells are the only building blocks of the generated cardiac tissue. We evaluate the self- 
assembled cardiac tissue with several assays including antibody markers, electromechanical 
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beating rates, extracellular matrix production and influence of drugs on 2D and 3D synthesized 
cardiac tissues. To our knowledge, this is the first example of a 3-dimensional cardiac tissue that 
initially only consists of cells and does not contain any external supporting structure or scaffold. 
 
2.3 Experimental 
2.3.1 Ethical Statement 
Experimental animals were housed in a temperature controlled environment under 12 h light and 
12 h dark conditions, and were fed ad-libitum. Animal facilities met Canadian Council on 
Animal Care guidelines and all protocols used were approved by the York University Animal 
Care Committee. 
 
2.3.2 Cardiomyocytes isolation 
Neonatal cardiomyocytes were isolated from newborn 1–2 day old Sprague Dawley rat pups. The 
pups were euthanized via spinal dislocation and their hearts were excised. The atrial parts of the 
hearts were removed and the hearts were cut in half to remove blood fluid. The procedure was 
performed in CBFHH buffer: 137 mM NaCl, 20 mM Hepes, 0.44 mM KH2PO4, 5.6 mM 
dextrose, 5.4 mM KCl, 0.8 mM MgSO4, pH 7.4. The hearts were then trimmed with surgical 
scissors into small pieces (1–1.5 mm2). The cardiac tissue was digested via serial digestion in 
enzymatic buffer: CBFHH buffer + 1.5 mg/ml of trypsin. Digestion was performed in a series of 
steps, 5 min each at 37 °C. The digests were collected into a test tube containing 5 mL of 
concentrated FBS. The cells were centrifuged at 800 rpm for 5 min. The cells were placed in a 
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flask containing Ham’s F-12 Medium (10% FBS, 1% penicillin/streptomycin) medium and 
incubated for 45 min, to allow cardiac fibroblasts present in the tissue to adhere to the bottom of 
the flask. The medium containing purified cardiomyocytes was then transferred to a separate 
flask. 
 
2.3.3 Tissue culture 
Human umbilical vein endothelial cells (HUVEC) were purchased from ATCC (Canada). The 
cells were cultured on round 10 cm plastic tissue culture plates. The medium used was F-12K 
Medium (Kaighn’s Modification of Ham’s F-12 Medium) with 10% fetal bovine serum (FBS), 
0.1 mg/ml heparin (Sigma), 0.05 mg/ml endothelial cell growth supplement (ECGS) (Sigma) and 
1% penicillin/streptomycin. The cells were incubated at 37 °C, 5% CO2, the medium was 
replaced every 48 h and the cells were passaged upon reaching 90% confluence. Human neonatal 
dermal fibroblasts were purchased from ATCC (Canada). The fibroblasts were cultured in 
Dulbecco’s modified Eagle high glucose medium (DMEM) with 10% FBS and 1% 
penicillin/streptomycin. 
 
2.3.4 Preparation of liposomes 
To prepare oxyamine and ketone-tethered liposomes, chloroform solutions of palmitoyl-oleoyl 
phosphatidylcholine (POPC), 1,2 dioleoyl-3-trimethyammonium-propane (DOTAP) were mixed 
with O-dodecyloxyamine (for oxyamine-tethered liposomes) or dodecanone (for ketone-tethered 
liposomes on the following ratios: POPC (430 μL,10 mg/mL in CHCl3 at 86 mol%); DOTAP 
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(10 μL, 10 mg/mL in CHCl3 at 2 mol%); and O-dodecyloxyamine or dodecanone (60 μL, 10 mM 
in CHCl3 at 12 mol%). The mixtures of lipids were thoroughly dried and then re-suspended in 
3 ml of phosphate-buffered saline (PBS). The suspension was then sonicated with a tip sonicator 
at the power of 20 Watts for 20 min until it was clear. 
 
2.3.5 Tissue assembly 
Isolated cardiomyocytes were centrifuged at 600 rpm for 5 min and the medium was discarded. 
HUVECs and human neonatal fibroblasts were allowed to achieve 85–90% confluence prior to 
tissue assembly and were trypsinized and centrifuged at 800 rpm for 5 min. 500 μl of oxyamine- 
or ketone-tethered liposomes were added to the cell pellet, the cells were re-suspended and 
incubated at 37 °C for 5 min. The cells were then washed with PBS and re-centrifuged. The PBS 
was discarded and the oxyamine- and ketone- labeled cardiomyocytes, HUVECs and fibroblasts 
were mixed in a small volume of combined (1:1) Ham’s F12: F-12K Kaighn’s medium with 
heparin and ECGF. The total cell concentration was 5 × 106 cells/ml. 50 μL drops of the 
concentrated re-suspended cell solutions were then placed on 1 cm2 nitrocellulose-coated glass 
slides and given a slight shake to induce cell assembly. Each mixed (co-culture) 2D or 3D 
sample contained 1 × 105 cardiomyocytes, 1 × 105 HUVECs and 5 × 104 fibroblasts. Each 2D and 
3D cardiomyocyte-only culture (monoculture) contained 1 × 105 cells. The cells were then 
incubated at 37 °C and 5% CO2 for 24 h to achieve full spreading into tissues. Upon spreading of 
cells, fresh medium was added to the plates. Cells in the control samples were treated with non-
functionalized liposomes. 
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2.3.6 Immunohistochemistry and confocal microscopy 
Prior to tissue assembly, cells were incubated in serum-free medium containing fluorescent live 
stain (Life Technologies) dyes. Neonatal rat cardiomyocytes, HUVECS, and human neonatal 
fibroblasts were treated with 25 μM CellTracker™ Blue CMAC (7-amino-4-
chloromethylcoumarin), 25 μM CellTracker™ Green CMFDA (5-chloromethylfluorescein 
diacetate), and 25 μM CellTrackerTM Red CMTPX respectively. The cells were incubated at 
37 °C for 45 min, and then washed thoroughly with PBS and incubated in serum-free medium for 
an additional 45 min. The cells were then assembled into 3D tissues and incubated for 24 h. 
Subsequently, the tissues were fixed with 4% formalin for 10 min and visualized with LSM-700 
(Zeiss) confocal microscope. 
 
2.3.7 Immunostaining 
The cells were fixed with 4% formalin for 10 min at room temperature and washed 4 times with 
PBS. To permeabilize the cell membrane, the samples were incubated in cold (−20 °C) 90% 
methanol for 5 min at 4 °C. Methanol was decanted and the cells were rinsed 3 times with PBS. 
The samples were treated with a blocking solution of 5% FBS in PBS at 37 °C for 60 min. While 
blocking, the dilution of primary monoclonal antibodies were prepared in 5% FBS. The 500–
600X dilutions of anti-connexin 43, anti-cardiac troponin T or anti-CD31 primary antibodies 
(Abcam) were used. The blocking solution was removed and the samples were incubated with 
the solution of primary antibodies at 4 °C for 12 h. The solution was aspirated and the samples 
were washed 3 times with PBS. Following that, the samples were incubated in solution 900X-
diluted FITC- and TRITC-conjugated secondary antibodies in the dark for 2 h at room 
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temperature. The samples were washed 3 times with PBS and visualized under fluorescent 
microscope. 
 
2.3.8 Fluorescent staining for Collagen and Elastin 
To observe the secretion of ECM over time for the various assembled 2D and 3D tissues, the 
samples were treated with Col-F fluorescent probe (Immunochemistry Technologies, MN), 
which has an affinity for collagen and elastin. The stock solution of Col-F (20 mM) was prepared 
in DMSO. The medium was replaced with the medium containing 20 μM Col-F. The cells were 
incubated at 37 °C for 60 min, after which they were washed thoroughly with PBS and fixed with 
4% formalin for 10 min with subsequent staining with DAPI for visualization of cellular nuclei. 
The samples were visualized under fluorescent microscope with excitation wavelength of 488 nm 
and emission of 520 nm. 
 
2.3.9 Fluorescent Calcium Imaging 
The tissues were incubated with 5 μM of the calcium-sensitive dye Fluo-4 AM (Life 
Technologies) for 20 min at 37 °C. The samples were washed with Tyrode salt solution for 
20 min and calcium transients were recorded using fluorescent imaging with excitation 
wavelength of 488 nm. Recording was performed for the duration of 10 s with the frequency of 
67 frames per second (fps). 
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2.3.10 Cardiotoxicity testing 
72 h upon tissue assembly, the tissue response to cytotoxic effects of two drugs, isoprenaline and 
doxorubicin (Sigma) were evaluated. The stock solutions of the drugs were prepared in DMSO. 
Each drug was dissolved in the culture medium and added to the slide containing assembled 
tissue. The control samples were treated with DMSO containing medium. The samples were 
incubated for 25 min with the corresponding drug and the change in the beating rate relative to 
the control was measured. Twenty independent experiments were performed for each drug to 
obtain statistically reliable data. 
 
2.3.11 Real time image processing 
To measure the variances in cardiomyocyte beating in response to drug treatment, a movie of 
beating cardiomyocytes in 3D co-cultures was captured under a light microscope. The series of 
images that make up the movie were analyzed using ImageJ software plugin SSIM index. This 
program compares two images and assigns a similarity score (SSIM index). Identical images 
receive a SSIM index of 1, and completely different – a similarity index of 0. The image with the 
tissue being completely contracted was taken for reference and assigned a similarity index of 1 
and all other images of tissue undergoing different stages of contraction was measured against 
the reference image. As a result, when the tissue fully contracted, its SSIM index approached a 
value of 1.0, and as it was relaxing, the SSIM index was decreasing. To eliminate the noise 
signal, the image series of non-moving fixed tissues were recorded. The average SSIM 
measurement of non-moving fixed tissues was taken as the control and was subtracted from each 
result. The resulting number was plotted and resulted in a cardiogram-like graph. 
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2.4 Results and Discussion 
Cardiac tissue is one of the most cell dense organs due to the cardiomyocytes requirement 
to be physically connected in order to propagate electrical signals that result in large scale 
mechanical rhythmic beating with a synchronous pattern. Most of the heart organ is made up of 
cells with very little extracellular matrix proteins. For eg. other organs, such as aorta 25.7%, skin 
64.5–72.1%, bone 15.1%, chordae (tendons) 77.1% contain much higher amounts of 
extracellular matrix and much less cell density than heart.18,19 
In order to generate scaffold free functional 3-dimensional cardiac tissue, we used the 
combination of liposome fusion, cell surface engineering and bio-orthogonal chemistry.20-23 We 
have previously shown the rapid installation of bio-orthogonal ketone and oxyamine groups to a 
range of cell types via liposome fusion (ViaGlue).24-26 As ketone and oxyamine presenting cells 
come into contact the cells rapidly click together via the stable oxime ligation and assemble into 
spheroids and then tissues (Figure 2.1). The interfacial oxime reaction is fast, chemoselective, 
occurs at physiological conditions (37 °C, pH 7) and requires no catalyst.27-29 Furthermore, the 
resulting oxime bond has no side reactions with biomacromolecules, is bio-orthogonal and 
therefore does not interfere with native biological processes.30 
The delivery of the bio-orthogonal groups to cells’ is based on rewiring the cell 
membranes with oxyamine and ketone moieties under mild conditions through the rapid process 
of liposome fusion. Ketone and oxyamine-functionalized lipids (O-dodecyloxyamine and 
dodecanone) together with widely used phospholipid palmitoyl-oleoyl phosphatidylcholine 
(POPC) and a cationic lipid 1,2 dioleoyl-3-trimethyammonium-propane (DOTAP) are 
incorporated into a liposome. When the bio-orthogonal liposomes (ViaGlue) are added to cells in 
84 
 
cell culture, the liposomes rapidly fuse with the cellular membrane resulting in delivery of 
chemical functionality onto the cell surface. Membrane-engineered cardiac cells from different 
cell types are then clicked together to form a complex multicellular cardiac 3D tissue. 
 
 
 
 
 
 
The delivery of the bio-orthogonal groups to cells’ is based on rewiring the cell membranes with 
oxyamine and ketone moieties under mild conditions through the rapid process of liposome 
fusion. Ketone and oxyamine-functionalized lipids (O-dodecyloxyamine and dodecanone) 
together with widely used phospholipid palmitoyl-oleoyl phosphatidylcholine (POPC) and a 
cationic lipid 1,2 dioleoyl-3-trimethyammonium-propane (DOTAP) are incorporated into a 
liposome. When the bio-orthogonal liposomes (ViaGlue) are added to cells in cell culture, the 
liposomes rapidly fuse with the cellular membrane resulting in delivery of chemical functionality 
Figure 2.1:  Schematic description for generating a scaffold free complex cardiac tissue 
by combining cell surface engineering and bio-orthogonal chemistry. The cells are 
initially treated with a rapid and mild liposome fusion method to install the bio-orthogonal 
groups onto the cell surface. Ketone and oxyamine groups on cell surface have been shown to 
rapidly click cells together via the oxime linkage and to form stable cell assemblies and tissues.  
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onto the cell surface. Membrane-engineered cardiac cells from different cell types are then 
clicked together to form a complex multicellular cardiac 3D tissue. 
In this work, primary cardiomyocytes were harvested from newborn Sprague Dawley rat pups 
(Figure 2.2). Harvested cardiomyocytes together with HUVEC’s and fibroblasts were treated 
with ketone or oxyamine-containing liposomes.  
 
 
 
 
 
 
 
 
 
 
Figure 2.2. The schematic diagram representing the process of generating scaffold free 3 
dimensional cardiac tissue via cell surface engineering and bio-orthogonal chemistry. The  
heart organ was first excised from new-born 24h rat pups. The neonatal cardiomyocytes were 
isolated from the hearts. The fresh cardiomyocytes were immediately decorated with bio-
orthogonal groups via liposome fusion and mixed with similarly engineered neonatal fibroblasts 
and human vascular endothelial cells (HUVECS) to form 3-dimensional cardiac tissue. The cells 
that were not treated with liposomes do not form a 3D tissue but instead form a standard 2D 
monolayer. 
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The liposome fusion process occurs in seconds to minutes and installs the bio-orthogonal groups 
onto the cell surface.  It should be noted that the liposome fusion/bio-orthogonal delivery 
technology works on many mammalian cell types and is fast, mild and works within seconds to 
tailor cell surfaces on freshly harvested cardiomyocytes from rat hearts. The 3 surface-
engineered cell types were mixed and rapidly clicked together and assembled into 3D tissues. 
The non-treated control cells (empty liposomes, or with unpaired bio-orthogonal groups) when 
mixed did not assemble and as expected formed only a single monolayer of cells in culture. 
Figure 2.3 shows confocal images of various 2 dimensional and 3 dimensional cardiac 
tissues.  
 
Figure 2.3: Confocal image representations of various 2D and 3D scaffold free cardiac 
tissue.  Cardiomyocytes, HUVEC and fibroblast cells were live stained with fluorescent dyes 
(blue, green and red respectively).  (A)  The three cell types were mixed together and formed a 
single monolayer (10 µm thick). (B)  The three cell types presented bio-orthogonal groups and 
when mixed clicked together and formed a random 3-dimensional multi-layer cardiac tissue (55 
µm thick).  (C)  The three bio-orthogonal presenting cells were added sequentially to generate an 
oriented 3-dimensional cardiac tissue (20 µm thick). Scale bar = 60 µm. 
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The ability to generate scaffold free thick 3D tissues as well as 3D tissues with controlled 
orientation was demonstrated via liposome fusion, cell surface engineering and bio-orthogonal 
chemistry. Prior to assembly, the cardiomyocytes HUVEC’s and fibroblasts were labeled with 
live-cell stain dyes, treated with liposomes and assembled into 3D tissues. Using oxime 
chemistry, it was possible to generate thick (55µM) complex 3D tissues. In addition, this 
technology allows for assembly of tissues with defined multi-layer orientation when the different 
cell types are added in sequential order. Figure 2.3C shows three cell types may be oriented in 
layers allowing for strict pattern control. In the control sample, the cells were not treated with 
liposomes or treated with non-functionalized liposomes and as a result only 2D monolayers were 
obtained with an average thickness of 10µM. The 3 dimensional tissues generated by the 
ViaGlue strategy were stable for several weeks (Figure 4). 
 
 
 
 
 
 
Figure 2.4: Cell viability in 2D and 3D tissues measured using propidium iodide viability 
assay.  The various tissue constructs were stable and viable for several weeks. 2D Cardio = 
monolayer of cardiomyocytes. 2D mix = monolayer of mixed cardiomyocytes, fibroblasts and 
HUVEC cells. 3D cardio = 3 dimensional tissue comprising of only cardiomyocytes assembled 
via bio-orthogonal cell surface chemistry. 3D mix = 3 dimensional multilayer of mixed 
cardiomyocytes, fibroblasts and HUVEC cells assembled via bio-orthogonal cell surface 
chemistry. 
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Figure 2.5: Fluorescent antibody staining for expression of cardiac-specific markers 96h 
after tissue assembly. 2D Cardio = monolayer of cardiomyocytes. 2D mix = monolayer of 
mixed cardiomyocytes, fibroblasts and HUVEC cells. 3D cardio = 3 dimensional tissue 
comprising of only cardiomyocytes assembled via bio-orthogonal cell surface chemistry. 3D mix 
= 3 dimensional multilayer of mixed cardiomyocytes, fibroblasts and HUVEC cells assembled 
via bio-orthogonal cell surface chemistry.  (A-D) DAPI nuclear staining.  (E-H) Expression of 
cardiac gap-junction protein Connexin 43 (Cx 43) in 3D tissues and 2D control monolayers. (I-
L) Expression of myocardial regulatory protein cardiac troponin T (cTnT). (M-P). Merged 
fluorescent images. (Q-T) Merged fluorescent images magnified four times. (A-P) Scale bar = 
80µM. (Q-T) Scale bar = 20µM. 
 
 
To evaluate the function of the scaffold free 3-dimensional assembled cardiac tissues, the various 
tissues were immunostained for the expression of cardiac-specific genetic markers (Figure 2.5). 
Cardiac troponin T (cTnT) is responsible for contraction of cardiac muscle and is present in 
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healthy tissue.32 Connexin 43 (Cx 43) is a gap junction transmembrane protein that is expressed 
in working myocardium and facilitates propagation of calcium ions.33   Both proteins are 
expressed in both 2D monolayers and 3D tissues.  However, the 3D mixed tissues showed higher 
levels of expression in both cTnT and Cx 43, compared to the 2D mix monolayer.  Both proteins 
are expressed in 3D cardiac and 3D mixed tissues demonstrating that the cardiomyocytes are 
well connected and the tissues are functional. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Fluorescent immunostaining for endothelial genetic marker CD31 expressed by 
HUVEC cells in 2D and 3D co-cultures 96h after tissue assembly.  (A-B) DAPI staining of 
cell nuclei. (C-D) Expression of CD 31 marker by HUVEC cells. (E-F) The merged fluorescent 
image. Scale bar = 60µM. 
 
To demonstrate the proper function of HUVEC cells in 3D tissue, the tissues were also stained 
for CD31, a genetic marker expressed on endothelial cells. CD31 is known to have various roles 
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in vascular biology including angiogenesis, platelet function, and thrombosis. It is a mechano-
sensor of endothelial cell response to fluid shear stress and it is involved in the regulation of 
leukocyte migration through venular walls.34 Figure 2.6B shows high levels of expression for 
CD31 marker in 3D co-cultures compared to the 2D control. This demonstrates the proper 
functioning of HUVEC cells in 3D co-cultures. 
Expression of extracellular matrix (ECM) by cells constituting myocardium is essential for 
proper functioning of cardiac tissue. The bio-orthogonal cell surface engineering strategy allows 
for the initial contact and assembly of the cells.  However, over time, the cells in the assembly 
secrete their own extracellular matrix. The interfacial oxime bond click reaction initially 
nucleates the cell assembly process that does not naturally occur without scaffolds in vitro.  To 
visualize production of ECM over time after the click cell assembly, the cells were stained with 
fluorescent probe markers specific for collagen and elastin (Figure 2.7).35    
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Figure 2.7: Fluorescent staining of collagen and elastin secreted over time by 2D monolayers 
and 3D tissues. The cells were assembled into tissues and stained for collagen and elastin with 
Col-F fluorescent dye at selected time points: 3h (A-D), 24h (E-H) and 48h (I-L). Green is the 
fluorescent dye Col-F, blue is the DAPI nuclear stain. Scale bar = 80µM 
Upon tissue assembly, the cells were treated with the dye marker and fixed with 4% formalin for 
various durations.  The images show gradual secretion of ECM.  It is observed that 3D tissues 
secrete more extracellular matrix than 2D tissues, even 3h after cell assembly. After 48h, the 
amount of ECM expressed is the highest, which demonstrates that the stability of the cell 
associations in the tissue is primarily through secretion of extracellular matrix and that the bio-
orthogonal cell surface click chemistry is used primarily to initiate the assembly process. Over 
time, the cells excrete their own extracellular matrix, which then becomes the main adhesive glue 
that holds the cells and tissues together. Taken together, the bio-orthogonal cell surface 
engineering method does not interfere with normal cell processes in tissue formation.  
For cardiac tissue to function properly, the propagation of Ca+2, Na+ and K+ ions is essential for 
contractile activity throughout the myocardium. 36  The propagation of signal is also necessary to 
synchronize the electromechanical beating between the cells in the myocardium. Calcium 
staining was performed to measure the rate of signal wave through the various assembled 2D and 
3D tissue constructs (Figure 2.8). To demonstrate that there is an uninhibited calcium ion flow 
through the cell cytoplasms of interconnected cells via connexins, which are formed upon tissue 
assembly. After 48h assembly, the various tissues were treated with fluo-4 – a calcium-binding 
fluorescent dye and visualized with fluorescence microscopy.  
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Figure 2.8: Native propagation of calcium across cardiac tissues without external 
stimulation. 48h after assembly, the tissues were life-stained with Fluo-4 calcium binding 
fluorescent probe. The propagation of calcium wave was recorded as the video time series. The 
fluorescent pulse rate differed depending on the type of cell assembly and was 0.92s for 2D 
cardiomyocytes (row A), 0.64s for 3D cardiomyocytes (row B), 0.78s for 2D mix. (row C) and 
0.83s for 3D mix (row D). Scale bar = 80µM. 
 
Snapshots were taken with frequency of 67 fps (frames per second) for 10s, and combined 
into a video. The frequency of calcium pulses varied across the different tissue types: in 3D 
cardiomyocytes, the frequency was the greatest: every 0.64s vs 0.83s for 3D mixed tissues.  The 
normal heart rate is approximately 0.80s, which corresponds well with the mix 3D tissue generated.  
The intensity of fluorescence was the greatest in 3D cardiomyocytes monoculture and was due to 
the highest density of cardiomyocytes. In mixed 3D co-culture, the cardiomyocytes constitute only 
~ 40% of all cells and the intensity of fluorescence is weaker. Overall, cardiac calcium signal 
propagation shows that there are proper cell-cell junctions between the cells in the tissue as well 
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as a coordinated, simultaneous contraction of all cells.  These scaffold free 3 dimensional tissues 
show intrinsic long range beating throughout the tissue without the application of an external 
voltage.  This result is significant to show that the cells are tightly packed through the tissue and 
can conduct ion flow over large areas in order to beat synchronously as an entire unit.  In our 
laboratory, we have found polymer or scaffold containing 3 dimensional cardiomyocyte tissues 
require an external applied current in order for all the cells to beat synchronously.  We observed, 
in a hydrogel or collagen scaffold that there are local high density regions of beating 
cardiomyocytes that are independent populations and not synchronized to other regions due to the 
polymer matrix inhibiting physical contact between various populations of cells throughout the 
tissue (data not shown).  Our method is scaffold free where the cells are self-assembled via cell 
surface engineering and therefore there is no need for outside stimulation for a synchronous 
beating of tissue.  
Cardiac toxicity is a major cause for drug candidates to fail clinical trials. Standard in vitro 
cytotoxicity studies, utilize 2D monocultures of cardiomyocytes. 2D monolayers, however cannot 
recapitulate the complex 3D environment of myocardium and therefore, new in vitro 3D models 
are needed for accurate assessment of cardiac cytotoxicity of drug candidates.  A major criteria for 
testing drugs in 3D cell culture versus 2D cell culture is that cells in three dimensions form multi-
layers of cells, whereas cells grown in two dimensions form a single monolayer. When testing a 
drug in two dimensions, it needs only to diffuse a short distance across the cell membrane in order 
to reach its intended target cell. However, in three dimensions, the situation is more realistic to an 
organ and a drug needs to diffuse across multi-layers of cells.  The diffusion across multi-layers 
of cells more closely mimics the challenges found in the human body or in cancer tissues in which 
a drug needs to diffuse through multiple layers of cells before it reaches its intended target. 
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Furthermore, cells in three dimension tissues will form natural barriers to drugs, such as 
extracellular matrix and tight junctions that bind cells together and block or slow the diffusion of 
drugs, again making for a more realistic test model. For example, in a comparison of microarray 
data for gene expression of 3D cultured Hodgkin lymphoma line L1236 cells, of 2D cultured 
L1236 cells and of tumor samples from biopsy, gene expression patterns of the 3D cells were 
found to be more closely related to those of tumor samples than those cultured in two dimensions, 
with a marked difference for cell-substrate (2D) and cell-matrix (3D) adhesion molecules.37   
In this study, we evaluated the effect on beating rate of two chronotropic drugs, isoprenaline and 
doxorubicin on the various cardiac tissues (Figure 2.9).38,39   Both drugs are known to affect the 
beating rate of cardiomyocytes.  Isoprenaline is a drug used for treatment of bradycardia (slow 
heart rate) and asthma (acts as a bronchiadilator). Doxorubicin is an anticancer drug commonly 
used to treat stomach cancer, leukemia, as well as soft tissue sarcomas. The most profound side 
effect of doxorubicin and isoprenaline is cardiomyopathy, which leads to congestive heart failure. 
The tissues were treated with different concentrations of isoprenaline (5nM and 10nM) or 
doxorubicin (100µM and 200µM) for the duration of 25 min, followed by light microscopy videos 
to record the alteration in tissue beating. Figure 2.9A shows percent increase (for isoprenaline) or 
decrease (for doxorubicin) in beating rate of cardiomyocytes in 2D or 3D tissues compared to the 
control samples (treated with DMSO only). All tissues had an increase in beating rate in response 
to an increase of concentration of isoprenaline.  As expected, the 2D cardiomyocytes were the 
most sensitive due to the accessibility of the drug to the cells in a monolayer compared to a 3D 
tissue.  This phenomena of 2D sensitivity over 3D is well known and indicative that 2D monolayers 
are not realistic model systems of organ function. Doxorubicin treatment decreased the beating 
rate of cardiomyocytes and had the greatest effect on 3D mixed tissues. Cardiogram-like graphs 
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were constructed to graphically represent the effect of isoprenaline and doxorubicin on cardiac 
beating rate (Figure 2.9B).  
 
Figure 2.9: Chronotropic effects of cardiac tissues under treatment with varying 
concentrations of isoprenaline and doxorubicin. A) A representative beating signal for 3D mix 
tissues. The increase in beating interval was in response to treatment with 10nM isoprenaline. B) 
A representative beating signal comparisons for 3D mix tissues.  The beating interval decreased in 
response to treatment with 100µM doxorubicin. C) Percentage increase in beating rate for tissues 
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treated with 5nM and 10nM isoprenaline. D) Percentage decrease in beating rate for tissues treated 
with 100µM and 200µM doxorubicin. Error bars represent the standard error of the mean (s.e.m). 
n=20, p<0.05. 
 
 
The image series were analyzed using ImageJ and a similarity score was assigned. The graph 
shows the increase in beating frequency for cells treated with isoprenaline and decrease in beating 
frequency for cells treated with doxorubicin.  These results show the scaffold-free cardiac tissues 
beat spontaneously without external stimulation and react accordingly to known cardiomyocyte 
drug stimulants. 
 
2.5 Conclusion 
 
In summary, we have used the combination of bio-orthogonal chemistry and cell surface 
engineering to program the rapid self-assembly of 3 different cell types into a functional 3-
dimensional cardiac tissue.  This click ligation method requires no polymers or extrinsic scaffold 
to trap or encapsulate cells.   Cardiac tissue requires a high density of cells that are physically in 
contact in order to generate long range synchronous beating throughout the tissue.  Significantly, 
the tissues generated by the ViaGlue liposome reagents were able to spontaneously beat 
synchronously throughout the entire tissue, due to high cell density and efficient cell contacts, 
without the requirement of external electrical stimulation.   To evaluate the function of the various 
constructed cardiac tissues several cardiomyocyte antibody markers and drug toxicity assays were 
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performed.  Furthermore, we observe gradual production of extracellular matrix from the cells 
soon after tissue assembly via the inter cell click ligation. The ViaGlue strategy is general and 
capable of assembling a variety of cell types to generate a range of tissues.  These tissues may be 
used for many applications including drug screening and as models for disease and infection as 
well as eventual cardiac patch in vivo applications.  Many different cell types including stem cells 
may be used with the strategy and the inter cell click ligation is compatible with microfluidic and 
3D printing technologies.23-30 We believe the combination of liposome fusion, bio-orthogonal 
chemistry and cell surface engineering to tailor cell surfaces will have a significant impact on 
autocrine and paracrine signaling studies and for the development and evaluation of tissues for 
drug screening and therapeutic organ on a chip based biotechnology applications. 
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Chapter 3 
Generation of a Scaffold-Free Three-Dimensional Liver 
Tissue via a Rapid Cell-to-Cell Click Assembly Process 
  
This work has been published in Bioconjugate Chemistry, Volume 27, Pages 1991-1998 in 2016 
under the title "Generation of a Scaffold-Free Three-Dimensional Liver Tissue via a Rapid Cell-to-
Cell Click Assembly Process." It is reprinted with permission (© American Chemical Society 
2016). Rogozhnikov, D.; Luo, W.; Elahipanah, S.; O’Brien, P. J.; Yousaf, M. N. are co-authors of 
this work. 
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3.1 Summary 
 
There has been tremendous interest in constructing in vitro liver organ models for a range of 
fundamental studies of cell signaling, metabolism, and infectious diseases, and as a commercial 
system to evaluate therapeutic drug discovery prioritization and toxicity. Although there has 
been progress toward studying two-dimensional hepatic function in vitro, there remain 
challenging obstacles to generate rapid and efficient scaffold-free three-dimensional multiple cell 
line co-culture tissue models of liver. Herein, we develop and employ a strategy to induce 
specific and stable cell–cell contacts among multiple hepatic cell lines to generate 3D tissues 
through cell-surface engineering based on liposome delivery and fusion to display bio-
orthogonal functional groups from cell membranes. We generate, for the first time, a three cell 
line co-culture 3D liver tissue model by assembling hepatocytes, hepatic endothelial cells, and 
hepatic stellate cells via a rapid inter-cell click ligation process. We compare and analyze the 
function of the superior 3D liver tissue chips with 2D co-culture monolayer by assessing 
mitochondrial metabolic activity and evaluating drug toxicity.  
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3.2 Introduction 
Recent strategies to assemble complex tissues in vitro have revolutionized biomaterial 
and bioengineering research and are now a central design feature for drug discovery and organ 
engineering research efforts to improve human health.1-5 In particular, the human liver is a 
complex multicellular organ containing a range of different cell types including hepatocytes as 
the key parenchymal cells and hepatic sinusoidal endothelial cells (HSEC), hepatic stellate cells 
(HSC), and Kupffer and pit cells as nonparenchymal cells.6-7 The liver organ is responsible for 
many diverse functions, including protein, carbohydrate, and lipid metabolism, detoxification of 
endogenous and exogenous compounds, storage of glucose, production of bile and cholesterol, 
secretion of albumin and clotting factors, production of urea, and many other vital 
processes.8 Due to its central importance, any liver function impairment may lead to a range of 
deleterious illnesses and diseases.9,10 Furthermore, many therapeutic drugs discovered in cell 
based assays result in hepatotoxicity in animal trials leading to high failure rates in drug 
approvals. This directly impacts the tremendous cost associated with drug discovery and may 
also result in the retrieval of existing drugs from the pharmaceutical market due to liver 
toxicity.11-12  
Despite the critical significance of establishing in vitro liver tissue models, many 
challenges limit the exploration and development of the field of liver tissue engineering.13 For 
example, in order to evaluate liver toxicity of drug molecules before animal studies or clinical 
trials, a functional liver tissue model system established in the laboratory would be highly 
desirable to assign drug priority.14 However, for in vitro models, it is very difficult to maintain 
hepatocyte cells, which rapidly lose liver-specific functions and stop growth under in vitro 
conditions.15 In order to address this severe cell culture limitation, many liver model systems 
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containing co-cultures of parenchymal hepatocytes with other nonparenchymal cells have been 
investigated.16 The current state of the art for 2D liver tissue is based on co-culturing 
nonparenchymal cells with hepatocytes in specific ratios or patterns.17 Pioneering research 
discovered that hepatocytes could survive and maintain liver-specific functions for much longer 
periods when surrounded by certain (maintenance) cell lines.18 These artificial co-culture 
systems have greatly expanded the range of liver studies possible and as an in vitro drug 
screening platform.19  
 
While two-dimensional co-cultured hepatocytes were used in various drug analyses to 
help researchers estimate liver function and drug responses, most of these systems remain as 
traditional cell monolayer systems (two-dimensional systems).14 The two-dimensional tissue on a 
chip systems have advanced in vitro liver model systems, but there remain many challenges to 
generating appropriate functional three-dimensional in vitro tissue models with more than two 
liver specific cell types. These 3D co-culture systems would be better mimics of real liver tissue 
and may expand liver cell viral and toxicity studies, which in turn may lead to potential new liver 
organ assays and functional liver construction. 
To achieve 3D cell culture and tissue construction, a variety of synthetic scaffolds were 
developed to support cell adhesion and growth and to study cell behavior in 3D. These scaffolds 
usually contain synthetic polymers such as poly(ε-caprolactone) (PCL), poly(L-lactic acid) 
(PLLA), polyglycolic acid (PGA), and poly(lactic-co-glycolic acid) (PLGA) or biological 
materials such as collagen, gelatin, chitosan, alginate, and agarose.20,21 While synthetic scaffolds 
were widely studied to support cell proliferation and construct 3D tissues, many limitations 
remained for cell based research and applications, including the inherent stability of the 
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scaffolds, toxicity of degradation byproducts, potential inflammation and immune responses, 
interference with cell–cell interactions, duration for cell saturation in the scaffold, and 
unpredictable impact on signaling pathways.22,23 Although some scaffolds are biocompatible and 
capable of mimicking certain features of the extracellular matrix, their long-term safety and side 
effects are still unclear. Therefore, scaffold-free tissues may present an alternative and 
complementary system for future applications in tissue engineering and regenerative medicine. 
Herein, we introduce a scaffold-free platform system to generate rapid, efficient, and controlled 
multiple cell type co-culture cell assemblies of 3D liver tissues. The strategy relies on mildly 
rewiring cell surfaces in order to click cells together to form stable complex structures without 
the use of polymer scaffolds or encapsulating gel materials.24 This system is based on integrating 
a universal cell surface engineering method to install chemoselective and bioorthogonal lipid-
like groups onto cell membranes to which interfacial click reactions among different cell type 
membranes can be induced.25 Upon this multivalent interfacial ligation, cells can be clicked 
together and thus result in rapid cell–cell assembly with high cell economy. With simple 
manipulation, cell orientation and positioning can be potentially achieved to construct 
multicellular tissues approaching the complexity of organs.26  
 
3.3 Experimental 
3.3.1 Tissue Culture 
Immortalized human hepatocytes Fa2N-4 were obtained from Xenotech, KS. The cells 
were thawed and cultured on collagen I-coated plates in multifunction enhancing (MFE) plating 
medium containing 10% newborn calf serum (Xenotech, KS), and 1% penicillin/streptomycin 
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solution (Sigma). At 24 h upon plating, the medium was replaced with MFE serum-free support 
medium containing component A. The medium was replaced every 48 h. The cells were 
passaged upon reaching confluence (every 3–4 days). 
Primary human hepatic stellate cells (HSC) were obtained from Sciencell, CA. The cells 
were cultured on poly(L-lysine)-coated plates in stellate cell medium (SteCM) consisting of 500 
mL basal medium, 5 mL of stellate cell growth supplements (SteCGS), 10 mL of fetal bovine 
serum (FBS), and 5 mL of penicillin/streptomycin solution. The cells were passaged upon 
reaching 95% confluence. The medium was changed every 48 h. 
Primary human hepatic sinusoidal endothelial cells (HSEC) and their medium were 
purchased from Sciencell, CA. The cells were cultured on fibronectin-coated plastic plates in 
endothelial cell medium (ECM) consisting of 500 mL of basal medium, 5 mL of endothelial cell 
growth supplement (ECGS), 25 mL FBS, and 5 mL penicillin streptomycin solution. The cells 
were passaged upon reaching 95% confluence (every 2–3 days) and the medium was changed 
every 48 h. 
All cells were maintained at 37 °C, 5% CO2. 
 
3.3.2 Preparation of Liposomes 
To prepare oxyamine and ketone-tethered liposomes, chloroform solutions of palmitoyl-
oleoylphosphatidylcholine (POPC) and 1,2 dioleoyl-3-trimethyammonium-propane (DOTAP) 
were mixed with O-dodecyloxyamine (for oxyamine-tethered liposomes) or dodecanone (for 
ketone-tethered liposomes on the following ratios: POPC (430 μL,10 mg/mL in CHCl3 at 86 mol 
%); DOTAP (10 μL, 10 mg/mL in CHCl3 at 2 mol %); and O-dodecyloxyamine or dodecanone 
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(60 μL, 10 mM in CHCl3 at 12 mol %). The mixtures of lipids were thoroughly dried and then 
resuspended in 3 mL of phosphate-buffered saline (PBS). The suspension was then sonicated 
with a tip sonicator for 20 min until it was clear. 
3.3.3 Liver Tissue Assembly 
Prior to tissue assembly the cells were allowed to reach 85–95% confluence. Cells were 
then treated with liposome solution (50 μL of liposomes/1 mL of medium) and incubated at 37 
°C for 4 h. The medium was discarded and the cells were washed with PBS twice. The ketone- 
and oxyamine-tethered cells were removed from the plate with 0.25% trypsin and centrifuged at 
800 rpm. The medium was discarded and the oxyamine- and ketone-labeled hepatocytes, HSC 
and HSEC, were mixed in a small volume of medium (2 × 106 cells/mL). Small drops of 
concentrated resuspended cell solutions were then placed in 12-well (3.7 cm2) collagen I-coated 
plates and given a slight shake to induce cells to aggregate and assemble. Each mixed (co-
culture) 2D or 3D sample contained 1 × 105 of Fa2N-4 hepatocytes, 1 × 105 of HSEC and 5 × 
104 of HSC. Each 2D and 3D hepatocyte-only culture contained 1 × 105 of Fa2N-4 hepatocytes. 
The cells were then incubated at 37 °C and 5% CO2 for 16 h to achieve full spreading of cells in 
the tissues. Upon spreading of cells, fresh MFE plating medium was added into the plates. After 
24 h, the medium was exchanged with a 1:1 mixture of MFE support medium and endothelial 
cell medium (ECM). Cells in the control samples were treated with nonfunctionalized liposomes. 
 
3.3.4 Fluorescent Staining for Collagen and Elastin in 2D and 3D Assemblies 
To visualize the secretion of ECM by tissues over time, the cells were stained with the 
green fluorescent probe Col-F (Immunochemistry Technologies, MN), which binds collagen and 
elastin. A 20 mM stock solution of Col-F reagent in DMSO was prepared. The stock solution 
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was dissolved in the medium to give a final 20 μM concentration. The tissues were treated with 
the medium containing 20 μM of Col-F reagent and incubated for 1 h at 37 °C. The medium was 
removed and the cells were washed twice with PBS. The cells were then fixed with 10% 
formalin for 15 min and visualized via fluorescent microscopy with excitation of 488 nm and 
emission of 520 nm. 
3.3.5 Immunohistochemistry and Confocal Microscopy 
Prior to tissue assembly cells were incubated in serum-free medium containing 
fluorescent live stain (Life Technologies). Fa2N-4 hepatocytes, HSEC, and HSC were treated 
with 25 μM CellTracker Blue CMAC (7-amino-4-chloromethylcoumarin), 25 μM CellTracker 
Green CMFDA (5-chloromethylfluorescein diacetate), and 25 μM CellTracker Red CMTPX, 
respectively. The cells were incubated for 45 min, after which they were washed thoroughly with 
PBS and incubated in serum-free medium for an additional 45 min. Cells were then assembled 
into 3D tissues and incubated for 24 h. Subsequently, the tissues were fixed with 10% formalin 
for 15 min and visualized with LSM-700 (Zeiss) confocal microscope. 
3.3.6 Activation of Cytochrome P450 3A4 
To induce cytochrome P450 3A4, the 3D tissue samples were incubated in MFE support 
medium containing 10 μM Rifampin (Sigma) for 72 h at 37 °C, 5% CO2. The control samples 
were treated with DMSO vehicle only for calculation of fold activation. The medium was 
changed every 24 h. The samples were analyzed via P450-Glo CYP3A4 Assay Kit (Luciferin-
IPA) (Promega) by using the manufacturer’s instructions for the nonlytic cycle. The sample’s 
medium was exchanged with fresh MFE support medium containing 3 μM Luciferin-IPA and the 
samples were incubated for 50 min. 50 μL of medium was then transferred into a white 96-well 
plate. 50 μL of the detection reagent was then added into each well. The samples were covered 
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with aluminum foil and incubated for 20 min at room temperature. The luminescence was read 
with a Biotek Synergy Multidetection Plate Reader (Biotek). 
3.3.7 Albumin Analysis 
Culture medium was collected from the various samples and the albumin content was 
measured via Human Albumin Pincer Assay kit (Mediomics). New medium (1:1 MFE support 
medium and endothelial cell medium (ECM)) was added 24 h prior to collection for albumin 
quantification. 
3.3.8 Toxicity Assays 
Liver tissues were incubated with 10 μM troglitazone, 150 μM rosiglitazone, or 7.5 μM 
cyclophosphamide dissolved in MFE support medium for 16 h. The control samples were treated 
with DMSO vehicle. Subsequently, cell viability was analyzed by (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) assay (Sigma), where the tetrazolium ring is cleaved by 
mitochondrial dehydrogenase enzymes. The samples were then incubated in DMEM phenol red-
free medium containing MTT reagent for 1 h resulting in production of a purple precipitate 
which was subsequently dissolved in a 1:1 solution of isopropanol and DMSO. The absorbance 
was measured at 570 nm using a Synergy Biotek assay device. The data was analyzed via 
Student T test analysis by comparing two groups of data: 3D and 2D monocultures as well as 3D 
and 2D co-cultures.   
3.4 Results and Discussion 
As shown in Figure 3.1, parenchymal (hepatocytes) and nonparenchymal (stellate and 
endothelial) liver cells can be surface-engineered via functionalized liposomes presenting ketone 
or oxyamine groups. After cell surface engineering, these ketone or oxyamine-tailored cells can 
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be chemoselectively ligated together through interfacial multivalent oxime bonding. The oxime 
conjugation is stable, bio-orthogonal, and instantaneous through polyvalency under physiological 
conditions.27-33 Moreover, it does not require any catalyst or produce any toxic side product.  
 
 
Figure 3.1. General schematic process of engineering cell surfaces with bio-orthogonal 
chemistry groups for the programmable assembly of multiple cell lines into complex 
coculture spheroids and tissues. The bio-orthogonal groups were delivered to parenchymal and 
nonparenchymal liver cells via a straightforward liposome fusion strategy. The cells were 
surface-engineered to present oxyamine and ketone functional groups. The tailored cells rapidly 
assemble on demand through an interfacial oxime ligation. 
 
These velcro-like features on the cell surface allow for the installation of only minimal amounts 
(several thousand) of ketone or oxyamine groups onto cells surfaces to initiate the multivalent 
oxime conjugation, while ensuring no cytotoxic impact on cells. Previous studies have shown 
that the liposome fusion delivery of cargo and bio-orthogonal lipids is a transient transfection 
that helps to initiate the cell-to-cell assembly process.24-39 Over time, the cells proliferate and 
dilute the bio-orthogonal lipids; however, during this time period the cells excrete new 
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extracellular matrix which then holds the assemblies and eventually tissues together with high 
cell density.40 
Based on the cell surface engineering method, human immortalized hepatocytes Fa2N-4, 
human hepatic stellate cells (HSC), and human hepatic sinusoidal endothelial cells (HSEC) were 
surface-engineered to present oxyamine or ketone molecules, respectively. Fa2N-4 hepatocytes 
are noncancerous and widely used in liver model systems due to their ease of maintenance and 
similar expression profile of liver-specific functions.41 As shown in Figure 3.2, through the 
interfacial oxime conjugation between oxyamine and ketone, these surface-engineered liver cells,  
 
Figure 3.2. Fluorescent images and digital photograph of single layer and three-dimensional 
liver tissue. (A) 3D and sideview confocal image of a three cell type co-culture as a single layer. 
The cells do not have bio-orthogonal groups and therefore only form a mixed monolayer. (B) 
Confocal image of three-dimensional tissue containing the three cells types engineered with ketone 
and oxyamine groups via liposome fusion. The three cell types formed mixed multilayers. (C) 
Confocal images of surface-engineered liver tissue assembly with orientation control. Stellate cells 
(red) were at the bottom, and mixed hepatocytes (blue) and endothelial cells (green) were on the top. 
Hepatocytes, hepatic endothelial cells, and hepatic stellate cells were live-stained as blue (D), green 
(E), and red (F), respectively. (D–F) show monolayers of the individual cells used to construct the 
liver tissue. Scale bar (A–F) represents 50 μm. (G) Digital camera photograph of macroscale liver 
tissue that was fabricated based on surface-engineered hepatocytes, stellate cells, and hepatic 
endothelial cells. 
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when mixed, rapidly assemble into 3D tissue on demand. 
To easily distinguish among the three cell types in co-culture, hepatocytes, hepatic 
endothelial cells, and hepatic stellate cells were live-stained as blue, green, and red with vital 
dyes, respectively. Without the surface engineering process, mixing the three cell types only 
resulted in a 2D monolayer (Figure 3.2A). In contrast, 3D multilayer liver tissues were easily 
and rapidly constructed when the three bio-orthogonal cell surface engineered cells were mixed 
(Figure 3.2B). Due to the interfacial ligation, the surface-engineered cells may also be oriented 
depending on the manner of sequential addition. For example, stellate cells (red) were seeded 
first to form a bottom layer to which mixed hepatocytes (blue) and endothelial cells (green) were 
seeded to form an oriented multilayer structure (Figure 3.2C). Without the surface engineering 
procedure the cells only formed 2D monolayers (Figure 3.2D–F). This controllable cell 
assembly and orientation system can only occur with surface-engineered cells. This unique 
system provides researchers the opportunity for truly scaffold-free construction of any tissue in a 
range of orientations. Furthermore, the cell ligation assembly method allows for large-scale 
tissues to be generated (Figure 3.2G) rapidly with efficient cell economy. We found the 
assembled tissues were stable for many weeks with no change in liver specific functions. Future 
studies combined with 3D printing technology may afford complex tissues approaching the 
complexity of organs. As a representative example shown in Figure 3.2G, a macroscale liver 
tissue was constructed in 4 h through the efficient bio-orthogonal tissue click method. 
To demonstrate that the co-culture assemblies excrete their own extracellular matrix 
(ECM) after initial adhesion through the interfacial click ligation method we examined over time 
the production of collagen and elastin. Figure 3.3 shows fluorescent images of ECM production 
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over time for 2D and 3D co-culture assemblies of the three cell lines. The cell nuclei were 
stained blue with DAPI and the secretion of ECM is visualized over time as green through 
fluorescent small molecule Col-F staining of collage and elastin. It is clear that the initial cell-to-
cell adhesion process is rapidly induced through oxime ligation which is then re-enforced over 
time through the production of ECM. 
 
 
 
 
Figure 3.3. Fluorescent image comparisons of extracellular matrix (ECM) production over 
time after two-dimensional co-culture monolayer and three-dimension multilayer tissue 
assembly. (Left) Nuclei of the three cell lines are stained blue and the production of ECM is 
stained green with a small molecule probe for collagen and elastin. After initial rapid 3D cell 
assembly via bio-orthogonal ligation, the cells soon excrete extracellular matrix to further support 
cell adhesion. Scale bar = 40 μm. (Right) Secretion of extracellular matrix over time by 2D 
monolayers and 3D tissues of mixed cells. Relative fluorescent intensity produced by Col-F 
staining of collagen and elastin was measured at 3, 24, and 48 h and expressed in arbitrary units 
(a.u). n = 15, p < 0.05. All fluorescent intensity images were relative to the 48 h time point image 
(assigned 100 arbitrary units). 
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To further demonstrate the utility and scope of the system, four representative liver tissues were 
fabricated and then analyzed and compared for various liver specific functions (Figure 3.4A).  
 
 
 
As a comparison, 3D co-culture liver tissue (Mix 3D – containing all three cell lines), 3D 
hepatocyte liver tissue (Hep 3D – containing only the hepatocyte cell line), 2D co-culture liver 
tissue (Mix 2D – containing all 3 cell types, and 2D hepatocytes liver tissue (Hep 2D – 
containing only hepatocyte cell line) were studied for enzyme activity of cytochrome P450 
Figure 3.4. Fabrication and analysis of various types of liver chips generated via an intercell bio-
orthogonal ligation strategy. (A) Schematic of different types of liver chips for liver function 
analysis. (B) Study of cytochrome P450 3A 4-fold activation in different liver tissues treated with 10 
μM rifampin over 72 h. (C) Rates of albumin secretion by different liver tissues over 14 days. Error 
bars represent standard error of the mean. 
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3A4—a well-known enzyme responsible for drug metabolism in hepatocytes (Figure 3.4B).42 
These liver tissues were treated with rifampin, a common cytochrome p450 3A4 activator, for 72 
h. It was observed that the 3D co-culture liver chip (Mix 3D) showed highest activation (∼4-
fold), and 2D hepatocytes tissue (Hep 2D) showed the lowest activation. It is well-known that 
the albumin secretion is an important liver-specific function and therefore we performed an 
albumin secretion assay over 14 days. According to the results from the assays, 3D coculture 
(Mix 3D) and 3D hepatocyte (Hep 3D) liver tissues showed excellent liver function over 14 
days. These results provide clear evidence that the scaffold-free 3D liver tissue system has 
tremendous potential in liver tissue engineering and liver on a chip fabrication and applications. 
Liver toxicity is one of the primary reasons for withdrawal of drugs from the market as 
well as from lengthy and expensive clinical trials.14 Therefore, drug screening of model livers or 
liver chips before clinical trials is considered a critical step during the evaluation and 
prioritization of drug candidates. In order to highlight the potential of the tissue click system 
described for drug screening application, several representative drugs were tested on the various 
liver tissue chips fabricated (Figure 3.5). It has been shown that cellular interactions between 
hepatocytes and other nonparenchymal cells such as HSC and HSEC modulate the physiological 
response of liver to drugs in 2D monolayer coculture systems. Thus, when modeling the drug 
response in vitro it is important to account for interactions of parenchymal and nonparenchymal 
cells in a complex 3D tissue environment. In this work, we compared the responses of four 
different liver tissue chips to the treatments with common hepatotoxic compounds including 
troglitazone, rosiglitazone, and cyclophosphamide. These various liver chips were treated with 
10 μM troglitazone, 150 μM rosiglitazone, or 7.5 mM cyclophosphamide, respectively, over 16 h 
to screen for acute liver toxicity (Figure 3.5B–D). To evaluate the responses, a standard MTT 
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assay for analyzing mitochondrial activity was performed after 16 h drug treatment. It was found 
that the 3D coculture liver chip showed the highest mitochondrial activity in response to these 
drugs while 2D hepatocytes showed the lowest mitochondrial activity. These results further 
support that 3D cocultured liver tissue containing parenchymal and nonparenchymal liver cells 
displayed the best liver function and highest resistance to drug toxicity. 
 
Figure 3.5. Study of mitochondrial activity for evaluation of liver toxicity in different 
types of liver constructed chips. (A) Drug screening of fabricated liver chips based on MTT 
assay after treating tissues for 16 h with (B) 10 μM troglitazone, (C) 150 μM rosiglitazone, 
and (D) 7.5 mM cyclophosphamide. (E) Plots of MTT assay for a range of drug 
concentrations for various tissue constructs. 
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3.5 Conclusion 
In this report, we established for the first time a scaffold-free 3D tissue construction system 
based on a straightforward bio-orthogonal cell surface engineering tissue click ligation and 
applied it to liver fabrication and study. Based on this strategy we were able to rapidly construct 
a range of complex 3D liver tissues containing multiple parenchymal hepatocytes and 
nonparenchymal liver cell lines and evaluate their ability to recapitulate liver function through a 
variety of metabolic and drug assays. The 3D coculture liver tissue showed similar function to a 
real liver organ, and expressed excellent liver-specific functions. Furthermore, the 3D liver chip 
fabricated provides a new platform to generate a wide range of complex tissues with multiple 
cell types for a variety of future drug screening and tissue specific assays. The method can be 
used to generate a range of length scales of oriented 3D cocultures and multilayer tissues with 
many cell type components. The bioorthogonal ligation between cells initiates the assembly 
process, which is then further enhanced (held together) over time by the production of 
extracellular matrix. This strategy is also amenable to bioprinting and microfluidic methods to 
assemble stable spheroids and tissues in flow without post-encapsulation materials and may be 
combined with 3D printing and biodegradable polymers for the generation of many complex 
tissues.43-47 Due to the efficient cell assembly (cell economy) process this method in combination 
with polymer strategies may allow for filling of polymer molds or decellularized scaffolds 
rapidly for bioreactor applications since the cell types attach to each other and the polymer to 
rapidly generate thick tissues in a range of length scales. Finally, many complex thick tissues 
may be generated in 3D for organ on a chip type drug screens or viral assay screens, or as model 
systems for paracrine and autocrine signaling. 
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Chapter 4 
Cell Polymerization via a Biocompatible Crosslinker  
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4.1 Summary 
 
The crosslinker is a small molecule which is used to chemically link synthetic polymer threads or 
biomolecules into a complex superstructure with distinct properties. Molecules that are currently 
used today as crosslinking agents include divinyl and multivinyl agents that work via radical 
polymerization, cysteine amino acids which produce disulfide linkages, as well as metal ions 
which establish connections with monomers by forming ionic bonds. In this work, we created a 
di-functional bio-orthogonal dioxyamine crosslinker which was used to assemble cells into 
complex 3D tissues. The GFP- and RFP- expressing fibroblasts were surface engineered to 
present ketone functionalities via liposome fusion and crosslinked with the dioxyamine 
crosslinker into 3D spheroids. The technology was also used to assemble hepatocytes, stellate 
cells and endothelial cells into a functional liver tissue for the drug toxicity studies. Unlike 
previously used technologies, this novel method is scaffold free and does not rely on the use of 
exogenous polymer materials to support the cell mass.     
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4.2 Introduction 
 
 
Cross-link has been used as a general term in both synthetic polymer science and biological 
science to describe covalent or ionic bonding between different polymer chains, including 
synthetic polymers and natural polymers like proteins. By cross-linking polymer chains via a 
cross-linking agent, also called a cross-linker, a polymer network and even a macromolecule with 
infinite moleculular weight can be obtained, thus modified physical and chemical properties as 
well as a variety of important applications may be achieved.1-3  
 
In polymer science, a cross-linker is usually a divinyl or multivinyl agent, through which 
radical polymerization or copolymerization of vinyl monomers can be extended to a cross-linked 
network. To date, radical polymerization and cross-linking is still the main stream in conventional 
the polymer system, and nearly 50% of all commercial synthetic polymers are produced via 
conventional radical polymerization and cross-linking.1,4-6 By simply adjusting the conditions of 
cross-linking, physical and chemical properties of polymers can be modified significantly, and 
various polymers can be produced on demand.7-9 Thus, divinyl and multivinyl cross-linkers have 
been considered  crucial components to  polymer science and industry.10,11  
In biological science, non-vinyl cross-linking compounds containing two reactive 
functionalities is also widely used and have played an important role in a range of biological 
applications.12-14 For instance, chemical cross-linking of proteins via a bifunctional cross-linker is 
very important in the stabilization and analysis of the native molecular structures of proteins, 
enzymes and oligopeptides.15-18 Another example is the bifunctional alkylator, also known as DNA 
cross-linker, which has been used as an important class of cancer chemotherapeutic regimens.19  
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Moreover, there are many other types of cross-linkers such as metal ions,20-23 proteins with two or 
multiple binding specificities,24-27 etc.  
 
While cross-linkers and cross-linking systems have been broadly used in many fields like 
polymer, biology, biomaterial, and even nanomaterial,28-31 the concept and application are still 
limited to the construction of a material network from chemical monomers. For the first time  live 
cells have  been considered  monomers in the construction of  3D tissue networks,  thus  enabling 
the ability to control cell assembly and tissue construction for a range of important applications 
such as regenerative medicine, tissue engineering, and organ transplantation.   
To date, 3D cell culture and tissue construction still rely heavily on 3D matrices such as 
collagen, gelatin, alginate, and agarose hydrogels, as well as other porous polymer scaffolds and 
decellularized organ scaffolds. However, there are many challenges associated with the use of 3D 
matrices for cell based research and applications, including the stability of scaffolds, toxicity of 
degradation products, potential inflammation and immune responses, interference with cell-cell 
interaction, and unpredictable impacts on signaling pathways.32 Moreover, despite the fact that 
some biocompatible scaffolds can mimic the extracellular matrix and allow cells to adhere and 
proliferate, these man-made environments are still not ideal for making applicable tissues and 
organs. Therefore, scaffold-free tissue construction methodology would be of central importance 
to future applications in tissue engineering and regenerative medicine.  
Herein, we developed a new cross-linking system as well as a new technique based on the 
cross-linking of surface-engineered cellular “monomers”. This new, innovative system has been 
demonstrated to be applicable to  a variety of biological studies, and is also expected toexpand to 
applications in nanomaterials, micro-size materials and micro-size biological units under the 
condition that  they can be surface-tailored to present certain functionalities which are clickable to 
126 
 
specific cross-linkers. In particular, a bioorthogonal oxime chemistry was introduced into our 
system for cross-linking ketone-tailored cells via a dioxyamine cross-linker. Oxime conjugation 
between an oxyamine and ketone is well known to be efficient and bioorthogonal under 
physiological conditions.33-36 By installing ketone functionality onto the cell surface through a 
universal surface engineering method,37-40 any type of cell can be assembled together by a 
poly(ethylene glycol)- or oligo(ethylene glycol)-based dioxyamine cross-linker.  
In this work, it is the first time that a biocompatible difunctional cross-linker was integrated 
with a recently developed cell surface engineering method for cross-linking live cells and 
achieving controllable cell assembly and 3D tissue construction. Based on this novel system, 
scaffold-free tissue construction can be easily achieved.  
 
4.3 Experimental 
All chemical reagents were obtained from Sigma-Aldrich and Fisher Scientific. O-
Dodecyloxyamine was synthesized as previously reported.37 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) were 
purchased from Avanti Polar Lipids (Alabaster, AL). 3T3 Swiss Abino Fibroblasts were purchased 
from ATCC. RFP Expressing Human Neonatal Dermal Fibroblasts (RFP-HNDFs) were purchased 
from Olaf Pharmaceuticals. NIH3T3/GFP cell line was purchased from Cell Biolabs, Inc. These 
cell lines were transferred by Cedarlanelabs (Burlington, Canada). Immortalized human 
hepatocytes Fa2N-4 (cells that were transformed with the SV-40 large T antigen), were obtained 
from Xenotech, KS.  Primary human hepatic stellate cells (STeC) were obtained from Sciencell, 
CA. Primary human hepatic sinusoidal endothelial cells (EC) and their medium were purchased 
from Sciencell, CA. 
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4.3.1 Synthesis of Dioxyamine Crosslinker 
 
To a round bottom flask equipped with a stir bar was added TEG (1 eq.) in THF. To this solution 
was added Et3N (2 eq.) and a catalytic amount of DMAP. To this mixture a solution of 4-
toluenesulfonyl chloride (2 eq.) in THF was added to the reaction mixture and the reaction was 
allowed to proceed for 24 h. The reaction mixture was then filtered and concentrated in vacuo to 
remove THF. The resulting residue was then diluted with DCM and the mixture was washed with 
a saturated aqueous solution of ammonium chloride and the aqueous phase was separated.  The 
organic phase was washed with brine, dried using magnesium sulfate and concentrated in vacuo.  
The crude product was purified by flash column chromatography (hexanes: EtOAc, 1:1) to yield 
the product as a clear oil. 
 
  
 
To a round bottom flask equipped with a stir bar was added N-hydroxyphthalimide (2 eq.) and 
NaHCO3 (2 eq.) in DMF. This mixture was stirred at 80°C for 1 h, until turning dark brown. A 
solution of tosylated TEG (1 eq.) in DMF was added dropwise and the reaction was allowed to 
proceed for 24 h at 80°C. Upon completion, the reaction mixture was filtered and concentrated in 
vacuo to remove DMF. The product was washed with DCM and saturated ammonium chloride 
and the aqueous phase was separated.  The organic phase was washed with brine, dried using 
magnesium sulfate and concentrated in vacuo.  The crude product was purified by flash column 
chromatography (hexanes: EtOAc, 1:1) to yield a clear oil product. 
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To a round bottom flask equipped with a stir bar was added the phthalate  (1 eq.) in DCM. To this 
solution was added hydrazine hydrate (10 eq.) dropwise and the reaction was allowed to proceed 
for 24 h at r.t. Upon completion, the excess hydrazine was washed with water and the aqueous 
phase separated.  The organic phase was washed with brine, dried using magnesium sulfate and 
concentrated in vacuo to yield the product as a pale yellow oil. 
 
4.3.2 Preparation of Functionalized Liposomes 
Liposomes were prepared as previously reported. The ligand to be incorporated into the liposome 
was added to CHCl3 to make a 10 mM solution. To 60 𝜇L of this solution was added 430 𝜇L of 
POPC solution (10 mg/mL) and 10 𝜇L of DOTAP solution (10 mg/mL).  This mixture was then 
concentrated in vacuo to remove CHCl3. To the thoroughly dried mixture was added 3 mL PBS to 
make a 1.5 mg/mL suspension, which was then sonicated by tip sonicator for 20 min to make a 
clear liposome solution. 
 
4.3.3 Cell Culture 
3T3 Swiss Abino Fibroblasts, RFP Expressing Human Neonatal Dermal Fibroblasts, and 
C3H/10T1/2 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) with 10% fetal 
bovine serum (FBS) and 1% penicillin/streptomycin. NIH3T3/GFP cells were cultured in DMEM 
containing 10% FBS, 0.1 mM MEM Non-Essential Amino Acids, 2 mM L-glutamine, 10 μg/mL 
Blasticidin, and 1% penicillin/streptomycin. Immortalized human hepatocytes Fa2N-4 were 
cultured on collagen I-coated plates in multifunction enhancing (MFE) plating medium containing 
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10% newborn calf serum (Xenotech, KS), and 1% penicillin/streptomycin solution. At 24h upon 
plating, the medium was replaced with MFE serum-free support medium containing component 
A. The medium was replaced every 48h. The cells were passaged upon reaching confluence (every 
3-4 days). Primary human hepatic stellate cells (STeC) were cultured on poly-L-lysine-coated 
plates in stellate cell medium (SteCM) consisting of 500ml basal medium containing 5ml of 
stellate cell growth supplements (SteCGS), 10ml of fetal bovine serum (FBS) and 5ml of 
penicillin/streptomycin solution. The cells were passaged upon reaching confluence. The medium 
was changed every 48h. Primary human hepatic sinusoidal endothelial cells (EC) were cultured on 
fibronectin-coated plastic plates in endothelial cell medium (ECM) containing 5ml of endothelial 
cell growth supplement (ECGS), 25ml FBS and 5ml penicillin streptomycin solution in 500ml of 
basal medium. The cells were passaged upon reaching confluence (every 2-3 days) and the medium 
was changed every 48h. All these cells were incubated at 37°C in a humidified atmosphere of 5% 
CO2, and released from tissue culture plates using 0.05% trypsin in 0.53 mM EDTA.   
 
4.3.4 Cell Surface Engineering via Liposome Fusion 
To fresh cell media was added 5% volume of functionalizing liposome solution. The cells were 
maintained in this media for 4h before exchanging the media.  
 
 
4.3.5 Cell – Cell Crosslinking  
To a ketone functionalized cell suspension was added 5% volume of 100 mM oxyamine 
crosslinking solution to reach a final concentration of 5 mM. Cells were maintained in this media 
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for 30 min, and then pipetted onto glass substrates for imaging or further maintenance. A control 
sample was also prepared using cells bearing no functionality. 
 
4.3.6 Confocal Microscopy 
The cell samples for confocal microscopy were fixed with formaldehyde (3.2% in PBS) for 20 
min, rinsed with PBS, and then secured in fluorescence mounting medium (Dako, Carpinteria, CA, 
USA), which enhances the visualization of cells when viewed under a fluorescent microscope, 
with a thin glass cover slip. The mounted samples were imaged by Zeiss LSM 700 laser scanning 
confocal microscope and analyzed by ZEN 2000 imaging software. 
 
4.3.7 Liver Tissue Assembly 
Prior to tissue assembly the cells were allowed to reach 90-100% confluence. After that, all cells 
were treated with ketone liposome solution (50µl of liposomes/1ml of medium) and incubated at 
37oC for 4h. The medium was discarded and the cells were washed with PBS twice. Following 
that, the ketone- and oxyamine-tethered cells were removed from the plate with 0.25% trypsin and 
centrifuged down at 800rpm. The medium was discarded and ketone-labeled hepatocytes, stellate 
cells and endothelia cells were mixed with crosslinker solution for 30 min, before placed on 12-
well (3.7cm2) collagen I-coated plates and given a slight shake to induce cells assembly. Each 
mixed (co-culture) 2D or 3D sample contained ~1x105 of Fa2N-4 hepatocytes, ~1x105 of HSEC 
and ~ 5x104 of HSC. Each 2D and 3D hepatocyte-only culture contained~1x105 of Fa2N-4 
hepatocytes. The cells were than incubated at 37oC and 5%CO2 for 16h to achieve full spreading 
of cells in the tissues. Upon spreading of cells, fresh MFE plating medium was added onto the 
plates. After 24h, the medium was replaced with 1:1 mixture of MFE support medium and ECM.  
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4.3.8 Immunohistochemistry and Confocal Microscopy 
Prior to tissue assembly cells were incubated in serum-free medium containing fluorescent 
live stain (Life Technologies). Fa2N-4 hepatocytes, endothelia cells, and stellate cells were treated 
with 25µM CellTracker™ Blue CMAC (7-amino-4-chloromethylcoumarin), 25µM CellTracker™ 
Green CMFDA (5-chloromethylfluorescein diacetate), and 25µM CellTracker Red CMTPX 
respectively. The cells were incubated for 45min, after which they were washed thoroughly with 
PBS and incubated in serum-free medium for another 45min. Following that, the cells were 
assembled into 3D tissues and incubated for 24h. Subsequently, the tissues were fixed with 10% 
formalin for 30min and visualized with LSM-700 (Zeiss) confocal microscope.  
 
4.3.9 Activation of Cytochrome P450 3A4  
To induce cytochrome P450 3A4, the 3D tissue samples were incubated in MFE support 
medium containing 10µM Rifampin (Sigma) for 72h at 37oC, 5% CO2. The control samples were 
treated with DMSO vehicle only for calculation of fold activation.  The medium was changed 
every 24h. The samples were analyzed via P450-Glo™ CYP3A4 Assay Kit (Luciferin-IPA) 
(Promega) by using the manufacturer’s instructions for the non-lytic cycle. The sample’s medium 
was replaced with fresh MFE support medium containing 3µM Luciferin-IPA and the samples 
were incubated for 50min. Following that, 50µl of medium was transferred into white 96-well 
plate. After that, 50µL of the detection reagent was added into each well. The samples were 
covered with the aluminum foil and incubated for 20 min at room temperature. The lumiscence 
was read using Biotek Synergy Multi-detection Plate Reader.  
 
4.3.10 Albumin Analysis of Liver Tissues 
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Liver tissues were maintained for 14 days before culture medium was collected from the 
samples. The albumin content was measured via Human Albumin Pincer Assay kit (Mediomics). 
New medium (1:1 MFE support medium and ECM) was added 24h prior to collecting it for 
albumin quantification.   
 
4.3.11 Liver Toxicity Assays 
Liver tissues were incubated with 7.5µM Cyclophosphamide dissolved in MFE support 
medium for 16h. The control samples were treated with DMSO vehicle. Subsequently, the cell 
viability was analyzed by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
assay (Sigma), where the tetrazolium ring is cleaved by mitochondrial dehydrogenase enzymes.  
The samples were incubated in DMEM phenol red-free medium containing MTT reagent for 1h 
resulting in production of a purple precipitate which was subsequently dissolved in 1:1 solution of 
isopropanol and DMSO. The absorbance was measured at 570nm using Synergy Biotek device. 
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4.4 Results and discussion 
As shown in Figure 1, a lipid-like molecule (dodecanone) was mixed with a neutral lipid, 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and a cationic lipid, 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP), in order to make a functionalized liposome, which was 
then used for cell surface engineering (Figure 1A). After cells were engineered with the lipid-like 
molecule (2-dodecanone) to present a functional group (ketone) on cell membrane, the specially 
designed cross-linker (dioxyamine) can then chemoselectively react with the functional groups 
(ketone) on cells surfaces. Although any bioorthogonal molecular recognition pair can be 
integrated into this universal surface engineering and cross-linking system, a low-toxicity and 
water-soluble ethylene glycol based dioxyamine was used as the cross-linker in this work, while a 
ketone group was introduced to cell surface as the chemoselective recognition group. Oxime 
conjugation between an oxyamine and ketone is well known as bioorthogonal, stable and efficient 
under physiological conditions. Based on our cell surface engineering system, there are only a 
small amount (several thousand) of functional groups (ketones) present on each cell membrane.15 
This means that ketone molecules were so dispersed on cell surface that the distance between any 
two ketone molecules can be considered infinitely large compared to the molecular length of the 
cross-linker, thus the chance of one dioxyamine quenched by two ketones on the same cell surface 
is negligible. With excess dioxyamine cross-linker in cell suspension, multivalent oxime bonding 
between dioxymine cross-linkers and ketones among different cells can be achieved, and various 
cells can be cross-linked and assembled into spheroids and microtissues due to the interfacial 
oxime conjugation (Figure 1B). When different cell lines were surface-engineered with ketones 
and mixed in presence of dioxyamine cross-linker, multicellular cross-linking and three-
dimensional (3D) co-culture tissue can be constructed on demand (Figure 1C).       
134 
 
 
 
Figure 4.1. Schematic of cell surface engineering and cross-linking surface-engineered cells. 
(A) Liposome formation. Functionalized liposomes were made from POPC, DOTAP, and lipid-
like molecule with functionalized group (ketone). (B) Cell surface engineering and cell cross-
linking. Functionalized Liposomes were fused to cells to engineer cells surface to present 
functional group (ketone), which can then react with a specially designed cross-linker with 
chemoselective reacting group (oxyamine), to form a stable chemical bonding (oxime). Based on 
this interfacial chemoselective oxime conjugation, which is very efficient and stable under 
physiological condition, surface-engineered cells can be easily clicked and assembled to form 
clusters and microtissues. (C) By integrating cell surface engineering and crosslinking strategies, 
various ketone-labelled cell lines can be assembled together by the dioxyamine cross-linker to 
construct multicellular co-culture systems and three-dimensional (3D) tissues on demand. 
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To test the integrated surface engineering and crosslinking system, different cell lines were 
incorporated into this work as shown in Figure 4.2. As a representative study, RFP expressing 
human neonatal dermal fibroblasts (RFP-HNDFs) were surface-engineered with ketone groups, 
which efficiently react with an oxyamine group when a dioxyamine cross-linker was introduced 
to the cell suspension. After multivalent oxime bonding among different cell membranes, RFP-
HNDFs were locked together and cell spheroids were observed in a short period of time (15 min). 
In comparison, control experiment with the same condition but no cross-linker involved showed 
no spheroids (Figure 4.2A).  In another representative study, GFP expressing NIH3T3 (GFP-
NIH3T3) cells were also surface-engineered with ketone molecules by the same method. After 
mixing the ketone-tailored GFP-NIH3T3 cells with dioxyamine cross-linker, GFP-NIH3T3 
spheroids can be observed in 15 min, while no spheroid was found in the control experiment in the 
absence of cross-linker. In order to further test our system for future tissue engineering application 
and tissue construction purpose, which requires assembly of multiple cell lines to build up 
multicellular co-culture system,  RFP-HNDFs and GFP-NIH3T3 cells were both surface-
engineered and then incorporated into the cross-linking system to achieve co-cultured microtissue 
as shown in Figure 4.2C. In a common co-culture system, different cell lines usually have the 
tendency to exclude other cell populations and find their own population. This phenomenon leads 
to uncontrollable cell separation in a normal co-culture system. However, our cross-linking system 
allows different cell populations to be efficiently locked together and well connected on demand. 
This important merit provides a great opportunity for studying controllable cell-cell contact as well 
as intercellular interaction between different cell populations.  To further exhibit the potential of 
this powerful strategy, a representative application in liver tissue engineering was performed in 
this work.  
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Figure 4.2. Schematic and fluorescent microscopy showing cross-linking and assembly of 
surface-engineered cells. (A) Ketone-tailored RFP expressing human neonatal dermal fibroblasts 
(RFP-HNDFs) were assembled by the dioxyamine cross-linker to form RFP-HNDFs spheroid 
microtissue. Control treated with the same conditions except cross-linker resulted in regular cell 
culture. (B) Ketone-tailored GFP expressing NIH3T3 (GFP-NIH3T3) cells were assembled by the 
dioxyamine cross-linker to form GFP-NIH3T3 spheroid microtissue. Control without cross-linker 
showed regular cell culture. (C) Mixing surface-engineered RFP-HNDFs and GFP-NIH3T3 with 
the cross-linker resulted in co-culture spheroid microtissue, while control without cross-linker 
showed random cells mixture.    
 
The liver is one of the most important organs in the human body and has over 500 functions 
including the metabolism of proteins, carbohydrates, and lipids; detoxification of endogenous and 
exogenous compounds; the production of bile for digestion; and secretion of many serum proteins 
(i.e. albumin, coagulation factors). Despite significant efforts devoted to liver tissue study and 
engineering, the liver tissue remains one of the most difficult tissues to reconstruct and analyze in 
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the laboratory. The main reason is that hepatocytes are very difficult to maintain and rapidly lose 
liver-specific functions under in vitro conditions. The most common method for the maintenance  
of liver functionality and to allow for  hepatocytes to survive longer,  coculture systems are 
fabricated or 3D tissue/scaffold hybrids are constructed to provide the specific cell-cell contact 
hepatocytes require. While various methodologies were developed for better maintenance of 
hepatocytes and certain functions, construction of scaffold free 3D liver tissue remains 
challenging.  
In this work, 3D liver tissue was constructed via the integrated crosslinking and surface 
engineering system as another representative application. Through surface engineering liver cells 
such as hepatocytes, stellate cells, and endothelial cells, ketone functionality can be installed onto 
the cell membranes to allow for an interfacial oxime reaction with a dioxyamine cross-linker in 
physiological conditions.  In particular, 3D multilayer tissue can be constructed by mixing three 
ketone-engineered liver cell lines with the bioxyamine cross-linker, while 2D monolayers can be 
obtained without a cross-linker (Figure 4.3A). By altering the conditions of the crosslinking 
system, various cell assembly and tissue constructions can be achieved. For instance, multicellular 
spheroids can be made by coculturing three engineered cell lines in the presence of a crosslinker 
for 20 min (Figure 4.3B).   More importantly, 3D multilayer hepatocytes (Figure 4.3C) and 3D 
multilayer coculture liver tissues (Figure 4.3D) were constructed on demand. Without 
incorporating the integrated cross-linking system, only a 2D monolayer was obtained (Figure 
4.3E). It was observed that the liver tissue constructed by the cross-linking system can survive and 
maintain liver specific functionality for several weeks (data not shown here). This merit is of 
central importance to potential liver chip fabrication and drug analysis.  
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Figure 4.3. Constructing model 3D liver tissue by the integrated surface engineering and 
cross-linking system. (A) Surface-engineered liver cell lines including hepatocytes (Hep), stellate 
cells (STeC), and endothelial cells (EC), were assembled together by the cross-linker to form a 3D 
co-culture multilayer tissue. Control without cross-linker resulted in 2D monolayer. (B) Overlay 
fluorescent micrograph of liver spheroid microtissue. (C) Confocal microscopy images (3D view 
and side view) of multilayer 3D hepatocytes, made by mixing surface-engineered hepatocytes with 
cross-linker.  (D) Confocal microscopy images of multilayer 3D co-culture tissue, made by mixing 
three surface-engineered liver cell lines with a cross-linker. (E) Confocal images of 2D monolayer, 
made by mixing three surface-engineered liver cell lines but without cross-linker. Hepatocytes 
(Hep), stellate cells (STeC), and endothelial cells (EC) were live stained with blue, red, and green 
respectively. Scale bars represent 50 µm. 
 
Since the 3D multilayer live tissue can be easily fabricated on demand, a further exploration 
was performed  to evaluate and demonstrate the potential applicability of our system in  liver chip 
studies. To make a parallel comparison, standard liver assay and drug toxicity tests were performed 
simultaneously based on various liver tissues, including a 2D coculture monolayer, 3D coculture 
multilayer, 2D hepatocytes monolayer, and 3D hepatocytes multilayer (Figure 4.4). With the same 
amount of cells involved in all the liver chips, different levels of albumin expression and drug 
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resistance were recorded. It was found that the 3D multilayer liver chips are far superior to the 2D 
monolayer liver chips comparing the albumin expression, which is a well-known liver-specific 
function. Moreover, the 3D multilayer coculture liver chip is superior to others comparing the drug 
resistance (cyclophosphamide, 7.5 mM). Therefore, based on this study, it can be concluded that 
the 3D coculture multilayer liver chip is superior at both albumin expression and drug resistance. 
This preliminary result showed a great potential of the 3D coculture liver chip as future candidate 
of liver-specific functions and drugs screening.  
 
Figure 4.4. Constructed model 3D liver tissue for liver chip assay application. (A) Liver 
microtissues were constructed by the integrated surface engineering and cross-linking system, and 
applied as liver chip for the liver assay study and drug analysis. (B) Albumin assay was performed 
and analyzed based on the constructed liver chips. (C) Liver toxicity test of Cyclophosphomide 
(7.5 mM) was performed and analyzed based on the constructed liver chips. 
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4.5 Conclusion 
In this work, a scaffold-free tissue assembly method has been developed by integrating a 
cell surface engineering strategy with a novel cell cross-linking method. Based on this surface 
engineering strategy, many different cell lines can be tailored with specific functionalities allowing 
for interfacial conjugation with corresponding cross-linkers to achieve efficient cell-cell assembly 
and tissue construction. In this work, ketone-tailored cells and a low-toxicity tetra(ethylene 
glycol)-based dioxyamine crosslinker were introduced as a demonstration of this universal 
methodology. Due to the efficient bioorthogonal conjugation between ketone and oxyamine, a 
variety of ketone-tailored cells were cross-linked via the dioxyamine cross-linker, resulting in 
multicellular tissue formation on demand. As a representative application of this integrated system, 
three major liver cells were surface-engineered and cross-linked to form 3D liver tissue, which 
was then used as a 3D liver chip for a liver function assay and drug analysis. This integrated cell 
surface engineering and cross-linking methodology provides us with an incredible opportunity for 
the efficient and controllable assembly of any cell lines, and can open the doors for a range of 
future applications in tissue engineering, regenerative medicine, and organ transplantation. 
 
 
 
 
 
 
 
141 
 
4.6 References 
 
1. Matyjaszewski, K. (Krzysztof), Gnanou, Y., Leibler, L. & Wiley InterScience (Online 
service). Macromolecular engineering : precise synthesis, materials properties, 
applications. (Wiley-VCH, 2007). 
2. Li, B. et al. A New Strategy to Microporous Polymers: Knitting Rigid Aromatic Building 
Blocks by External Cross-Linker. Macromolecules 44, 2410–2414 (2011). 
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Chapter 5 
Assembly of Cells into 3D Tissues via Bio-orthogonal 
Chemistry and Preferential Differentiation of Stem Cells 
in Co-cultures with Controlled Cell Orientations. 
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5.1 Summary 
 
In vivo, cells exist in a complex environment where they interact with other cell types via 
cytokines and physical contact. It is important to recapitulate the natural 3D structure of tissue 
for use in organ transplantation, biological modeling and drug screening. For the successful 
formation of 3D tissue ex vivo, one requires a method for the assembly of cells from different 
cell types into multilayers with controlled orientation. The technology must be selective, non-
cytotoxic, applicable under physiological conditions and inexpensive. Here, we introduce a 
method which is based on bio-orthogonal oxime chemistry. In this study, we tailored cell 
membranes with oxyamine- and ketone-functionalized lipids which were delivered onto cell 
membranes via liposome fusion. The cells with functionalized cell surfaces were mixed in a 
small volume and the functional groups on cell membranes clicked with each other producing a 
covalent oxime bond, resulting in cell assembly. The oxime click-chemistry method can be used 
to assemble cells from different cell types into 3D co-cultures with variable thickness, cell 
composition and orientation within the co-culture.  
In this project we applied the oxime click-chemistry method to assemble cells into 
different 3D co-cultures to study stem cell differentiation. Two types of stem cells, hMSC and 
C310T1/2, were assembled into 3D structures with different orientations and treated with 
adipogenic or osteogenic factors to induce differentiation. The orientation of the cells in the co-
culture influenced the rate of stem cell differentiation and choice of lineage. 
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5.2 Introduction 
 
Cell behaviour is determined by multiple factors such as hormones, cytokines and 
physical interactions between cells in a complex three-dimensional (3D) environment1-4. The 
interplay of these signals results in coordinated cell behaviours such as migration, differentiation 
and apoptosis5-7. Therefore, developing in vitro systems capable of recapitulating the natural 
interactions between cells is important for further advancement in medicine, pharmaceutical 
science and fundamental biology8-10. Traditional tissue culture methods involve culturing cells in 
monolayers on various substrates. In vivo, however, cells form complex 3D tissues composed of 
multiple cell layers11. Formation of tissues in vitro requires the assembly of different cell types 
into organized 3D structures with defined orientations. This co-culture system must also enable 
intercellular communication and the formation of cell-cell junctions, which is challenging12-14. In 
recent years, numerous attempts have been made to construct 3D tissues using materials such as 
hydrogels, polymers and components of the extracellular matrix15-18. The major limitation of 
these technologies is that the material, which works as a scaffold, occupies space within the 
tissue and creates a physical barrier between the cells. As a result, instead of forming cell-cell 
junctions, the cells attach to the scaffold material, hampering physical and cytochemical 
signaling19. Therefore, a new strategy is needed to assemble cells into multi-layers with a 
controlled 3D orientation while maintaining effective intercellular communication. The method 
must be inexpensive, precise and non-cytotoxic. It has to utilize a minimal amount of material, 
be general for a range of cell types, be simple and quick and allow scaling for mass production.  
Our group has developed a methodology which is based on bio-orthogonal lipids 
delivered onto cell surfaces via liposome fusion (Figure 5.1). A reaction between two functional 
groups, an oxyamine and a ketone, results in the formation of an oxime bond. The reaction is 
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quick, chemoselective, non-cytotoxic and occurs under physiological conditions (37°C, pH 7).20-
24 Cells with engineered cell membranes can be mixed together and the functional groups on the 
membranes will react and form a strong covalent bond, thus attaching these cells together. Using 
bio-orthogonal click chemistry it is possible to click-assemble cells into 3D structures with 
controlled orientations.25 These multilayers can be used for two different purposes: to study 
cellular behavior in 3D as well as to construct functional tissues for transplantation and drug 
testing.26,27 
 
 
 
 
 
 
Here in, we developed a scaffold-free system to assemble stem cells into 3D co-cultures 
with controlled orientation and studied stem cell differentiation in 3D co-culture. 
 Human mesenchymal stem cells (hMSC) are very important tool of regenerative 
medicine.28-30 These stem cells are multipotent and are capable of differentiating into three major 
lineages: adipogenic (fat), osteogenic (bone), and chondrogenic (connective tissue).31 The ability 
to be transformed into different cell types, makes hMSC useful for the development of artificial 
tissues and organs.  The goal of this project is to assemble two different types of stem cells: 
Figure 5.1: The schematic representation of cell surface engineering and the bio-
orthogonal reaction between oxyamine and ketone functionalities. The delivery of bio-
orthogonal ketone and oxyamine groups onto cell surfaces is accomplished via liposome 
fusion and results in the formation of two differently labeled cell populations. When the 
ketone- and oxyamine-tethered cells are brought into contact, oxyamine and ketone groups 
click with each other, producing a stable oxime bond and resulting in cell assembly. 
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mouse embryonic fibroblasts (C3H 10T1/2) and human mesenchymal stem cells into 3D co-
cultures with different orientations and to study how the orientation of stem cells in co-culture 
affects the rate of their differentiation as well as the lineage into which these cells differentiate.  
 
5.3 Experimental  
 
5.3.1 Tissue Culture 
Human mesenchymal stem cells (hMSC) were obtained from Lonza (Bazel, Switzerland). 
Mouse embryonic fibroblasts (C3H10T1/2) were obtained from Prof. McDermott’s group. The 
cells were cultured in high-glucose (4500 mg/L) Dulbecco’s Modified Eagle’s Medium 
(DMEM) with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin solution at 37°C and 
5% CO2.  
To passage the cells, the medium was removed and the cells were washed twice with 
phosphate buffered saline (PBS). After that, the cells were treated with 0.25% Trypsin-EDTA for 
3 min, followed by the neutralization of the Trypsin solution with two volumes of medium. The 
cells were centrifuged at 800 rpm for 5 min, and the cell pellet was re-suspended with DMEM 
and passaged onto new plates. All experiments involving hMSC were conducted with cells at 
passage 4. 
 
5.3.2 Formation of Liposomes 
   To form oxyamine- and ketone-tethered LUVs, chloroform solutions of palmitoyl-oleoyl 
phosphatidylcholine (POPC);  1,2-dioleoyl-3-trimethylammonium-propane (DOTAP); 
dodecanone (for ketone-containing liposomes); and O-dodecyloxyamine  (for oxyamine-
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containing liposomes) were mixed as follows: POPC (430 L,10 mg/mL in CHCl3 at 86 mol %); 
DOTAP (10L, 10mg/mL in CHCl3 at 2 mol %); and O-dodecyloxyamine or dodecanone (60 
L, 10 mM in CHCl3 at 12 mol %). The samples were air-dried for 18 h and then re-suspended 
in 3 mL of PBS (pH 7.4). The mixture of lipids was then sonicated with a tip sonicator for 20 
min until the solution was clear.  
 
5.3.3 Formation of Cell Multi-layers 
Prior to the formation of cell multi-layers, both hMSC and 10T1/2 cells for both the top 
and the bottom layers were cultured to 95–100% confluence. 
Liposomes were mixed with DMEM in the following proportions: 50 µL of liposome 
solution per 1 mL of medium. The cells were incubated with the liposomes for 4 h at 37°C. After 
that, the medium was removed and the cells were washed twice with PBS. Following that, the 
oxyamine-labeled cells were removed from the plate with 0.25% trypsin and centrifuged down at 
800 rpm, the medium was decanted and the cells were re-suspended with 3 mL of fresh medium 
and added to the plate containing ketone-labeled cells. The average concentration of cells seeded 
as the second layer was 1.5 x 105 cells per 1 mL of medium. 
 
5.3.4 Adipogenic Differentiation  
hMSC and 10T1/2 cells (monolayers, multi-layers and spheroids) were induced with 
DMEM (Sigma), containing 4500 µg/mL of glucose 10% FBS, 1 µM dexamethasone (DEX) and 
500 µM 3-isobutyl-1-methylxanthine (IBMX) and 1 µg/mL insulin for 7 days at 37°C, 5% CO2.  
After that, the cells were cultured for 11 more days in DMEM containing 4500 µg/mL of 
150 
 
glucose; 10% FBS; 1% penicillin-streptomycin; and 1 µg/mL insulin at 37°C, 5% CO2. The 
medium was changed every 3-4 days. The samples were run in triplicates. 
 
5.3.5 Preferential Differentiation 
For the first 7 days, monolayers and multi-layers and spheroids of hMSC and 10T1/2 
cells were in the medium containing 4500 µg/mL of glucose, 10% FBS and the following 
combination of adipogenic and osteogenic inducing factors: 1 µM DEX and 500 µM IBMX, 1 
µg/mL insulin, 10mM β-Glycerophosphate and 0.05mM L-ascorbic acid-2-phosphate at 37°C, 
5% CO2. After that, the medium was changed to DMEM containing 4500 µg/mL of glucose, 
10% FBS, 100 nM DEX and 500 µM IBMX, 1 µg/mL insulin, 10mM β-Glycerophosphate and 
0.05mM L-ascorbic acid-2-phosphate and the cells were cultured for 11 more days at 37°C, 5% 
CO2. The samples were run in triplicates. 
 
5.3.6 Immunohistochemistry  
Adipogenic differentiation was characterized with staining by Oil Red O solution. The 
working solution of Oil Red O was prepared as follows: dry Oil Red O powder was dissolved in 
99.5% isopropanol to give a 3% stock solution (w/v). The stock solution was suction-filtered 
through a paper filter and the working solution was prepared by diluting 3 volume parts of the 
filtered stock solution with 2 parts of distilled water. After the 3D co-culture and adipogenic 
differentiation, hMSC and 10T1/2 cells were fixed with 3.8% formaldehyde for 15 min, then 
washed twice with PBS, once with water and once with 60% isopropanol (3–5 min). After that, 
the cells were stained with the working solution of Oil Red O stain (15 min), rinsed with water, 
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stained with Harris Hemotoxylin dye for 3 min, washed with water again and visualized with the 
light microscope.  
Osteogenic differentiation was characterized with Alizarin Red S staining. The cells were 
fixed with 10% formaldehyde for 20 min, rinsed with distilled water and incubated for 15 min in 
2% (w/v) solution of Alizarin Red S at pH 4.2. Then, the samples were washed twice with 
distilled water and visualized under the inverted light microscope.  
 
5.3.7 Cell Viability Assay 
The medium was decanted and the cells were washed twice with PBS. After that, the 
cells were incubated in a 0.4% solution of Trypan Blue (Sigma) for 2 min. The samples were 
subsequently washed twice with PBS and visualized under the light microscope. 
 
5.3.8 Statistical Analysis 
Following differentiation, the cells were stained and the images of the cells were taken 
with the bright field microscope. The degree of adipogenic and osteogenic differentiation was 
assessed using Image J. The program calculated the number of red pixels in the image. The 
number of red pixels was divided by the total number of pixels in the picture. The ratios were 
compared between the co-culture types. 10 images were taken per sample and there were 3 
samples in each category. The data were analyzed and graphed as a three-dimensional plot using 
Microsoft Excel 2010 software. The co-culture type with the highest level of differentiation was 
set to 100% and the data from other categories were adjusted relative to this value. 
 
5.3.9 Confocal Microscopy 
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The cells were fixed with 3.8% formaldehyde for 15 min, followed by permeation with 
0.1% Triton X for 30 min. After that, the cells were incubated for 2 h in the PBS mixture of the 
following dyes: 1 µg/mL phalloidin-TRITC (actin) and 0.3 µg/mL DAPI (nucleus). Cell multi-
layers were visualized with a Zeiss LSM-700 confocal microscope. The data were recorded and 
analyzed using ZEN software. On average, 50 images were taken to produce each 3D 
representation. The average exposure times were 400 ms for DAPI and 1200 ms for TRITC 
stains. 
5.3.10 RT-PCR 
Following adipogenic differentiation, the total RNA was extracted from the cells using 
RNeasy® kit (Qiagen). A total of 1 µg of total RNA was converted into cDNA using random 
primers and AMV reverse transcriptase in GoScript Transcription System (Promega). Following 
that, the cDNA was amplified using Hot Start Taq DNA Polymerase kit (New England Biolabs) 
using markers for 3 genes (Lp1, PPARγ2, β2mg).  The following primers were used:  
 
PPARγ2 (sense 5-GCTGTTATGGGTGAAACTCTG-3, antisense 
(5ATAAGGTGGAGATGCAGGCTC-3),  
 
Lpl (sense 5-GAGATTTCTCTGTATGGCACC-3, antisense 5-
CTGCAAATGAGACACTTTCTC-3’),  
 
β2mg (sense5-ACCCCCACTGAAAAAGATGA-3, antisense 5-
GCATCTTCAAACCTCCATGAT-3)  
 
The annealing temperatures for the primers are 55, 52 and 53°C respectively. The time for each 
amplification cycle was 1 min and 30 cycles in total were performed. The products were resolved 
via agarose gel electrophoresis β2mg at 1.5% agarose concentration. The transcript sizes are as 
follows:  351bp (PPARγ2), 276bp (Lpl) and 116bp (β2mg) respectively.   
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5.4 Results and Discussion  
The objective of this study was to generate 3D co-culture systems of hMSC and C3H 
10T1/2 cells with different cell orientations and then to study how the orientation of stem cells in 
the co-culture influences their differentiation. To form 3D multilayers the stem cells were first 
cultured in mono-layers and then treated with ketone- or oxyamine-tethered liposomes (Figure 
5.2). After that, the cells with engineered membranes were seeded onto the oxyamine- or ketone-
functionalized cell monolayers forming a multilayer.  
 
 
 
 
 
 
Figure 5.2: Schematic representation of 3D co-cultures of C3H 10T1/2 and hMSC generated via 
liposome fusion technology. Control of cell orientation via bio-orthogonal chemistry. A) A 
monolayer of  C3H10T1/2 was treated with ketone-tethered liposomes to produce a ketone-labeled 
cell monolayer which is seeded with oxyamine-labeled hMSC to produce a cell multilayer with 
controlled orientation. B) A monolayer of hMSC was treated with oxyamine-tethered liposomes to 
produce an oxyamine-labeled hMSC which was subsequently seeded with ketone-tethered  cells C3H 
10T1/2 to produce a multilayer with a reversed orientation. C) Ketone- and oxyamine-tethered C3H 
10T1/2 and hMSC were mixed together and seeded onto a substrate. D) All co-culture types were 
treated with adipogenic factors for 18 days and the percentage of differentiated cells was measured at 
different points in time to produce a 3D plot (the percentage of differentiated cells vs. co-culture type 
vs time).  
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Alternatively, a co-culture of mixed hMSC and C3H 10T1/2 cells with controlled cell orientation 
can be produced. The functionality of bio-orthogonal chemistry was demonstrated with GFP- 
and RFP-transfected NIH3T3 fibroblasts which were arranged into 3D structures (Figure 5.3). 
 
 
 
 
 
GFP and RFP cells treated with functionalized (ketone and oxyamine) liposomes could be 
arranged into 3D structures with thick green and red zones. The structures contain an average of 
three cell layers per zone, with a total of six cell layers. The thickness of these multilayers is ~50 
µm. GFP and RFP cells treated with liposomes containing no oxyamine or ketone groups (non-
functionalized liposomes) did not form 3D structures and remained as monolayers with an 
Figure 5.3: Control of orientation and thickness of cell multilayers via bio-orthogonal 
chemistry. Formation of cell zones with controlled orientation A) RFP expressing NIH3T3 cells 
transfected with functionalized (ketone and oxyamine) liposomes seeded with GFP-expressing 
NIH3T3 cells transfected with functionalized liposomes. B) Ketone-tethered RFP cells mixed with 
oxyamine-tethered GFP cells. C) Functionalized GFP cells seeded with functionalized RFP cells. 
RFP (E), GFP and RFP (F) or GFP (G) monolayers treated with non-functionalized liposome and 
seeded with fluorescent GFP or RFP cells treated with a ketone- or oxyamine-tethered liposomes. 
The scale bar is 50 µm.  
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average thickness of 10 µm. Therefore, cell multilayers can only form if ketone and oxyamine 
groups are present on the cell surfaces.  
 Using bio-orthogonal chemistry we can form co-culture systems with C3H 10T1/2 cells 
and hMSC stem cells with different orientations. The cells treated with oxyamine and ketone 
liposomes formed multilayers, while the cells treated with no liposome or non-functionalized 
liposome did not generate multilayers. Upon formation of multilayers, the cells were treated with 
adipogenic differentiation factors to observe which co-culture differentiates into adipocytes (the 
fat cells) the fastest (Figure 5.4). The cells were treated for 18 days and the adipocytes were 
stained with Oil Red O. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Multilayers of co-culture of human mesenchymal stem cells (hMSC) with 
murine (mouse) C3H10T1/2 fibroblasts and their adipogenic differentiation (visualized 
with Oil Red O staining). The table contains the schematic representation of the multiple 3D 
co-culture types of hMSC and C3H10T1/2 cells with controlled orientations (column 2), 
confocal images of cell multilayers (top and side views), Phaloidin TRITC (red)-actin, DAPI 
(blue)-nucleus (column 3) and the results of orientation-based adipogenic differentiation on day 
18. Adipogenic Oil Red O staining of differentiated hMSC and C3H10T1/2 cells was visualized 
under the light microscope (column 4). The scale bar is 50 µm. 
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Figure 5.4 (continued): Multilayers of co-culture of human mesenchymal stem cells 
(hMSC) with murine (mouse) C3H10T1/2 fibroblasts and their adipogenic differentiation 
(visualized with Oil Red O staining). The table contains the schematic representation of the 
multiple 3D co-culture types of hMSC and C3H10T1/2 cells with controlled orientations 
(column 2), confocal images of cell multilayers (top and side views), Phaloidin TRITC(red)-
actin, DAPI (blue)-nucleus (column 3) and the results of orientation-based adipogenic 
differentiation on day 18. Adipogenic Oil Red O staining of differentiated hMSC and 
C3H10T1/2 cells is visualized under the light microscope (column 4). The scale bar is 50 µm. 
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The average thickness of the cell bilayers was 12 µm, monolayer 7 µm, mixed 4–5 cell 
layers (25 µm). The orientation of cells in a multilayer influences stem cell differentiation. With 
oxime click-chemistry it is possible to control co-culture orientation and, to some extent, the 
thickness of cell zones in the multilayers. 
To further confirm adipogenic differentiation, we checked the stem cells for expression 
of PPARγ2 and Lpl, the adipogenic genetic markers,32 as well as β2mg – a control marker 
expressed in all human cells.33 The RT-PCR analysis confirmed the expression of these markers 
in adipogenically-induced cultures.  
The results of the differentiation experiment are summarized as a 3D plot (Figure 5.5). 
This plot shows a difference in the rate of stem cell differentiation depending on orientation.  
 
 
 
 
 
 
 
 
 
 
Figure 5.5: 3D plot describing the rate of adipogenic differentiation based on stem cell orientation. 
(A) The x-axis is the co-culture orientation, the y-axis is the time points at which the adipogenic 
differentiation was measured (Days 0, 6, 13 and 18), and the z-axis represents the percentage 
differentiation, with the most profound differentiation adjusted to 100%. n=3. Average SEM= ±4.2%. 
P<0.05  B) The RT-PCR of hMSC on day 18, depicting the expression of adipogenic markers (PPARγ2, 
LPL) and the loading control marker β2mg in cells treated with adipogenic differentiation media (+) and 
the control group treated with standard media (DMEM) only (-). 
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Out of all the orientations, the co-culture system with 10T1/2 cells on the bottom and 
hMSC cells at the top differentiates the fastest. The process of liposome fusion does not affect 
the rate of adipogenic differentiation, as can be seen from the graph, where the percent of 
differentiated hMSC and 10T1/2 cells does not vary regardless of whether they were treated with 
a non-functionalized liposome or no liposome at all. 
These data are the first to show that the oriented tissue microenvironment influences the 
rate of stem cell differentiation. These studies would not be possible without quick and 
controlled cell assembly to form multi-layers of various orientations.  
Physical and cytochemical interactions between cells are of great importance to biology 
and medicine. Understanding how a microenvironment created by physical and cytochemical 
interactions between cells influences stem cell fate (direction of stem cell differentiation) is 
highly relevant for multiple fields such as biology, bio-engineering and health care.19 Therefore, 
the development of methods to direct stem cell differentiation is of major biotechnological and 
medical interest. One of the interesting questions to answer is: Do stem cells alter the direction of 
their differentiation depending on orientation in co-culture? To study the potential dependence of 
stem cell fate on orientation in co-culture, we compared co-culture multilayers of two different 
types of stem cells (hMSC and C3H10T1/2) with different orientations to observe the difference 
in cell fate (Figure 5.6). In this experiment, the cells were provided a general media containing 
the growth factors required for both adipogenic and osteogenic differentiation, thus the cells 
were given the option to choose or not to choose a particular lineage. The cells can differentiate 
into adipocytes, osteoblasts or both or not differentiate at all. 
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The treatment was continued for 18 days, after which the cells were stained for the presence of 
adipocytes and osteoblasts and the relative quantities of both adipocytes and osteoblasts were 
assessed (Figure 5.7). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Schematic representation of the experiment involving a choice of cell lineage. Co-
cultures with different orientations of hMSC and C3H 10T1/2 cells were treated for 18 days with a 
combination of adipogenic and osteogenic growth factors. The cells, therefore, can differentiate into 
adipocytes or osteoblasts or into a mixture of both. 
Figure 5.7: The orientation of stem cells in co-culture influences their lineage preference. The cells 
are incubated in the DMEM for 18 days containing growth factors for both adipogenic and osteogenic 
differentiation. Column 2: Schematic representation of a co-culture orientation. Column 3: Oil Red O 
staining of co-culture incubated in DMEM only. Column 4: Co-culture treated with adipogenic and 
osteogenic factors and stained for the presence of adipocytes with Oil Red O. Column 5: The co-cultures 
were treated with standard media (DMEM) for 18 days and stained for the presence of osteoblasts with 
Alizarin S Red. Column 6: The co-cultures were treated with the medium containing adipogenic and 
osteogenic growth factors and stained for the presence for osteoblasts with Alizarin S Red. n=3. 
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Figure 5.7 continued: The orientation of stem cells in co-culture influences their lineage preference. 
The cells are incubated in the DMEM, containing growth factors for both adipogenic and osteogenic 
differentiation, for 18 days. Column 2: The schematic representation of a co-culture orientation. 
Column 3: Oil Red O staining of co-culture incubated in DMEM only. Column 4: Co-culture treated 
with adipogenic and osteogenic factors and stained for presence of adipocytes with Oil Red O. Column 
5: The co-cultures were treated with the standard media (DMEM) for 18 days and stained for the 
presence of osteoblasts with Alizarin S Red. Column 6: The co-cultures were treated with the medium 
containing adipogenic and osteogenic growth factors and stained for the presence for osteoblasts with 
Alizarin S Red. n=3. 
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Depending on the orientation in co-culture, some co-cultures differentiated into adipocytes, some 
into osteoblasts and some into both, while some did not differentiate at all. The results of the 
experiment are summarized in Figure 5.8.  
  
 
 
 
 
 
 
 
 
From the graph it can be seen that most co-cultures produced a mix of adipocytes and 
osteoblasts with some cells remaining undifferentiated. In mixed co-cultures of 10T1/2 and 
hMSC, the monolayers of the differentiated cells chose only the adipogenic lineage, while in the 
multi-layers, these cells produced an almost equal mix of adipocytes and osteoblasts. In co-
cultures with layered orientations of 10T1/2 and hMSC, when hMSC are at the top and 10T1/2 
are on the bottom, more cells differentiated into adipocytes, while in the co-culture with reversed 
orientation, there was less adipogenic differentiation and a similar level of osteogenic 
differentiation. In both monolayer and multi-layer cultures of hMSC, there was a very small 
Figure 5.8: Plot describing the differentiation of co-cultures with different cell orientations into 
adipocytes and osteoblasts after 18 days of incubation in media containing both adipogenic and 
osteogenic growth factors. The red regions of the graph represent the percentage of adipocytes in the co-
culture, blue osteogenic differentiation and grey no differentiation. n=3. P<0.05 Average SEM= ±6.3%. 
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amount of adipogenic differentiation observed with no osteogenic differentiation at all. Between 
all the 10T1/2 cultures, the amount of differentiation was the same (with about 60% of all 
differentiated cells going into the osteogenic and 40% into the adipogenic lineage). These data 
demonstrate that the choice of lineage depends on stem cell orientation. Recent studies 
conducted on stem cell differentiation have shown that the rate of stem cell differentiation as 
well as the choice of lineage are influenced by the surface on which these cells grow20,21. In this 
experiment, there are two surfaces, one is the plastic substrate on which the cells grow, and the 
other is the membrane of the cell above. We hypothesized that the difference in the rate of 
differentiation as well as the choice of lineage are due to physical forces such surface tension 
(the hard surface of the culture plate vs. the soft surface of the bottom cell layer) as well as 
signaling between the cell lines. The dependence of cell lineage choice on cell orientation in co-
culture needs to be further investigated using contemporary genomic and proteomic methods, 
and the ability to generate co-cultures with controlled orientation is critical for these new types 
of studies.  
 
5.5 Conclusion 
Bio-orthogonal chemistry is a powerful tool which allows for the assembly of cells into 3D 
structures. It is simple and reliable and works with multiple cell types. Here it was demonstrated 
how this method can be used to study the differentiation of stem cells in a 3D microenvironment. 
It showed that hMSC and C3H10T1/2 co-cultures differentiate at different rates as well as into 
different lineages if given a choice to do so, and their fate depends on orientation of these cells 
inside the co-culture. Our technique is versatile and can be used for different types. This is the 
first scaffold-free method used to create 3D stem cell co-culture models.  
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Chapter 6 
Spheroid and Tissue Assembly via Click Chemistry in 
Microfluidic Flow 
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in 2015 under the title "Spheroid and Tissue Assembly via Click Chemistry in Microfluidic 
Flow" This work was reprinted with permission (© American Chemical Society 2015). O’Brien, 
P. J., Luo, W., Rogozhnikov, D., Chen, J. & Yousaf, M. N are co-authors of this work. 
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6.1 Summary 
 
Three-dimensional co-cultures are important tools that can be used to study cell behavior in vitro, 
model cancer progression and analyze the potential toxic effect of drug candidates. Modern 
methods used to generate complex 3D tissues utilize natural or polymer scaffolds to support the 
cell mass. Such approaches, although beneficial for applications where tensile strength is 
required, have a range of limitations which include low cell density, obstruction of intercellular 
connection and accumulation of degradation byproducts. Herein, we show a new strategy to 
rapidly and efficiently assemble 3D tissues via microfluidic flow without the use of polymers or 
biological scaffolds. The system relies on bio-orthogonal click chemistry, microfluidics and cell 
surface engineering. Simple bio-orthogonal lipids are synthesized and delivered onto cell 
membranes via liposome fusion. The reaction between the bio-orthogonal molecules is quick and 
specific which enables rapid cell assembly in flow. We demonstrate the efficiency of our method 
by assembling different types of spheroids and oriented 3D tissues in flow. 
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6.2 Introduction 
Three dimensional co-culture systems have become an increasingly popular technology 
in the fields of transplantation, disease modeling and drug testing.1-8 The most recent methods to 
produce 3D tissues are based on either additive technologies such as 3D printing and 
electrospinning to build 3D scaffolds or on production of organoids through stem cell 
technology. 9-13 Both methods are relatively slow and require hours or even days to manufacture 
a functional tissue. To address this issue, rapid technologies such as microfluidics are being 
developed. 
Microfluidics is the modern method of microfabrication which is used extensively in the 
fields of analytical chemistry nanotechnology and microelectronics.14,15 The core principle of 
microfluidics is based on the physical phenomenon of laminar flow.16 Unlike in turbulent flow, 
where the fluids undergo irregular fluctuation and mixing with constant changes in flow 
direction and speed, in laminar flow fluids move in parallel layers with no mixing between the 
layers.17 In this orderly flow, molecules present in flowing solution migrate between the parallel 
layers via diffusion. To achieve laminar flow several important parameters must be controlled. 
These are the flow rate, width of the micro-channel as well as the viscosity of the flowing 
solution.18 To prevent the turbulent flow which has a large shear force, the width of the flow 
channel is optimized to be between 50-300 µm. The flow rate of solution is usually adjusted to 
be within the range of 0.1-2 µL/min. This orderly laminar flow reduces the sheer force which 
exists in a turbulent flow, enabling the use of microfluidics for such delicate processes as cell 
sorting, disease diagnostics as well as genomic analysis.19-21  
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The use of microfluidics for generation 3D tissues is still in early development.  
Technologies used today for tissue assembly via microfluidic flow rely on use of exogenous 
polymer materials or extracellular matrix proteins to make cells “sticky” and promote 3D cell 
assembly.22-24 Such approach relies on encapsulation of cells, thus isolating them from contact 
with neighboring cells and the environment. In these experiments single cells are flown within 
the microchannel together with charged collagen or polymer monomers resulting in formation of 
solid polymer-cell complexes. Tissues that are obtained in these experiments, although durable 
due to presence of elastic materials have relatively low cell density, a factor which is crucial for 
manufacturing of cell-dense tissues such as cardiac tissue. Biodegradation of exogenous 
polymers also presents a problem due to accumulation of degradation byproducts which may 
potentially induce an immunological response if transplanted into the body.25-27  
Therefore, a general method to rapidly assemble cells with sufficient cell economy would 
stimulate the emergence of new technological platforms for therapeutic drug screening, 
regenerative medicine as well as in vitro modeling systems to simulate disease progression.  This 
method should be inexpensive, scaffold-free and applicable for different cell types.  
Herein we introduce a new scaffold-free bio-orthogonal click chemistry method based on 
ligation between two functional groups, an oxyamine and a ketone to form a covalent oxime 
bond. The reaction is chemoselective, occurs under physiological conditions and is non-
cytotoxic. An exceptional selectivity of this reaction enables rapid cell assembly without the use 
of exogenous scaffolds promoting formation of tissues with high cell density. To deliver 
oxyamine and ketone moieties onto cell surface liposomal delivery vesicles are used. Liposomes 
are commonly used for drug encapsulation and delivery. Here, we use bio-orthogonal liposomes 
to engineer the cell surfaces and assemble cells into 3D tissues in flow.   
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6.3 Experimental 
O-Dodecyloxyamine-tetra(ethylene)glycol was synthesized as previously described.(25, 26) 1-
Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) were purchased from Avanti Polar Lipids (Alabaster, 
AL). All other chemicals were obtained from Sigma-Aldrich or Fisher Scientific. 3T3 Swiss 
albino mouse fibroblasts, C3H/10T1/2 mouse embryonic fibroblast cells, RFP Expressing 
Human Neonatal Dermal Fibroblasts, and GFP expressing NIH3T3 cells were obtained from 
ATCC. Human mesenchymal stem cell (hMSC), hMSC basic, growth, and differentiation media 
were obtained from Lonza. 
6.3.1 Cell Culture 
C3H/10T1/2 were cultured in Petri dishes at 37 °C and 5% CO2 with DMEM media 
containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S). RFP Expressing 
Human Neonatal Dermal Fibroblasts (RFP) were maintained in DMEM containing 10% FBS and 
1% P/S. The cell cultures used for experiments were between 3 and 8 passages. GFP expressing 
NIH3T3 (GFP) cells were cultured in DMEM (high glucose), with 10% FBS, 0.1 mM MEM 
Non-Essential Amino Acids, 2 mM l-glutamine, 1% P/S, and 10 μg/mL Blasticidin. 3T3 Swiss 
albino mouse fibroblasts were cultured in Dulbecco’s Modified Eagle Medium (Gibco) 
containing 10% FBS and 1% penicillin/streptomycin at 37 °C in 5% CO2. hMSCs were cultured 
in growth media at 37 °C in 5% CO2. Adipogenic differentiation was induced by adipogenic 
induction medium and kept by induction/maintenance cycles as described in the Lonza protocol. 
Osteogenic differentiation was induced by osteogenic induction medium provided by Lonza. 
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6.3.2 Microfluidic Device Fabrication and Design 
The microchannel was designed with a simple Y-shape, where cell suspensions are brought 
together in the Y-joint mixing zone. In order to make a simple, cheap, and robust device, PMMA 
blocks were used as the device substrate. The experimental device was fabricated using laser 
ablation to etch PMMA blocks (1/8 in thickness, 1.25 in length, and 1.42 in width). The PMMA 
channels were laser etched using Versalaser 2.30 with a CO2 laser at 14.25 W power to produce 
parabolic channels with a measured base width of 170 μm, a peak height of 200 μm, and a 
channel length of 1.5 cm. The fluid inlet connections were fabricated using 406 μm (0.016 in) 
OD stainless steel capillary tubes with an 203 μm (0.008 in) ID and a length of 2.0 cm, which 
were embedded into the PMMA blocks using thermal heating to be in line with the 
channel flowaxes, while the fluid outlet capillary was cut to 2.0 cm and embedded by thermal 
heating and pressure similarly to the fluid inlets and allowed to cool. The top block of PMMA is 
used to cap the channel through thermal bonding with the etched bottom block in a convection 
oven for 2 h at 275 °C and allowed to cool completely to room temperature over 2 h under 
pressure. Once cooled, the fluid connections are finished by slipping PEEK tubing (ID 203 
μm/0.008 in) over the metal capillary and sealed using epoxy resin (3M). Finally, high pressure 
HPLC 1 mL Luer lock glass syringes (Hamilton) are connected to the PEEK tubing using finger 
tight female Luer fittings (UpChurch Scientific). 
 
6.3.3 Liposome Formation and Formulation 
To prepare liposomes bearing ketone or oxyamine functionalities, 60 μL 2-dodecanone-
tetra(ethylene)glycol (10 mM in CHCl3) or O-dodecyloxyamine-tetra(ethylene)glycol (10 mM in 
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CHCl3) was mixed with 430 μL POPC (10 mg/mL in CHCl3) and 10 μL of DOTAP (10 mg/mL 
in CHCl3), and then thoroughly dried via N2. After the CHCl3 was evaporated, the lipid mixture 
was suspended in 3 mL of PBS, followed by tip sonication for 15 min until the suspension 
became clear. 
 
6.3.4 Cell Surface Modification Using Liposome Fusion 
Once cells reach 90% confluency, 5% (v/v) liposomes (ketone or oxyamine bearing liposomes) 
were added to the cell culture media, and incubated with cells at 37 °C and 5% CO2 for 1 h to 
create ketone- or oxyamine-tailored cells. 
 
6.3.5 General Method for Spheriod Generation in Microfluidic Device 
GFP NIH 3T3 and RFP HNDF cells were grown to approximately 90% confluency and then 
treated with oxyamine and ketone bearing liposomes, respectively, using the standard protocol. 
Once the cells were surface engineered, they were washed 3 times with PBS and then detached 
using 0.25% trypsin/EDTA at 37 °C and 5% CO2. Once the cells were detached and neutralized 
by DMEM media (10% FBS), cell suspensions were transferred to separate 15 mL centrifuge 
tubes and centrifuged down at 800 rpm for 5 min. The supernatant was discarded and the 
remaining pellet was resuspended in DMEM media to reach a final concentration of 4 × 106/mL. 
Once the ketone and oxyamine-tailored cell suspensions were ready, 250 μL of each cell 
suspension was immediately loaded into separate sterilized 1 mL gastight Luer lock Hamilton 
gas chromatography syringes. The connection tubing and microfluidic device were sterilized by 
passing 1 mL 70% ethanol solution, followed by 1 mL of PBS buffer. Once sterilized, the loaded 
syringes were finger tightened onto male Luer connections and placed onto a Harvard 11 PLUS 
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syringe pump. The flow rate was set to 8 μL/min for 5 min to purge air bubbles from the system, 
then reduced to 0.4 μL/min for 5 min, where the fluid was discarded and subsequent eluent was 
collected onto 1 cm2 glass slides. The 1 cm2 glass slides were prepared in advance and sterilized 
by sonication in 70% ethanol solution for 30 min. The microfluidic experiments typically lasted 
around 45 min. After experiments were done, the collecting slides were transferred 
to tissue culture plates and incubated at 37 °C and 5% CO2 for 25 min. The cells on the slides 
were then fixed by 3.8% formaldehyde solution for 15 min, followed with gentle washing with 
PBS. The cell samples were observed and imaged using a Nikon Eclipse TE2000-U 
Fluorescence Microscope. 
 
6.3.6 Engineered Spheroid Growth Kinetics Using Microfluidics 
C3H/10T1/2 cells were cultured to approximately 90% confluency and engineered using 
standard conditions. Once the cells were detached, the suspension would be diluted using serum 
containing growth medium to obtain different cell densities; 250 μL of each cell suspension was 
immediately loaded into separate sterilized 1 mL gastight Luer lock Hamilton gas 
chromatography syringes. The connection tubing and microfluidic device were sterilized by 
passing 1 mL 70% ethanol solution, followed by 1 mL of PBS buffer. The loaded syringes were 
then finger tightened onto male Luer connections and placed onto a Harvard 11 PLUS syringe 
pump. The flow rate is set to 8 μL/min for 5 min to purge air bubbles from the system, then 
the flow rate was lower to the experimental flow rate (0.2–0.6 μL/min) for 5 min to discard 
enough fluid before collecting cell clusters. Live cell images were obtained in situ at 10× 
magnification using an Olympus CKX41 microscope to record the size and growth of the 
clusters. The images of cell clusters were recorded at 0 mm, 7.5 mm, and 15.0 mm of the 
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microfluidic channel to collect data of cluster size, while the flow rate and the cell density were 
changed to study the relationship between microtissue generation and 
microfluidic flow conditions as shown in the 3D plot. 
 
6.3.7 Confocal Microscopy of RFP/GFP 3D Coculture Microtissues 
To obtain confocal images of coculture microtissues, GFP and RFP cells were grown to 
approximately 95% confluency and treated with oxyamine and ketone bearing liposomes, 
respectively, using our standard protocol. Engineered cells (250 μL, 2 × 106/mL) were 
immediately loaded into separate sterilized 1 mL gastight Luer lock Hamilton gas 
chromatography syringes, which were finger tightened onto male Luer connections and placed 
onto a Harvard 11 PLUS syringe pump. The flow rate was set to 8 μL/min for 5 min to purge air 
bubbles from the system, and then reduced to 0.4 μL/min for 5 min. After that, collection of cells 
was started. Flow experiments were performed for 3 h, before the collecting slides were 
transferred to tissue culture plates and incubated at 37 °C and 5% CO2. After culturing the cell 
clusters for 12 h, cell samples were fixed with 3.8% formaldehyde, washed with PBS, and 
mounted onto thin glass slides with Light Diagnostics Mounting Fluid (Millipore) for 3D 
confocal microscopy using a Zeiss LSM 700. 
6.3.8 Confocal Microscopy of Three-Cell Lines (Red/Green/Blue) Microtissues 
To generate three-cell line microtissues and observe by confocal microscopy, oxyamine 
engineered C3H/10T1/2 cells were treated with 0.3% v/v of CellTracker Blue CMAC (Life 
Technologies) for 45 min, and then mixed with ketone engineered GFP cells and RFP cells. 
Blue-stained C3H/10T1/2 cells presenting oxyamine (4 × 106/mL) were loaded into a 1 mL 
Hamilton glass syringe, while ketone engineered GFP cells (2 × 106/mL) and ketone engineered 
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RFP cells (2 × 106/mL) were loaded into another 1 mL Hamilton glass syringe. The two syringes 
were connected to the microfluidic device and flow rate was controlled at 0.4 μL/min. Cell 
clusters were dispensed onto 1 cm2 glass slides for 45 min and then incubated in tissue culture 
plates for 12 h at 37 °C with 5% CO2. Cell samples were fixed with 3.8% formaldehyde, washed 
with PBS, and mounted onto thin glass slides with Light Diagnostics Mounting Fluid (Millipore) 
for 3D confocal microscopy using a Zeiss LSM 700. 
 
6.3.9 3D Coculture Multilayers of HMSCs and 3T3 Fibroblasts 
HMSCs and 3T3 fibroblasts were surface engineered with ketone and oxyamine 
liposomes, respectively. 3T3 fibroblasts presenting oxyamines were then trypsinized and added 
(1 × 105cells/mL) to the hMSCs. These cells were cocultured in adipogenic, fibroblast, and 
osteoblast induction and maintenance media, resulting in the 3D multilayered, tissue-like 
structures of adipocytes, fibroblasts, osteoblasts, and 3T3 fibroblasts. After differentiation, the 
3D coculture was fixed with formaldehyde (4% in PBS, 30 min). Substrates were then immersed 
in a solution containing water and 60% isopropyl alcohol (3–5 min), followed by staining with 
Oil Red O (5 min) and Harris Hemotoxylin (1 min). Substrates were visualized by phase contrast 
microscopy using a Zeiss inverted microscope. The substrates for fibroblast differentiation were 
fixed with formaldehyde and permeated with 0.1% Triton X-100. Monoclonal antibody of 
collagen I was applied for 1 h, and then incubated with secondary antibody anti-mouse IgG 
(FITC conjugate) for 30 min, followed by DAPI for 30 min for nucleus staining (reagents from 
Fisher Scientific). The substrates for osteogenic differentiation were stained with sigma Alkaline 
Phosphatase (ALP) kit (sigma kit 85). 
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6.3.10 Collagen Based RFP and GFP Tissue Formation 
To make macro-size (2 × 2 cm2) robust tissue, collagen was introduced. Oxyamine tailored GFP 
cells (2 mL, 4 × 106/mL) and ketone tailored RFP cells (2 mL, 4 × 106/mL) were loaded into the 
microfluidic device to generate RFP/GFP microtissue. The flow rate was set to 8 μL/min for 5 
min to purge air bubbles from the system, and then reduced to 0.4 μL/min for 5 min. After that, 
collection of cells was started. The cell clusters were collected onto a 2 × 2 cm2 slide loaded 
with liquid collagen solution. After collection, the collagen/cell hybrid was transferred to a tissue 
culture plate and incubated at 37 °C and 5% CO2 for 30 min to allow the collagen solution to 
solidify. Cell culture media were then added and the collagen/cell hybrid tissue was incubated 
for 12 h before being peeled off the glass slide. The collagen supported macrotissue was then 
fixed with 3.8% formaldehyde, washed with PBS, and mounted onto thin glass slides with Light 
Diagnostics Mounting Fluid (Millipore) for 3D confocal microscopy using a Zeiss LSM 700. 
 
6.3.11 3D Oriented Coculture Multilayers (RFP-GFP-RFP, thin) 
Microscope glass coverslips were cut into small pieces in advance and put into a 96-well 
microplate. RFP cells were grown on the slips in the microplate until 95% confluency was 
reached. Through standard liposome treatment, the RFP cells were surface engineered to present 
ketone group. GFP cells presenting oxyamine (200 μL, 5 × 105/mL) were then loaded by 
standard microfluidics procedure onto the ketone tailored RFP cells, and then cultured for 12 h. 
After removing most media, ketone tailored RFP cells (200 μL, 5 × 105/mL) were loaded onto 1 
cm2 glass slides by microfluidics, and cultured for 6 h. The slides were then gently picked up 
and fixed in 3.8% formaldehyde, washed with PBS, and mounted onto thin glass slides with 
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Light Diagnostics Mounting Fluid (Millipore) for 3D confocal microscopy using a Zeiss LSM 
700. 
 
6.3.12 3D Oriented Coculture Multizones (RFP-GFP-RFP, thick) 
Microscope glass coverslips were cut into small pieces in advance and put into a 96-well 
microplate. Ketone tailored RFP cells (150 μL, 1 × 106/mL) and oxyamine tailored RFP cells 
(150 μL, 1 × 106/mL) were loaded by standard microfluidics procedure onto the coverslips in the 
microplate, and cultured for 12 h. After removing most media, ketone tailored GFP cells (150 
μL, 1 × 106/mL) and oxyamine tailored GFP cells (150 μL, 1 × 106/mL) were loaded by 
microfluidics onto the RFP cells, and then cultured for 12 h. After removing most media, ketone 
tailored RFP cells (150 μL, 1 × 106/mL) and oxyamine tailored RFP cells (150 μL, 1 × 106/mL) 
were loaded by microfluidics again, and cultured for 6 h. The slides inside the microplate were 
then gently picked up and fixed in 3.8% formaldehyde, washed with PBS, and mounted onto thin 
glass slides with Light Diagnostics Mounting Fluid (Millipore) for 3D confocal microscopy 
using a Zeiss LSM 700. 
 
6.3.13 Oxime Bond Formation (Synthesis of 2-(Propan-2-ylideneaminooxy)acetic acid) 
To a 10 mL flask with magnetic stir bar, 1.1 mmol, 91.03g/mol, 100 mg) of o-
(carboxymethyl)hydroxylamine hemihydrochloride was added and purged with argon gas. 
Freshly distilled acetone (3 mL) was then added by syringe and stirred at room temperature for 4 
h. Excess acetone was removed by rotary evaporator to give (140 mg, 131.06 g/mol, 99%) 
conversion to the oxime product 2-(propan-2-ylideneaminooxy)acetic acid as a white solid. 1H 
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NMR (D2O, 300 MHz): δ 4.45 (s, 2H), 1.85 (s, 3H), 1.79 (s, 3H); 13C NMR (D2O, 400 MHz): δ 
175.45, 160.82, 69.81, 20.61, 15.31. 
 
6.3.14 Oxime Hydrolysis Analysis 
Oxime hydrolysis experiments were conducted by adding 1.5 mg (11 μmol) of 2-(propan-2-
ylideneaminooxy)acetic acid into five separate scintillation vials, followed by preparation of 0.1 
M buffered D2O solutions using pyridine (pH 11.0), sodium bicarbonate (pH 8.0), PBS (pH 7.4), 
sodium carbonate (pH 5.0), and sodium formate (pH 3.0), respectively. Once the five separate 
samples of 2-(propan-2-ylideneaminooxy)acetic acid were dissolved in 0.5 mL of the different 
pH buffered D2O solutions, their respective NMR spectra were taken (ns = 8). Data was gathered 
initially at 3 h intervals, followed by once a day, then once a week to determine the rate of 
hydrolysis of the starting material. 
 
6.3.15 Oxime Formation Kinetics Conditions 
Pseudo-first-order rate experiments were conducted using 1H NMR (300 MHz) spectroscopy. 
These experiments were performed in typical NMR tubes by dissolving methoxyamine 
hydrochloride (1.5 mg, 83.52 g/mol, 18 μmol) and freshly distilled acetone (150 μL, distilled 
over dririte) in 0.25 mL PBS buffered D2O (pH 7.4) at 37.0 °C, respectively. The two solutions 
were quickly mixed together in the NMR tube and placed into the spectrometer, and the first 
time point was immediately taken, with subsequent data points taken every 40 s. This experiment 
was repeated using 2-(propan-2-ylideneaminooxy)acetic acid (11 mg, 109.30 g/mol, 11 μmol) 
dissolved in 0.25 mL PBS buffered D2O (pH 7.4) in a NMR tube at 37.0 °C, and freshly distilled 
acetone was added into 0.25 mL PBS buffered D2O (pH 7.4) and warmed to 37.0 °C. The two 
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solutions were then mixed in a NMR tube followed by placement into a spectrometer and the 
first time point was immediately taken, with subsequent data points taken every 40 s. 
6.3.16 Stem Cell Differentiation in Coculture. RT-PCR Analysis 
Human mesenchymal stem cells (hMSCs) were induced to differentiate for 2 weeks. Total RNA 
was then extracted by RNA isolation kits (Qiagen). 1 μg of total RNA was converted to cDNA 
using AMV reverse transcriptase and random hexamer primers (Promega). The resulting cDNA 
was used in PCR with the following primer, LPL (sense 5′-GAG ATT TCT CTG TAT GGC 
ACC-3′, antisense 5′-CTG CAA ATG AGA CAC TTT CTC-3′), PPARγ2 (sense 5′-GCT GTT 
ATG GGT GAA ACT CTG-3′, antisense 5′-ATA AGG TGG AGA TGC AGG CTC-3′), 
Collagen I (sense 5′-TGC TGG CCA ACC ATG CCT CT-3′, antisense 5′-TTG CAC AAT GCT 
CTG ATC-3′), Collagen II (sense 5′-ATG ACA ACC TGG CTC CCA AC-3′, antisense 5′-GCC 
CTA TGT CCA CAC CGA-3′), RUNX2 (sense 5′-GAT GAC ACT GCC ACC TCT GAC TT-3′, 
antisense 5′-CCC CCC GGC ACC ATG GGA AAC TG-3′), ALPL (sense 5′-CCA TTC CCA 
CGT CTT CAC ATT-3′, antisense 5′-GAG GGC CAG CGC GAG CAG CAG GG-3′), at 
annealing temperatures of 52 °C, 55 °C, 53 °C, 57 °C, 61 °C, 66 °C, respectively. Amplification 
reactions were carried out for 1 min through 30 cycles, and the reaction products were subjected 
to 1% agarose gel electrophoresis. The reaction products are 276bp (Lpl), 351bp (PPARγ2), 
489bp (Collagen I), 359bp (Collagen II), 362bp (RUNX2), and 418bp (ALPL), respectively. 
 
6.3.17 Bubble Fusion via Oxime Chemistry 
 Commercially available soap bubble toys were obtained from Crayola. Control experiment was 
performed by directly using the commercial soap solutions for blowing and merging bubbles —
resulting in no fusion—only bubble adhesion. A second experiment was performed based on the 
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same soap solutions but doped with 5% O-dodecyloxyamine and 5% 2-dodecanone, respectively 
—resulting in bubble fusion via an interfacial oxime ligation. 
 
6.3.18 Spheroid Assembly 
Microfludic device was mounted on a Zeiss AXIO Observer Inverted Fluorescence Microscope. 
Ketone engineered GFP cells (2 × 106/mL) and oxyamine engineered GFP cells (2 × 106/mL) 
were prepared in PBS and loaded into the Hamilton glass syringes separately. The two syringes 
were connected to the microfluidic device and flow rate was controlled at 0.4 μL/min. Live 
recording of the two cell populations flowed through the microfluidic channels were taken 
automatically by the microscope. Control experiment was identical but without liposome fusion 
of bio-orthogonal groups to the cells. This resulted in only single cells floating through the 
channel and no spheroid assemblies observed. 
 
6.4 Results and Discussion 
To rewire cell surfaces with bio-orthogonal moieties that function as a chemical Velcro, two 
types of liposomes were synthesized. Figure 6.1 describes the general cell surface engineering 
strategy used to tether cells with bio-orthogonal chemical groups.  Oxyamine- (4) or ketone- (3) 
functionalized lipids were incorporated into liposomes along with naturally occurring neutral 
POPC (1) and the positively charged DOTAP (2) background lipid molecules. Cells (7,8) were 
treated with either ketone (5) or oxyamine (6) containing liposomes for 1h at 37 oC to deliver the 
functional groups onto cell surfaces. Two populations of cells with complimentary bio-
orthogonal moieties (9,10) were mixed resulting in contact between the cells triggering a reaction 
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between oxyamine and ketone moieties present on cell surfaces resulting in the formation of a 
strong covalent oxime bond with the subsequent cell assembly.   
 
 
 
 
 
 
Figure 6.1. Schematic describing the cell surface tailoring strategy to generate complex 
coculture tissue assemblies. The combination of bio-orthogonal lipids, liposome formation, and 
liposome fusion result in the generation of engineered cell surfaces that can subsequently be 
assembled through an interfacial click reaction. (A) Bio-orthogonal liposomes are formed by mixing 
POPC (1), DOTAP (2), and either a ketone (3) or oxyamine (4) terminated lipid-like molecules. (B) 
Cell surfaces (7) and (8) were engineered to present ketones or oxyamines via liposome fusion and 
delivery. The tailored cells (9) and (10) were then mixed and formed rapid assemblies (11) via the 
bio-orthogonal oxime (15) click ligation. (C) List of liposomes, cells, and tailored cells used in the 
study. (5) Ketone tailored liposome, (6) oxyamine tailored liposome, (7) contact inhibited cell line, 
(8) contact inhibited cell line, (9) ketone engineered  cell line, (10) oxyamine engineered  cell line, 
(11) spheroid  cell line, (12) spheroid cell line, (13) suspended ketone engineered  cell line, (14) 
suspended  oxyamine engineered cell line, and (15) oxime ligation bond between two membrane 
surfaces. 
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This co-culture assembly can be rapidly achieved due to polyvalent oxime chemistry ligation 
between the cells.  As controls, no cell assemblies were generated in cells which were treated 
with non-functionalized liposomes. As was demonstrated in previous studies, cell viability is not 
affected by the liposome fusion process. FACS analysis performed in previous studies was used 
to determine the amount of oxyamine and ketone moieties present on the cell surface. In this cell 
assembly process, the chemistry is only used to hold cells in place temporarily until they produce 
their own extracellular matrix and spread forming intact tissues. As cells proliferate, their 
membrane is renewed and the chemistry is gradually diluted out, but the cells are held together 
by the intercellular proteins and the extracellular matrix that they secrete.  
 In order to assemble cells into co-culture spheroids via microfluidics, the click reaction 
between the oxyamine and ketone on the cell surfaces must very rapid.  In the field of click 
chemistry there are several bio-orthogonal reactions that are extensively used. These include the 
copper-catalyzed reaction between alkyne and azide, the ring strain cycloaddition reaction and 
the Diels-Alders ligation.28 We, however, selected oxime chemistry because it is relatively easy 
to synthesize oxyamine- and ketone-tethered lipids and incorporate them into liposomes.  
Figure 6.2 describes kinetics experiment which was conducted to assess the reaction rate 
of ligation between the oxyamine and ketone, and stability of the oxime bond under 
physiological conditions (pH 7, 37 C) The experiment was performed in PBS and the process of 
oxime formation was monitored in real time via NMR analysis. The reaction was adjusted to be 
pseudo-1st-order where the concertation of the ketone molecule is significantly greater than the 
concentration of the oxyamine. The Ai peak at 3.92 ppm (Figure 6.2A) represents the oxyamine 
that is being converted into oxime as the result of the reaction with the ketone (the Bi peak 3.74 
ppm). The areas of both peaks add up to 1.00, so it is possible to deduce the concentration of  
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oxyamine and oxime at any given time point. The half-life of the oxime formation reaction is 9 s 
and k = 0.98 × 10−2 M s−1. However, we surmised that the rate of oxime formation on cell 
surfaces may be several orders of magnitude faster to multiple oxyamine and ketone moieties 
being present on the cell surface the ability of the bio-orthogonal lipid molecules to migrate 
Figure 6.2. NMR study of the kinetics and stability of a bio-orthogonal oxime conjugation 
reaction under physiological conditions. (A) The reaction of a ketone and oxyamine at 
physiological conditions (37 °C and pH 7.4) results in the rapid formation of the covalent and a 
stable oxime bond. 1H NMR was used to determine the oxime formation kinetics (k = 0.98 × 
10−2 M s−1, t1/2  = 9 s). (B) The stability of the oxime bond was studied with 1H NMR at 
physiological conditions (pH 3, 5.6, 7.4, 8.0, 11.0). The oxime bond was stable with no 
hydrolysis after 3 weeks in pH 3.0 and 5.6. At physiological conditions (pH 7.4) there was only 
3% hydrolysis over 3 weeks. 
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within the membrane dramatically changing their position and increasing their local 
concentration density. This polyvalent nature of surface chemistry is what promotes the rapid cell 
assembly which is necessary for the method to be usable with microfluidics. The stability of 
oxime was monitored over the course of three weeks in buffer solutions with different pH 
concentrations. It was demonstrated that oxime bond is stable at physiological conditions since at 
pH 7.4 and only 3% hydrolysis was observed. 
 Figure 6.3 shows the general strategy for controlled co-culture spheroid assembly via 
microfluidic flow. First, monolayers of confluent cells grown in micro-wells are treated with 
ketone or oxyamine-tethered liposomes. Liposomes fuse with the cell membrane delivering the 
ketone and oxyamine functionalities onto the cell surface. The cells are detached from the 
surface via trypsinization and transferred to a Y-joint microfluidic device.  
 
 
 
 
 
 
Figure 6.3. Schematic describing the use of microfluidic technology and tailored cell lines to 
generate multilayer coculture tissues. (Left) Different cell lines are grown in microwell plates to 
generate 2D contact inhibited monolayers. Liposomes containing either ketone (5) or oxyamines 
(6) are added to the microwells. The liposomes rapidly fuse to the cells and deliver the functional 
groups to rapidly produce engineered cell surfaces presenting ketones (9) or oxyamines (10). 
(Middle) The engineered cells are then transferred to a simple microfluidic device. As the cells are 
flown through the channels they come into contact and assemble into coculture spheroids through 
oxime click chemistry. The sizes of the spheroids are determined by the flow rate, cell 
concentration, and the length of the assembly chamber. (Right) The spheroids are then transferred 
to a microwell plate where they adhere and form coculture multilayered 3D tissues. As controls, 
cells without the bio-orthogonal functional groups produce no spheroids upon mixing in the 
microfluidic channels and result in no 3D assembly (only standard 2D single cell layer sheets are 
formed). 
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The microfluidics device is made using standard PMMA fabrication and contains three 
parts: two arms and one mixing chamber. The oxyamine-presenting cells are loaded into the first 
arm, while the ketone-presenting cells are loaded into the second arm. The cells flow through 
each arm and arrive into the mixing chamber. In the mixing chamber the cells collide, attach to 
each other instantly due to presence of bio-orthogonal chemistry and form a small spheroid. As 
the spheroid moves through the chamber, it comes in to contact with other single cells and 
becomes larger. Finally, the spheroid leaves the microfluidic chamber and attaches to the bottom 
of the micro-well. Over time the cells secrete ECM and spread forming 3D tissues.29,30 This 
microfluidics-based tissue assembly strategy is an effective method to assemble different types 
of cells into a complex 3D co-culture which can then be used for various applications such as 
tumor models as well as in studies focused on autocrine and paracrine signaling.  
 
 
Figure 6.4. Brightfield images of C3H10T1/2 cells at various stages of assembly in the 
microfluidic channel device. (A) Cartoon of the PMMA microfluidic device showing the flow of 
cells in the Y joint followed by mixing and assembly at different lengths of the channel. (B) Bright 
field images of representative cell cluster sizes at different flow points along the channel. (C) In situ 
bright field images of cells flowing through the microfluidic device at different flow points. Larger 
spheroid cell assemblies are produced at longer lengths of the channel. 
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Control studies clearly indicate that no cell assembly takes place if cells are not 
functionalized liposomes (Figure A1). A sequence of images of growing spheroids as they flown 
inside the microfluidic channel (Figure 6.4).  
The size of spheroids generated via microfluidic flow varies with the flow rate and 
position within the channel. This dependence is demonstrated graphically on Figure 5. The 
slower the rate of flow, the more time the cells have to collide with each other and form a cluster. 
The more cells are flown through the channel, the greater the size of the spheroid. It is interesting 
to note that cells with no chemistry or absence of either oxyamines or ketones on the cell surface 
formed no clusters. The resulting spheroids were stable and did not require collagen or Matrigel 
for stabilization. The assembled cells demonstrated good viability as shown on the Figure 6.5. 
 
 
 
 
 
 
 
 
 
Figure 6.5. 3D plot presenting the relationship between flow rate, channel distance, cell density, 
and resulting cell cluster size (spheroid) assembled within a microfluidic channel. As the cell 
density increases and flow rate decreases spheroids assemble at a faster rate. The absence of one 
(orange) or both (white) surface chemistries results in no spheroid formation. Statistical analysis 
showed cluster size was within 5% for each condition. 
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To generate different co-culture spheroids via microfluidic flow, we utilized GFP-expressing 
(green fluorescent protein) NIH3T3 fibroblasts and RFP-expressing (red fluorescent protein) 
Dermal Neonatal fibroblast cell lines (Figure 6.6). The cells were tailored with ketone and 
oxyamine functionalities and flown through the microfluidic chamber. Figure 6.6A graphically 
demonstrates the polyvalent nature of surface chemistry. The bio-orthogonal rapid ligation 
strategy generated different types of co-culture spheroids. Different stoichiometric ratios of GFP 
and RFP cells were utilized in the primary experiments. For example if the ratio of flown GFP 
and RFP cells was 1:8, the resulting spheroid where GFP NIH 3T3 cell surrounded by RFP 
Neonatal Dermal Fibroblast cells (Figure 6.6C). If the ratio of GFP and RFP cells was 8:1, the 
generated spheroids had one RFP-expressing cell surrounded by multiple GFP-expressing cells 
(Figure 6.6D). Three and more types of cells can be assembled into spheroids using our 
microfluidics method. Figure 6E shows ketone and oxyamine-functionalized GFP, RFP 
expressing cells combined with C3H10T1\2 stained with CMAC (7-amino-4-
chloromethylcoumarin) in 1:1:1 ratio resulting in the formation of a large co-culture spheroid 
containing three cell types (Figure 6.6E). Monoculture spheroids can also be formed via 
microfluidic strategy. Figure 6F shows a large monoculture spheroid made of ketone and 
oxyamine-presenting GFP cells. Figure 6.6H show a confocal-microscopy image of a spheroid 
containing an equal number of GFP and RFP cells. Microfluidics tissue assembly enables the 
formation of different kinds of spheroids with variable size, cell types and cell ratios. The 
spheroids are fast forming, stable and do not contain exogenous polymer materials. The cells that 
were not functionalized with ketone and oxyamine functional groups could not be assembled into 
spheroids. 
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Figure 6.6 Schematic cartoon and fluorescent images of resultant coculture spheroid assembly 
via click chemistry ligation. (A) Two cell lines engineered with complementary interfacial bio-
orthogonal groups where upon contact undergo click oxime ligation (B) resulting in coculture 
assembly. (C,D) Changing the engineered cell density ratio injected into the microfluidic device 
results in spheroids with different morphologies. A 1:8 ratio (GFP:RFP) of cells results in a single 
GFP NIH 3T3 cell surrounded by RFP Neonatal Dermal Fibroblast cells (C). Reversing the ratio to 
8:1 (GFP:RFP) results in a single RFP Neonatal Fibroblast cell surrounded by GFP NIH 3T3 cells 
(D). (E) Fluorescent image of large 3 cell type spheroid, generated by mixing 1:1:1 ratio of 
GFP:RFP:Blue C3H10T1\2 stained with CMAC (7-amino-4-chloromethylcoumarin) in flow. These 
third cell tissues were easily generated by engineering GFP and RFP cells with ketones while 
CMAC stained cells present oxyamine groups. (F) Large spheroid of GFP cells obtained by 
combining two different populations of GFP cells that present ketone and oxyamine groups. (G) 
Large spheroid of RFP cells obtained by combining two different populations of RFP cells that 
present ketone and oxyamine groups. (H) Large spheroid of RFP and GFP cells obtained by flowing 
a 1:1 ratio of engineered RFP and GFP cells in the microfluidic device. By adjusting the flow rate, 
cell density, and the ratio of cell density inputs, a range of stoichiometric coculture spheroid 
assemblies and spheroid sizes could be generated. 
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In the classical in vitro models cells are grown on flat substrates (i.e Petri dishes) where they 
form 2D monolayers. The cells in monolayers are contact inhibited and cannot be stacked on top 
of each other. Therefore such tissue model systems are limited and cannot recapitulate the 3D 
environment of tissues. Our bio-orthogonal click chemistry technology enables construction of 
3D tissues with variable size, thickness, cell composition and cell arrangement.  To demonstrate 
the capacity of our novel tissue assembly methodology, several 3D tissue constructs with 
variable morphology were assembled. Figure 6.7 A,B shows cells that were not functionalized 
with oxyamine or ketone groups, as the result only 2D cell monolayers were formed. Bio-
orthogonal click-chemistry technology enables formation of multilayered tissues with controlled 
cell orientation. Figure 6.7 C,D demonstrates a bilayer of GFP and RFP cells. Figure 6.7 E,F 
shows three layer of GFP and RFP fibroblasts forming three layers. These co-cultures were 
assembled sequentially, layer by layer via microfluidic flow. The system is flexible and allow for 
formation of thick tissues with oriented cell zones (Figure 6.7G, H). Precise cell deposition 
achieved via microfluidics allows to position cells exactly into the specific zone. Figure 6.7 I, J 
shows a confocal micrograph of a thick tissue formed via microfluidics by depositing several 
spheroids on top of each other. As was discussed above, bio-orthogonal chemistry is only used to 
hold cells together until they secrete their extracellular matrix and spread forming 3D tissues, 
therefore it is ECM that    As cells divide, renew their membrane and the chemistry is diluted 
out. Figure 6.7 K,L shows a 3D co-culture of hMSC cells with fibroblasts differentiating into an 
adipogenic lineage. Using microfluidics it is possible to flow three or more cell types at once. 
Figure 6.7 M,N shows RFP and GFP-expressing cells tethered with a ketone molecule mixed 
with oxyamine-tethered blue CMAC-stained cells. Although our methodology is scaffold-free, it 
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can be used with both ECM and polymer scaffolds. Figure 6.7 O,P shows GFP and RFP 
fibroblasts presenting  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7. Range of confocal and bright-field images of various combinations of GFP NIH 3T3 
fibroblasts, RFP neonatal fibroblasts, CMAC live stained C3H10T1/2 pluripotent embryonic 
fibroblast stem cells. HMSC cells and NIH Swiss 3T3 cells. (A) Top view of a standard contact 
inhibited single monolayer of GFP NIH 3T3 cells in culture. (B) Angled and side view of monolayer 
showing a thickness of approximately 6 μm. (C) Top view image of RFP-GFP bilayer generated by 
first assembly in microfluidic flow of RFP spheroids followed by deposition onto glass slides to 
generateRFP multilayer. GFP spheroids were added to this RFP multilayer generated in microfluidic 
flow. The sequential spheroid and multilayer generation resulted in a bilayer of multilayers of GFP and 
RFP cells (30 μm thick). (E,F,G,H) Image of serial RFP and GFP spheroid assembly in flow followed 
by sequential deposition resulting in control of coculture orientation multilayers and thickness (E,F, 30 
μm thick) (G,H, 120 μm thick). (I,J) Image of TRITC and DAPI stained thick multilayers of Swiss 
3T3 fibroblasts (140 um thick). (K,L) Brightfield image of multilayers of HMSC cells mixed with 
Swiss 3T3 fibroblasts. (L) After culturing for 10 days the HMSC cells differentiated to adipocytes in 
the coculture. (M,N) Image of mixed multilayers of 1:1:1 RFP:GFP:Blue C3H10T1/2 cells generated 
by assembly in flow followed by deposition onto glass slides: The RFP and GFP cells represented 
ketones and the blue cells represented oxyamines. (O) Photograph of a 2 cm × 2 cm × 0.5 cm thick 
collagen tissue containing RFP-ketone and GFP-oxyamine cells. Spheroids of RFP and GFP cells were 
generated in flow and then mixed with collagen. (P) Confocal top and side views of coculture cells in 
collagen. High cell density within collagen was achieved by the adhesion of large spheroids. The cells 
adhere to thecollagen and to each other, therefore generating high cell density thick tissue instantly. 
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bio-orthogonal molecules on their cell surfaces mixed with collagen hydrogel to form a 3D 
tissue. Since the cells are interconnected with oxime chemistry and are also bound to collagen, it 
is possible to achieve a high cell density and rapidly fill the ECM scaffold.   
 Three dimensional co-cultures are excellent models to study various biological processes such 
as cell, migration apoptosis as well as differentiation of stem cells. Using our bio-orthogonal 
technology in conjunction with microfluidics we generated mixed co-cultures of human 
mesenchymal stem cells with Swiss 3T3 fibroblasts (Figure 6.8).  
 
 
 
 
The hMSC cells were mixed with the fibroblasts in 1:1 ratio and the tissues were induced to 
differentiate into adipocytes, osteoblasts or fibroblasts by treatment with corresponding induction 
Figure 6.8. Construction of a 3D tissue coculture system via intercell click ligation and 
application to stem cell differentiation. (A−C) Coculture system of hMSCs/fibroblasts were 
assembled and then made to differentiate to adipocytes (A), fibroblasts (B), and osteocytes (C) via 
corresponding induction conditions.  Adipocytes, fibroblasts, and osteoblasts were stained red, 
green, and blue, respectively. Images were taken by 20× phase contrast microscopy. 
Corresponding gene makers (LPL for adipocytes, Collagen I for fibroblasts, ALPL for osteoblasts) 
were studied over 2 weeks. (1, day one; 2, 2 weeks) and are represented by the gels as shown in 
D, E, and F, respectively. 
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agents for 2 weeks. The samples were analyzed with reverse transcription PCR on day 1 and 
week 2 to characterize the expression of the lineage-specific genetic markers. An 
immunohistochemical analysis was also performed to characterize the lineage specification. This 
demonstration shows the utility of our technology to produce 3D co-cultures containing various 
cell types that can be used to study important biological processes such as stem cell 
differentiation. 
 
6.5 Conclusion 
In summary, we have developed a quick and simple method to rewire cell surfaces with bio-
orthogonal chemistry and to ligate cells into co-culture spheroids in flow via a fast click reaction 
between oxyamine and ketone moieties. The bio-orthogonal ligation reaction is quick, specific 
and occurs under physiological conditions. The oxime bond is stable, resilient to hydrolysis and 
its formation requires no catalyst. Lipids with bio-orthogonal moieties were synthesized, 
incorporated into liposomes and delivered onto cell surfaces via liposome fusion producing cells 
with engineered cell surfaces. Liposome delivery strategy is a well established method to 
transport molecular cargo inside cells, therefore it is possible to use our technology to 
simultaneously rewire cell surfaces with the molecule of interest and to deliver cargo such as 
DNA, RNA or a small molecule into a cell. Our cell surface engineering method allows for the 
decoration of cell membranes with a wide variety of molecules and nanoscale objects such as 
metal nanoparticles and fluorescent polymer beads changing properties of cells without 
modifying their DNA. Multiple cell chemistries can be incorporated into the cellular membrane 
simultaneously. Microfluidics allows for precise and rapid assembly of spheroids. Since the bio-
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orthogonal cell ligation strategy is compatible with a wide variety of cells, it is possible to 
generate 3D co-cultures containing two or more cell types. The precision of microfluidic 
technology enables the deposition of cells on top of each other forming complex multilayered 
tissues of variable thickness. Although no scaffolds are required for cell assembly, our method is 
compatible for use with biological and polymer materials and can be used in conjunction with 
modern layer-by-layer deposition methods such as electrospinning and 3D printing.31-34 The 
microfluidic tissue assembly method is a versatile platform that can be used to generate 3D 
tissues for transplantation, drug testing and disease modeling.   
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Conclusion and Future Work 
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In this work I have developed a new scaffold-free method to assemble cells into 
functional 3D tissues. This unique system combines bio-orthogonal click chemistry, 
microencapsulation, liposome fusion and cell surface engineering strategies.  This novel 
technique uses no scaffolds or exogenous polymers to support the cell mass.  The system exploits 
a simple ligation reaction between oxyamine and ketone moieties resulting in the formation of a 
stable covalent oxime bond. The reaction is quick, specific, non-cytotoxic and occurs under 
physiological conditions. Lipids containing oxyamine and ketone functionalities were 
synthesized and incorporated into liposomes for delivery onto cell surfaces. Liposomal vesicles 
are used routinely to transfer molecular cargo inside cells and many modern therapies utilize 
liposomes for targeted drug delivery.1 With our technique liposomes were used to engineer cell 
membranes for the first time. Traditional cell surface modification strategies have relied on the 
genetic expression of receptor proteins or on metabolic engineering to tether cells to the 
molecule of interest. Both approaches utilize cellular biochemical pathways which are altered 
during the process.2,3 Liposome delivery, however, works from the outside and does not disrupt 
the cellular machinery. Although genetic engineering enables changes in properties of the cell 
membranes via the expression of different surface proteins, the method cannot be used to install 
non-biological ligands such as small molecules, fluorescent beads or nanoparticles.  
Liposome fusion alone or in conjunction with bio-orthogonal chemistry opens the door 
for new possibilities in cell surface engineering. Using a simple synthetic chemistry, a 
hydrophobic lipid tail can be attached to a molecule or a nanoscale object, which will allow it to 
be incorporated into a liposome.4 Following membrane fusion, the molecule or the object will be 
displayed on the cell surface. Cells with rewired membranes can be used for a variety of 
applications such as fluorescent labeling, cell sorting and tissue engineering.  
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Bio-orthogonal chemistry combined with a liposomal delivery system allows for the  
assembly of cells into 3D tissues. Several cell types were combined to produce functional cardiac 
and liver tissues with variable thickness and layer orientations which were subsequently used to 
assess drug toxicity. In the future studies these tissues can be transplanted into animal models for 
treatment of conditions such as liver cirrhosis and ischemic heart disease.5,6 Since our system 
does not employ polymer scaffolds, high cell density can be achieved, which is crucial for cells 
to establish intercellular connections and promote cell-cell communications in the tissue. In 
addition , employing our scaffold-free technology will significantly lower the risk of 
immunological response due to the accumulation of immunologically active byproducts which 
occurs in the process of scaffold degradation.   
3D co-culture systems are powerful tools for in vitro modelling and are employed for 
studying complex biological systems involving interactions between cells from more than one 
cell type. These interactions take place in important biological processes such as stem cell 
differentiation, embryonic development and the maturation of lymphocytes. In this work, a 
complex multilayered co-culture system of hMSC and C3H10T1/2 cells was established and it 
was demonstrated that the change of cell orientation in the 3D co-culture has an impact on the 
choice of lineage. In other words, the same cells cultured under the same conditions differentiate 
into different tissues depending on whether they are positioned on the top or the bottom of the 
3D co-culture. Our technology is flexible and enables formation of customized co-culture 
systems which allows for the modelling of different biological processes.  
A future project in which our click chemistry system can be used is in the creation of a 
model of the blood-brain barrier – a highly-selective semipermeable membrane that separates the 
central nervous system from the circulating blood. The blood-brain barrier is formed by a single 
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layer of endothelial cells which are connected by tight junctions. It is permeable to water and gas 
molecules which can cross it via diffusion, and is impermeable to other lipophilic molecules 
including most drugs.7,8 Overcoming the blood-brain barrier, however, is essential for efficient 
drug delivery. With our technology, it is possible to simulate the blood-brain barrier by creating 
a multilayer 3D co-culture of neural cells with endothelial cells. The model can be used to screen 
the potential drug candidates for their ability to cross the barrier. If successful, the project can 
lead to the creation of a brain-on-a-chip screening platform.  
The bio-orthogonal oxyamine crosslinker is a simple molecule that was used to crosslink 
ketone-tethered cells resulting in a complex polymer where the monomer subunits are cells. This 
hybrid polymer-cell system opens new opportunities for polymer modifications and the 
construction of more complex tissues which would incorporate a wide variety of ligands. Such 
tissues may also include ketone-tethered nanoparticles, fluorescent beads, or biological 
molecules such as polysaccharides and could be easily decorated with ligands for different 
purposes. 
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Appendix 
 
 
Figure A1. Control and stability studies for the formation of cell aggregates and 
multilayers. (A) Representative control images of fibroblast cells that do not form 
aggregates/spheroids when no bio-orthogonal lipids are delivered to the cell surface. (B) 
Suspension cells (Jurkat Cells) that form spheroids through the interfacial oxime click 
reaction are stable for several days without the use of polymer scaffolds or encapsulating 
materials. (C) Adhesive cells that form aggregates in solution and then deposit and 
adhere to cell culture substrate surfaces to generate multilayers. Without the interfacial 
oxime click reaction the cells would not form 3D multilayers but would only form 
standard monolayers in culture. (D) 3 colored cell lines form spheroids via the interfacial 
oxime click reaction and then form multilayers upon deposition to a cell culture substrate 
